>sp|P26439|3BH2_HUMAN 3 beta-hydroxysteroid dehydrogenase/delta 5-->4-isomerase type II 
GWSCLVTGAGGLLGQRIVRLLVEEKELKEIRALDKAFRPELREEFSKLQNRTKLTVLEGD
ILDEPFLKRACQDVSVVIHTACIIDVFGVTHRESIMNVNVKGTQLLLEACVQASVPVFIY
TSSIEVAGPNSYKEIIQNGHEEEPLENTWPTPYPYSKKLAEKAVLAANGWNLKNGDTLYT
CALRPTYIYGEGGPFLSASINEALNNNGILSSVGKFSTVNPVYVGNVAWAHILALRALRD
PKKAPSVRGQFYYISDDTPHQSYDNLNYILSKEFGLRLDSRWSLPLTLMYWIGFLLEVVS
FLLSPIYSYQPPFNRHTVTLSNSVFTFSYKKAQRDLAYKPLYSWEEAKQKTVEWVGSLVD
RHKETLKSKTQ
>sp|P14893|3BHS_BOVIN 3 beta-hydroxysteroid dehydrogenase/delta 5-->4-isomerase (3Beta-HSD) 
AGWSCLVTGGGGFLGQRIICLLVEEKDLQEIRVLDKVFRPEVREEFSKLQSKIKLTLLEG
DILDEQCLKGACQGTSVVIHTASVIDVRNAVPRETIMNVNVKGTQLLLEACVQASVPVFI
HTSTIEVAGPNSYREIIQDGREEEHHESAWSSPYPYSKKLAEKAVLGANGWALKNGGTLY
TCALRPMYIYGEGSPFLSAYMHGALNNNGILTNHCKFSRVNPVYVGNVAWAHILALRALR
DPKKVPNIQGQFYYISDDTPHQSYDDLNYTLSKEWGFCLDSRMSLPISLQYWLAFLLEIV
SFLLSPIYKYNPCFNRHLVTLSNSVFTFSYKKAQRDLGYEPLYTWEEAKQKTKEWIGSLV
KQHKETLKTKIH
>sp|Q07011|TNR9_HUMAN Tumor necrosis factor receptor superfamily member 9 precursor (4-1BB 
MGNSCYNIVATLLLVLNFERTRSLQDPCSNCPAGTFCDNNRNQICSPCPPNSFSSAGGQR
TCDICRQCKGVFRTRKECSSTSNAECDCTPGFHCLGAGCSMCEQDCKQGQELTKKGCKDC
CFGTFNDQKRGICRPWTNCSLDGKSVLVNGTKERDVVCGPSPADLSPGASSVTPPAPARE
PGHSPQIISFFLALTSTALLFLLFFLTLRFSVVKRGRKKLLYIFKQPFMRPVQTTQEEDG
CSCRFPEEEEGGCEL
>sp|P41273|TNF9_HUMAN 4-1BB ligand (4-1BBL). 
MEYASDASLDPEAPWPPAPRARACRVLPWALVAGLLLLLLLAAACAVFLACPWAVSGARA
SPGSAASPRLREGPELSPDDPAGLLDLRQGMFAQLVAQNVLLIDGPLSWYSDPGLAGVSL
TGGLSYKEDTKELVVAKAGVYYVFFQLELRRVVAGEGSGSVSLALHLQPLRSAAGAAALA
LTVDLPPASSEARNSAFGFQGRLLHLSAGQRLGVHLHTEARARHAWQLTQGATVLGLFRV
TPEIPAGLPSPRSE
>sp|P10852|4F2_MOUSE 4F2 cell-surface antigen heavy chain (4F2hc). 
MSQDTEVDMKDVELNELEPEKQPMNAADGAAAGEKNGLVKIKVAEDETEAGVKFTGLSKE
ELLKVAGSPGWVRTRWALLLLFWLGWLGMLAGAVVIIVRAPRCRELPVQRWWHKGALYRI
GDLQAFVGRDAGGIAGLKSHLEYLSTLKVKGLVLGPIHKNQKDEINETDLKQINPTLGSQ
EDFKDLLQSAKKKSIHIILDLTPNYQGQNAWFLPAQADIVATKMKEALSSWLQDGVDGFQ
FRDVGKLMNAPLYLAEWQNITKNLSEDRLLIAGTESSDLQQIVNILESTSDLLLTSSYLS
NSTFTGERTESLVTRFLNATGSQWCSWSVSQAGLLADFIPDHLLRLYQLLLFTLPGTPVF
SYGDELGLQGALPGQPAKAPLMPWNESSIFHIPRPVSLNMTVKGQNEDPGSLLTQFRRLS
DLRGKERSLLHGDFHALSSSPDLFSYIRHWDQNERYLVVLNFRDSGRSARLGASNLPAGI
SLPASAKLLLSTDSARQSREEDTSLKLENLSLNPYEGLLLQFPFVA
>sp|P28824|NRP1_XENLA Neuropilin-1 precursor (A5 protein) (A5 antigen). 
MLLRLLSCCCWLLCSLRSSWASRNDKCGDTIKITSPSYLTSAGYPHSYPPSQRCEWLIQA
PEHYQRIMINFNPHFDLEDRECKYDYVEVIDGDNANGQLLGKYCGKIAPSPLVSTGPSIF
IRFVSDYETPGAGFSIRYEVFKTGPECSRNFTSSNGVIKSPKYPEKYPNALECTYIIFAP
KMQEIVLEFESFELEADSNAPGGQTCRYDWLGIWDGFPGVGPHIGRYCGQNTPGRVRSFT
GILSMIFHTDSAIAKEGFFANFSVVQSNTDEDFQCKEALGMESGEIHFDQISVSSQYSMN
WSAERSRLNYVENGWTPGEDTVKEWIQVDLENLRFVSGIGTQGAISKETKKKYFVKSYKV
DISSNGEDWITLKDGNKHLVFTGNTDATDVVYRPFSKPVITRFVRLRPVTWENGISLRFE
LYGCKITDYPCSRMLGMVSGLISDSQITASSQVDRNWVPELARLVTSRSGWALPPSNTHP
YTKEWLQIDLAEEKIVRGVIIQGGKHKENKVFMRKFKIGYSNNGTEWEMIMDSSKNKPKT
FEGNTNYDTPELRTFAHITTGFIRIIPERASASGLALRLELLGCEVETPTSIPTTPEVNG
GDECEGDLANCHSGTDEGFKLTVGATGQSTETPTVEASPEEPDMTHSDLDCKFGWGSQKT
VCNWQHDISSDLKWAVLNSKTGPVQDHTGDGNFIYSEADERHEGRAARLMSPVVSSSRSA
HCLTFWYHMDGSHVGTLSIKLKYEMEEDFDQTLWTVSGNQGDQWKEARVVLHKTMKQYQV
IVEGTVGKGSAGGIAVDDIIIANHISPSQCRAPEIDDSANKIGEEDSEIDKTGSTPNYAL
NEFNESISKKPGNVLKTLDPILITIIAMSALGVLLGAICGVVLYCACWHNGMSERNLSAL
ENYNFELVDGVKLKKDKLNTQNSYSEAS
>sp|P22967|ACET_MOUSE Angiotensin-converting enzyme, testis-specific isoform precursor 
MGQGWATPGLPSFLFLLLCCGHHLLVLSQVATDHVTANQGITNQATTRSQTTTHQATIDQ
TTQIPNLETDEAKADRFVEEYDRTAQVLLNEYAEANWQYNTNITIEGSKILLEKSTEVSN
HTLKYGTRAKTFDVSNFQNSSIKRIIKKLQNLDRAVLPPKELEEYNQILLDMETTYSLSN
ICYTNGTCMPLEPDLTNMMATSRKYEELLWAWKSWRDKVGRAILPFFPKYVEFSNKIAKL
NGYTDAGDSWRSLYESDNLEQDLEKLYQELQPLYLNLHAYVRRSLHRHYGSEYINLDGPI
PAHLLGNMWAQTWSNIYDLVAPFPSAPNIDATEAMIKQGWTPRRIFKEADNFFTSLGLLP
VPPEFWNKSMLEKPTDGREVVCHPSAWDFYNGKDFRIKQCTSVNMEDLVIAHHEMGHIQY
FMQYKDLPVTFREGANPGFHEAIGDIMALSVSTPKHLYSLNLLSTEGSGYEYDINFLMKM
ALDKIAFIPFSYLIDQWRWRVFDGSITKENYNQEWWSLRLKYQGLCPPVPRSQGDFDPGS
KFHVPANVPYVRYFVSFIIQFQFHEALCRAAGHTGPLHKCDIYQSKEAGKLLADAMKLGY
SKPWPEAMKLITGQPNMSASAMMNYFKPLTEWLVTENRRHGETLGWPEYNWAPNTARAEG
STAESNRVNFLGLYLEPQQARVGQWVLLFLGVALLVATVGLAHRLYNIRNHHSLRRPHRG
PQFGSEVELRHS
>sp|P10731|AMD_BOVIN Peptidyl-glycine alpha-amidating monooxygenase precursor 
MAGFRSLLVLLLVFPSGCVGFRSPLSVFKRFKETTRSFSNECLGTTRPVIPIDSSDFALD
IRMPGVTPKQSDTYFCMSVRLPMDEEAFVIDFKPRASMDTVHHMLLFGCNMPASTGNYWF
CDEGTCTDKANILYAWARNAPPTRLPKGVGFRVGGETGSKYFVLQVHYGDISAFRDNHKD
CSGVSLHLTRLPQPLIAGMYLMMSVDTVIPPGGKVVNSDISCHYKKYPMHVFAYRVHTHH
LGKVVSGYRVRNGQWTLIGRQSPQLPQAFYPVEHPVDVSFGDILAARCVFTGEGRTEVTH
IGGTSSDEMCNLYIMYYMEAKHAVSFMTCTQNVAPDIFRTIPPEANIPIPVKSDMVMMHG
HHKETENKDKTSLLQQPKREEEGVLEQGDFYSLLSKLLGEREDVVHVHKYNPTEKAESES
DLVAEIANVVQKKDLGRSDTRESAEQERGNAILVRDRIHKFHRLVSTLRPAESRVLSLQQ
PLPGEGTWEPEHTGDFHVEEALDWPGVYLLPGQVSGVALDPQNNLVIFHRGDHVWDGNSF
DSKFVYQQRGLGPIEEDTILVIDPNNAAVLQSSGKNLFYLPHGLSIDKDGNYWVTDVALH
QVFKLDPKSKEGPLLTLGRSMQPGSDQNHFCQPTDVAVDPDTGTIYVSDGYCNSRLVQFS
PSGKFITQWGEASLESSPKPGQFRVPHSLALVPPLGQLCVADRENGRIQCFKTDTKEFVR
EIKHPSFGRNVFAISYIPGLLFAVNGKPYFEDQEPVQGFVMNFSSGEIIDVFKPVRKHFD
MPHDIAASEDGTVYVGDAHTNTVWKFTSTEKMEHRSVKKAGIEVQEIKESEAVVETKMEN
KPASSELQKIQEKQKLVKEPGSGVPAVLITTLLVIPVVVLLAIALFIRWKKSRAFGDSER
KLEASSGRVLGRLRGKGGGGLNLGNFFASRKGYSRKGFDRLSTEGSDQEKDEDASESEEE
YSAPPPAPAPSS
>sp|P16406|AMPE_MOUSE Glutamyl aminopeptidase (EC 3.4.11.7) (EAP) (Aminopeptidase A) (APA) 
MNFAEEEPSKKYCIKGKHVAIICGVVVAVGLIVGLSVGLTRSCEQDTTPAPSQPPPEAST
ALPPQDQNVCPDSEDESGEWKNFRLPDFINPVHYDLEVKALMEEDRYTGIVTISVNLSKP
TRDLWLHIRETKITKLPELRRPSGEQVPIRRCFEYKKQEYVVIQAAEDLAATSGDSVYRL
TMEFKGWLNGSLVGFYKTTYMEDGQIRSIAATDHEPTDARKSFPCFDEPNKKSTYSISII
HPKEYSALSNMPEEKSEMVDDNWKKTTFVKSVPMSTYLVCFAVHRFTAIERKSRSGKPLK
VYVQPNQKETAEYAANITQAVFDYFEDYFAMEYALPKLDKIAIPDFGTGAMENWGLVTYR
ETNLLYDPLLSASSNQQRVASVVAHELVHQWFGNTVTMDWWDDLWLNEGFASFFEFLGVN
HAEKDWQMLSQVLLEDVFPVQEDDSLMSSHPVVVTVSTPAEITSVFDGISYSKGASILRM
LQDWITPEKFQKGCQIYLKKFQFANAKTSDFWDSLQEASNLPVKEVMDTWTSQMGYPVVT
VSGRQNITQKRFLLDSKADPSQPPSELGYTWNIPVRWADNDNSRITVYNRLDKGGITLNA
NLSGDAFLKINPDHIGFYRVNYEGGTWDWIAEALSSNHTRFSAADRSSFIDDAFALARAQ
LLNYKIALNLTMYLKSEEDFLPWERVISSVSYIISMFEDDRELYPMIETYFQGQVKPVAD
LLGWQDTGSHITKLLRASILGFACKMGDREALGNASQLFDSWLKGSASIPVNLRLLVYRY
GMQNSGNEAAWNYTLEQYQKTSLAQEKEKLLYGLASVKDVKLLARYLEMLKDPNIIKTQD
VFTVIRYISYNSYGKTMAWNWIQLNWDYLVSRFTINDRYLGRIVTIAEPFNTELQLWQMQ
SFFAKYPNAGAGAKPREQVLETVKNNIEWLNVNRQSIREWFASLP
>sp|P18910|ANPA_RAT Atrial natriuretic peptide receptor A precursor (ANP-A) (ANPRA) (GC-A) 
MPGSRRVRPRLRALLLLPPLLLLRGGHASDLTVAVVLPLTNTSYPWSWARVGPAVELALA
RVKARPDLLPGWTVRMVLGSSENAAGVCSDTAAPLAAVDLKWEHSPAVFLGPGCVYSAAP
VGRFTAHWRVPLLTAGAPALGIGVKDEYALTTRTGPSHVKLGDFVTALHRRLGWEHQALV
LYADRLGDDRPCFFIVEGLYMRVRERLNITVNHQEFVEGDPDHYPKLLRAVRRKGRVIYI
CSSPDAFRNLMLLALNAGLTGEDYVFFHLDVFGQSLKSAQGLVPQKPWERGDGQDRSARQ
AFQAAKIITYKEPDNPEYLEFLKQLKLLADKKFNFTVEDGLKNIIPASFHDGLLLYVQAV
TETLAQGGTVTDGENITQRMWNRSFQGVTGYLKIDRNGDRDTDFSLWDMDPETGAFRVVL
NYNGTSQELMAVSEHKLYWPLGYPPPDVPKCGFDNEDPACNQDHFSTLEVLALVGSLSLI
SFLIVSFFIYRKMQLEKELVSELWRVRWEDLQPSSLERHLRSAGSRLTLSGRGSNYGSLL
TTEGQFQVFAKTAYYKGNLVAVKRVNRKRIELTRKVLFELKHMRDVQNEHLTRFVGACTD
PPNICILTEYCPRGSLQDILENESITLDWMFRYSLTNDIVKGMLFLHNGAICSHGNLKSS
NCVVDGRFVLKITDYGLESFRDPEPEQGHTLFAKKLWTAPELLRMASPPARGSQAGDVYS
FGIILQEIALRSGVFYVEGLDLSPKEIIERVTRGEQPPFRPSMDLQSHLEELGQLMQRCW
AEDPQERPPFQQIRLALRKFNKENSSNILDNLLSRMEQYANNLEELVEERTQAYLEEKRK
AEALLYQILPHSVAEQLKRGETVQAEAFDSVTIYFSDIVGFTALSAESTPMQVVTLLNDL
YTCFDAVIDNFDVYKVETIGDAYMVVSGLPVRNGQLHAREVARMALALLDAVRSFRIRHR
PQEQLRLRIGIHTGPVCAGVVGLKMPRYCLFGDTVNTASRMESNGEALKIHLSSETKAVL
EEFDGFELELRGDVEMKGKGKVRTYWLLGERGCSTRG
>sp|P16067|ANPB_RAT Atrial natriuretic peptide receptor B precursor (ANP-B) (ANPRB) (GC-B) 
MALPSLLLVVAALAGGVRPPGARNLTLAVVLPEHNLSYAWAWPRVGPAVALAVEALGRAL
PVDLRFVSSELDGACSEYLAPLRAVDLKLYHDPDLLLGPGCVYPAASVARFASHWHLPLL
TAGAVASGFAAKNEHYRTLVRTGPSAPKLGEFVVTLHGHFNWTARAALLYLDARTDDRPH
YFTIEGVFEALQGSNLSVQHQVYTREPGGPEQATHFIRANGRIVYICGPLEMLHEILLQA
QRENLTNGDYVFFYLDVFGESLRAGPTRATGRPWQDNRTQEQAQALREAFQTVLVITYRE
PPNPEYQEFQNRLLIRAREDFGVELAPSLMNLIAGCFYDGILLYAQVLNETIQEGGTRED
GLRIVEKMQGRRYHGVTGLVVMDKNNDRETDFVLWAMGDLESGDFQPAAHYSGAEKQIWW
TGRPIPWVKGAPPLDNPPCAFDLDDPSCDKTPLSTLAIVALGTGITFIMFGVSSFLIFRK
LMLEKELASMLWRIRWEELQFGNSDRYHKGAGSRLTLSLRGSSYGSLMTAHGKYQIFANT
GHFKGNVVAIKHVNKKRIELTRQVLFELKHMRDVQFNHLTRFIGACIDPPNICIVTEYCP
RGSLQDILENDSINLDWMFRYSLINDLVKGMAFLHNSIISSHGSLKSSNCVVDSRFVLKI
TDYGLASFRSTAEPDDSHALYAKKLWTAPELLSGNPLPTTGMQKADVYSFAIILQEIALR
SGPFYLEGLDLSPKEIVQKVRNGQRPYFRPSIDRTQLNEELVLLMERCWAQDPTERPDFG
QIKGFIRRFNKEGGTSILDNLLLRMEQYANNLEKLVEERTQAYLEEKRKAEALLYQILPH
SVAEQLKRGETVQAEAFDSVTIYFSDIVGFTALSAESTPMQVVTLLNDLYTCFDAIIDNF
DVYKVETIGDAYMVVSGLPGRNGQRHAPEIARMALALLDAVSSFRIRHRPHDQLRLRIGV
HTGPVCAGVVGLKMPRYCLFGDTVNTASRMESNGQALKIHVSSTTKDALDELGCFQLELR
GDVEMKGKGKMRTYWLLGERKGPPGLL
>sp|P17790|BASI_CHICK Basigin precursor (Blood-brain barrier HT7 antigen) (Neurothelin) 
MAAGADVPCAVLALLVLGSLAAGGDATGPVITGQYSSSADKVVLSCNISAPPTLIKGHKW
MLGDKVLKTDESDASSYISYTIEGKVEDHSGVYECIYNTNPVAKGNVSIEVEPQVVAYKK
SEHGNEGDVGVLTCKSPSYPPVDHWAWYKSGQTVPLESSAGIYNISRTGNKTELRILKLN
IEQDMGDYSCNGTNMKGSGSATVNLRVRSRLAALWPFLGIVAEVLVLVTIIFIYEKRRKP
DEVLDDDDGGSAPLKSNATNHKDKNVRQRNAN
>sp|Q02192|BCA_STRAG C protein alpha-antigen precursor. 
MFRRSKNNSYDTSQTKQRFSIKKFKFGAASVLIGLSFLGGVTQGNLNIFEESIVAASTIP
GSAATLNTSITKNIQNGNAYIDLYDVKLGKIDPLQLIVLEQGFTAKYVFRQGTKYYGDVS
QLQSTGRASLTYNIFGEDGLPHVKTDGQIDIVSVALTIYDSTTLRDKIEEVRTNANDPKW
TEESRTEVLTGLDTIKTDIDNNPKTQTDIDSKIVEVNELEKLLVLSVPDKDKYDPTGGET
TVPQGTPVSDKEITDLVKIPDGSKGVPTVVGDRPDTNVPGDHKVTVEVTYPDGTKDTVEV
TVHVTPKPVPDKDKYDPTGGETTVPQGTPVSDKEITDLVKIPDGSKGVPTVVGDRPDTNV
PGDHKVTVEVTYPDGTKDTVEVTVHVTPKPVPDKDKYDPTGGETTVPQGTPVSDKEITDL
VKIPDGSKGVPTVVGDRPDTNVPGDHKVTVEVTYPDGTKDTVEVTVHVTPKPVPDKDKYD
PTGGETTVPQGTPVSDKEITDLVKIPDGSKGVPTVVGDRPDTNVPGDHKVTVEVTYPDGT
KDTVEVTVHVTPKPVPDKDKYDPTGGETTVPQGTPVSDKEITDLVKIPDGSKGVPTVVGD
RPDTNVPGDHKVTVEVTYPDGTKDTVEVTVHVTPKPVPDKDKYDPTGGETTVPQGTPVSD
KEITDLVKIPDGSKGVPTVVGDRPDTNVPGDHKVTVEVTYPDGTKDTVEVTVHVTPKPVP
DKDKYDPTGGETTVPQGTPVSDKEITDLVKIPDGSKGVPTVVGDRPDTNVPGDHKVTVEV
TYPDGTKDTVEVTVHVTPKPVPDKDKYDPTGGETTVPQGTPVSDKEITDLVKIPDGSKGV
PTVVGDRPDTNVPGDHKVTVEVTYPDGTKDTVEVTVHVTPKPVPDKDKYDPTGGETTVPQ
GTPVSDKEITDLVKIPDGSKGVPTVVGDRPDTNVPGDHKVTVEVTYPDGTKDTVEVTVHV
TPKPVPDKDKYDPTGKAQQVNGKGNKLPATGENATPFFNVAALTIISSVGLLSVSKKKED
>sp|P19467|C114_MOUSE Cell surface antigen 114/A10 precursor. 
MKGFLLLSLSLLLVTVGSSSQASSTTSSSGGTSPPTTVQSQSPGSSSQASTTTSSSGGAS
PPTTVQSQSPGSSSQASTTTSSSGGASPPTTVQSQSPGSSSQASTTTSSSGGASPPTTVQ
SQSPGSSSQASTTTSSSGGASPPTTVQSQSPGSSSQASTTTSSSGGASPPTTVQSQSPGS
SSQVSTTTSSSGGASPPTTVQSQSPGSSSQPGPTQPSGGASSSTVPSGGSTGPSDLCNPN
PCKGTASCVKLHSKHFCLCLEGYYYNSSLSSCVKGTTFPGDISMSVSETANLEDENSVGY
QELYNSVTDFFETTFNKTDYGQTVIIKVSTAPSRSARSAMRDATKDVSVSVVNIFGADTK
ETEKSVSSAIETAIKTSGNVKDYVSINLCDHYGCVGNDSSKCQDILQCTCKPGLDRLNPQ
VPFCVAVTCSQPCNAEEKEQCLKMDNGVMDCVCMPGYQRANGNRKCEECPFGYSGMNCKD
QFQLILTIVGTIAGALILILLIAFIVSARSKNKKKDGEEQRLIEDDFHNLRLRQTGFSNL
GADNSIFPKVRTGVPSQTPNPYANQRSMPRPDY
>sp|P35329|CD22_MOUSE B-cell receptor CD22 precursor (Leu-14) (B-lymphocyte cell adhesion 
MRVHYLWLLLILGHAASAQYSSANDWTVDHPQTLFAWEGACIRIPCKYKTPLPKARLDNI
LLFQNYEFDKATKKFKGTVLYNKAEPELYPPKQRRVTFLGNSIDNCTLKIHPIRANDSGN
LGLRMTAGTERWMEPIHLNVSEKPFQPYIQMPSEIRESQSVTLTCGLNFSCFEYDILLQW
FLEDSKITSVTPSVTSITSSVTSSIKNVYTESKLTFQPKWTDHGKSVKCQVQHSSEVLSE
RTVRLDVKYTPKLEIKVNPTEVEKNNSVTMTCRVNSSNPKLRTVAVSWFKDGRPLEDQEL
EQEQQMSKLILHSVTKDMRGKYRCQASNDIGPGESEEVELTVHYAPEPSRVHIYPSPAEE
GQSVELICESLASPSATNYTWYHNRKPIPGDTQEKLRIPKVSPWHAGNYSCLAENRLGHG
KIDQEAKLDVHYAPKAVTTVIQSFTPILEGDSVTLVCRYNSSNPDVTSYRWNPQGSGSVL
KPGVLRIQKVTWDSMPVSCAACNHKCSWALPVILNVHYAPRDVKVLKVSPASEIRAGQRV
LLQCDFAESNPAEVRFFWKKNGSLVQEGRYLSFGSVSPEDSGNYNCMVNNSIGETLSQAW
NLQVLYAPRRLRVSISPGDHVMEGKKATLSCESDANPPISQYTWFDSSGQDLHSSGQKLR
LEPLEVQHTGSYRCKGTNGIGTGESPPSTLTVYYSPETIGKRVALGLGFCLTICILAIWG
MKIQKKWKQNRSQQGLQENSSGQSFFVRNKKARRTPLSEGPQSQGCYNPAMDDTVSYAIL
RFPESDMHNAGDAGTPATQAPPPNNSDSVTYSVIQKRPMGDYENVNPSCPEDESIHYSEL
VQFGAGKRPQAKEDVDYVTLKH
>sp|P15530|C79B_MOUSE B-cell antigen receptor complex associated protein beta-chain 
MATLVLSSMPCHWLLFLLLLFSGEPVPAMTSSDLPLNFQGSPCSQIWQHPRFAAKKRSSM
VKFHCYTNHSGALTWFRKRGSQQPQELVSEEGRIVQTQNGSVYTLTIQNIQYEDNGIYFC
KQKCDSANHNVTDSCGTELLVLGFSTLDQLKRRNTLKDGIILIQTLLIILFIIVPIFLLL
DKDDGKAGMEEDHTYEGLNIDQTATYEDIVTLRTGEVKWSVGEHPGQE
>sp|P55314|CO8B_RAT Complement component C8 beta chain (Fragment). 
ERGDAVQYIPAIIKSKAEPLYELVTATDFAYSSTVKQNMKKALEEFQKEVSSCRCAPCRN
NGVPILKESRCECICPVGLQGVACEVTNRKDIPIDGKWSCWSDWSPCSGGRKTRQRQCNN
PAPQRGGSPCSGPASETLNC
>sp|P08641|CAD1_CHICK Epithelial-cadherin precursor (E-cadherin) (Cadherin-1) (Liver cell 
MGRRWGSPALQRFPVLVLLLLLQVCGRRCDEAAPCQPGFAAETFSFSVPQDSVAAGRELG
RVSFAACSGRPWAVYVPTDTRFKVNGDGVVSTKRPLTLYGRKISFTIYAQDAMGKRHSAR
VTVGRHRHRRHHHNHHLQDTTPAVLTFPKHDPGFLRRQKRDWVIPPISCLENHRGPYPMR
LVQIKSNKDKESKVYYSITGQGADSPPVGIFIIERETGWLEVTEQLDREKIDRYTLLSHA
VSASGQPVEDPMEIIITVMDQNDNKPVFIKEVFVGYIEENAKPGTSVMTVNATDADDAVN
TDNGIVSYSIVSQQPPRPHPQMFTIDPAKGIISVLGTGLDRETTPNYTLIVQATDQEGKG
LSNTATAIIEVTDANDNIPIFNPTMYEGVVEENKPGTEVARLTVTDQDAPGSPAWQAVYH
IKSGNLDGAFSIITDPSTNNGILKTAKGLDYETKSRYDLVVTVENKVPLSVPITLSTASV
LVTVLDVNEPPVFVPPIKRVGVPEDLPVGQQVTSYTAQDPDRDMRQKITYRMGSDPAGWL
YIHPENGIVTATQPLDRESVHAINSTYKAIILAVDNGIPDTTGTGTLLLLLQDVNDNGPT
PEPRSFEICSRQPEKQILSIVDKDLPPHTYPFKAALEHGSSNNWTVEIRGQDELAMGLKK
ELEPGEYNIFVKLTDSQGKAQVTQVKAQVCECEGTAKNCERRSYIVGGLGVPAILGILGG
ILALLILLLLLLLFARRRKVEKEPLLPPEDDMRDNVYNYDEEGGGEEDQDYDLSQLHRGL
DARPEVIRNDVAPPLMAAPQYRPRPANPDEIGNFIDENLKAADTDPTAPPYDSLLVFDYE
GGGSEATSLSSLNSSASDQDQDYDYLNEWGNRFKKLAELYGGGEDDE
>sp|P33148|CADF_XENLA EP-cadherin precursor (C-cadherin). 
MGSTRLRNASVWLCGLLCLLQVVPSINADVSGCKPGFSSAEYIFSVNRRELERGRKLGKV
NFSDCTTRKHGLYDVGDSRFRVLPDGTVLVKRHVKLHKDTKFTISTWDARGIKHSTNIAV
ASKRHRSGEEAHSRSSKLPVLTFPETHTGLKRKKRDWVIPPIKVSENERGPFPKRLVQIK
SNKDRFNKVYYSITGQGADNPPQGVFRIEWETGWMLVTRPLDREEYDKYVLSSHAVSENG
SPVEEPMEITINVIDQNDNRPKFTQDVFRGSVREGVQPGTQVMAVSATDEDDNIDSLNGV
LSYSILKQDPEEPIPNLFTINRETGVISLIGTGLDREKFPEYTLTVQATDLEGAGLSVEG
KAIIQITDANDNAPIFDPKTYTALVPENEIGFEVQRLSVTDLDMPGTPAWQAVYKIRVNE
GGFFNITTDPESNQGILTTAKGLDFELRKQYVLQITVENAEPFSVPLPTSTATVTVTVED
VNEAPFFVPAVSRVDVSEDLSRGEKIISLVAQDPDKQQIQKLSYFIGNDPARWLTVNKDN
GIVTGNGNLDRESEYVKNNTYTVIMLVTDDGVSVGTGTGTLILHVLDVNDNGPVPSPRVF
TMCDQNPEPQVLTISDADIPPNTYPYKVSLSHGSDLTWKAELDSKGTSMLLSPTQQLKKG
DYSIYVLLSDAQNNPQLTVVNATVCSCEGKAIKCQEKLVGGFDLPIILVILGSVLALLIL
FLLLLLFLKRKKVVKEPLLLPEDDTRDNIFYYGEEGGGEEDQDYDLSQLHRGLDSRPDIM
RNDVVPTLMPAPHYRPRPSNPDEIGNFIDENLDAADNDPTAPPYDSLLVFDYEGSGSEAA
SLSSLNSSNSNDEHDYNYLSDWGSRFRKLADMYGGDDDEE
>sp|P33147|CADO_XENLA Neural-cadherin 2 precursor (N-cadherin 2). 
MCRKEPFLLPTALCILAALVLHQGPVEALGGSRLCKTGFLEDVYHASVYRSVHEGQPLLN
VKFTDCGADRRIHYETSNPTDFRIDGDGIVCASRTFDISPEQAEFLVYAQDEDTRELWHV
TVKITLRPRHVQDLHQGFHKVREIKFSTQRKHNGLQRQKRDWVIPPINVPENARGTFPQE
LVGIRSDRDKSLSLRYSVTGPGADQPPLGVFIINPISGQLSVTKPLDREQIATFHLRAHA
VDVNGNQVENPIDIVINVIDMNDNRPEFLHQIWNGTIPEGSKPGTYVMTVTAIDGDDPKQ
PNGMLRYKILSQTPASSSPNMFTINNETGDIITLAAGLDREKVQRYTLIIQATDMEGNPT
YGLSNTATAVIAVTDVNDNPPEFTAMTFYGEVPENRVDVVVANLTVTDKDQPHTPAWNAV
YRIVGGDGTGRFAIKTDANSNDGLVTVVKPIDYETKSTYILTVVAENQVELIRGIQYKPE
STATVSVTIIDVNENPYFTPNPKLIRQEEGLFAGKLLTTFSAQDPDRYMQQTIRYSKLSD
PANWLKIDPVNGFITTTAVLDRESIYVKNNMYNATFLATDSGIPPMSGTGTLQIYLLDIN
DNAPYVYPQEVEICDRPDPNAINITALDADINPNAGPFIFELPYSPMDIKKNWTVTRLSG
DHAQLSLKIGSLDYGIYNIPIQITDSGNPAMSNTSYLRVKVCSCEHGYCSTTAPIIGTGL
GTGAIIAILLCIIILLTLVLMFVVWMKRRDKERQAKQLLIDPEDDVRDNILKYDEEGGGE
EDQDYDLSQLQQPDTVEPDTIKPVGIRRMDERPIHAEPQYPIRSAAPHPGDIGDFINEGL
KAADNDPTAPPYDSLLVFDYEGSGSTAGSLSSLNSSSSGGEQDYDYLNDWGPRFKKLADM
YGGSDD
>sp|P13721|CAG1_RAT CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,6-sialyltransferase 
MIHTNLKKKFSLFILVFLLFAVICVWKKGSDYEALTLQAKEFQMPKSQEKVAMGSASQVV
FSNSKQDPKEDIPILSYHRVTAKVKPQPSFQVWDKDSTYSKLNPRLLKIWRNYLNMNKYK
VSYKGPGPGVKFSVEALRCHLRDHVNVSMIEATDFPFNTTEWEGYLPKENFRTKVGPWQR
CAVVSSAGSLKNSQLGREIDNHDAVLRFNGAPTDNFQQDVGSKTTIRLMNSQLVTTEKRF
LKDSLYTEGILIVWDPSVYHADIPKWYQKPDYNFFETYKSYRRLNPSQPFYILKPQMPWE
LWDIIQEISADLIQPNPPSSGMLGIIIMMTLCDQVDIYEFLPSKRKTDVCYYHQKFFDSA
CTMGAYDPLLFEKNMVKHLNEGTDEDIYLFGKATLSGFRNIRC
>sp|Q00973|CAG2_HUMAN Beta-1,4 N-acetylgalactosaminyltransferase (EC 2.4.1.92) ((N- 
MWLGRRALCALVLLLACASLGLLYASTRDAPGLRLPLAPWAPPQSPRRPELPDLAPEPRY
AHIPVRIKEQVVGLLAWNNCSCESSGGGLPLPFQKQVRAIDLTKAFDPAELRAASATREQ
EFQAFLSRSQSPADQLLIAPANSPLQYPLQGVEVQPLRSILVPGLSLQAASGQEVYQVNL
TASLGTWDVAGEVTGVTLTGEGQADLTLVSPGLDQLNRQLQLVTYSSRSYQTNTADTVRF
STEGHEAAFTIRIRHPPNPRLYPPGSLPQGAQYNISALVTIATKTFLRYDRLRALITSIR
RFYPTVTVVIADDSDKPERVSGPYVEHYLMPFGKGWFAGRNLAVSQVTTKYVLWVDDDFV
FTARTRLERLVDVLERTPLDLVGGAVREISGFATTYRQLLSVEPGAPGLGNCLRQRRGFH
HELVGFPGCVVTDGVVNFFLARTDKVREVGFDPRLSRVAHLEFFLDGLGSLRVGSCSDVV
VDHASKLKLPWTSRDAGAETYARYRYPGSLDESQMAKHRLLFFKHRLQCMTSQ
>sp|Q02745|CAG4_PIG CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 
MAPMRKKSTLKLLTLLVLFIFLTSFFLNYSHTVVTTAWFPKQMVIELSENFKKLMKYPYR
PCTCTRCIEEQRVSAWFDERFNRSMQPLLTAKNAHLEEDTYKWWLRLQREKQPNNLNDTI
RELFQVVPGNVDPLLEKRLVSCRRCAVVGNSGNLKESYYGPQIDSHDFVLRMNKAPTEGF
EADVGSKTTHHFVYPESFRELAQEVSMILVPFKTTDLEWVISATTTGRISHTYVPVPAKI
KVKKEKILIYHPAFIKYVFDRWLQGHGRYPSTGILSVIFSLHICDEVDLYGFGADSKGNW
HHYWENNPSAGAFRKTGVHDGDFESNVTTILASINKIRIFKGR
>sp|Q08345|DDR1_HUMAN Epithelial discoidin domain receptor 1 precursor (EC 2.7.1.112) 
MGPEALSSLLLLLLVASGDADMKGHFDPAKCRYALGMQDRTIPDSDISASSSWSDSTAAR
HSRLESSDGDGAWCPAGSVFPKEEEYLQVDLQRLHLVALVGTQGRHAGGLGKEFSRSYRL
RYSRDGRRWMGWKDRWGQEVISGNEDPEGVVLKDLGPPMVARLVRFYPRADRVMSVCLRV
ELYGCLWRDGLLSYTAPVGQTMYLSEAVYLNDSTYDGHTVGGLQYGGLGQLADGVVGLDD
FRKSQELRVWPGYDYVGWSNHSFSSGYVEMEFEFDRLRAFQAMQVHCNNMHTLGARLPGG
VECRFRRGPAMAWEGEPMRHNLGGNLGDPRARAVSVPLGGRVARFLQCRFLFAGPWLLFS
EISFISDVVNNSSPALGGTFPPAPWWPPGPPPTNFSSLELEPRGQQPVAKAEGSPTAILI
GCLVAIILLLLLIIALMLWRLHWRRLLSKAERRVLEEELTVHLSVPGDTILINNRPGPRE
PPPYQEPRPRGNPPHSAPCVPNGSALLLSNPAYRLLLATYARPPRGPGPPTPAWAKPTNT
QAYSGDYMEPEKPGAPLLPPPPQNSVPHYAEADIVTLQGVTGGNTYAVPALPPGAVGDGP
PRVDFPRSRLRFKEKLGEGQFGEVHLCEVDSPQDLVSLDFPLNVRKGHPLLVAVKILRPD
ATKNARNDFLKEVKIMSRLKDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLED
KAAEGAPGDGQAAQGPTISYPMLLHVAAQIASGMRYLATLNFVHRDLATRNCLVGENFTI
KIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEVLMLC
RAQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPPACPQGLYELMLRCWSRESEQRPPFSQ
LHRFLAEDALNTV
>sp|P35564|CALX_MOUSE Calnexin precursor. 
MEGKWLLCLLLVLGTAAVEAHDGHDDDAIDIEDDLDDVIEEVEDSKSKSDASTPPSPKVT
YKAPVPTGEVYFADSFDRGSLSGWILSKAKKDDTDDEIAKYDGKWEVDEMKETKLPGDKG
LVLMSRAKHHAISAKLNKPFLFDTKPLIVQYEVNFQNGIECGGAYVKLLSKTAELSLDQF
HDKTPYTIMFGPDKCGEDYKLHFIFRHKNPKTGVYEEKHAKRPDADLKTYFTDKKTHLYT
LILNPDNSFEILVDQSVVNSGNLLNDMTPPVNPSREIEDPEDRKPEDWDERPKIADPDAV
KPDDWDEDAPSKIPDEEATKPEGWLDDEPEYIPDPDAEKPEDWDEDMDGEWEAPQIANPK
CESAPGCGVWQRPMIDNPNYKGKWKPPMIDNPNYQGIWKPRKIPNPDFFEDLEPFKMTPF
SAIGLELWSMTSDIFFDNFIISGDRRVVDDWANDGWGLKKAADGAAEPGVVLQMLEAAEE
RPWLWVVYILTVALPVFLVILFCCSGKKQSNAMEYKKTDAPQPDVKDEEGKEEEKNKRDE
EEEEEKLEEKQKSDAEEDGVTGSQDEEDSKPKAEEDEILNRSPRNRKPRRE
>sp|Q05695|CAML_RAT Neural cell adhesion molecule L1 precursor (N-CAM L1). 
MVMMLWYVLPLLLCSPCLLIQIPDEYKGHHVLEPPVITEQSPRRLVVFPTDDISLKCEAR
GRPQVEFRWTKDGIHFKPKEELGVVVHEAPYSGSFTIEGNNSFAQRFQGIYRCYASNNLG
TAMSHEIQLVAEGAPKWPKETVKPVEVEEGESVVLPCNPPPSAAPLRIYWMNSKILHIKQ
DERVSMGQNGDLYFANVLTSDNHSDYICNAHFPGTRTIIQKEPIDLRVKPTNSMIDRKPR
LLFPTNSSSHLVALQGQSLILECIAEGFPTPTIKWLHPSDPMPTDRVIYQNHNKTLQLLN
VGEEDDGEYTCLAENSLGSARHAYYVTVEAAPYWLQKPQSHLYGPGETARLDCQVQGRPQ
PEVTWRINGMSIEKVNKDQKYRIEQGSLILSNVQPSDTMVTQCEARNQHGLLLANAYIYV
VQLPARILTKDNQTYMAVEGSTAYLLCKAFGAPVPSVQWLDEEGTTVLQDERFFPYANGH
LGIRDLQANDTGRYFCQAANDQNNVTILANLQVKEATQITQGPRSTIEKKGARVTFTCQA
SFDPSLQASITWRGDGRDLQERGDSDKYFIEDGQLVIKSLDYSDQGDYSCVASTELDEVE
SRAQLLVVGSPGPVPHLELSDRHLLKQSQVHLSWSPAEDHNSPIEKYDIEFEDKEMAPEK
WFSLGKVPGNQTSTTLKLSPYVHYTFRVTAINKYGPGEPSPVSETVVTPEAAPEKNPVDV
RGEGNETNNMVITWKPLRWMDWNAPQIQYRVQWRPLGKQETWKEQTVSDPFLVVSNTSTF
VPYEIKVQAVNNQGKGPEPQVTIGYSGEDYPQVSPELEDITIFNSSTVLVRWRPVDLAQV
KGHLRGYNVTYWWKGSQRKHSKRHVHKSHMVVPANTTSAILSGLRPYSSYHVEVQAFNGR
GLGPASEWTFSTPEGVPGHPEALHLECQSDTSLLLHWQPPLSHNGVLTGYLLSYHPLDGE
SKEQLFFNLSDPELRTHNLTNLNPDLQYRFQLQATTHQGPGEAIVREGGTMALFGKPDFG
NISVTAGENYSVVSWVPREGQCNFRFHILFKALPEGKVSPDHQPQPQYVSYNQSSYTQWD
LQPDTKYEIHLMREKVLLHHLAVKTNGTGPVRVSTTGSFASEGWFIAFVSAIILLLLILL
ILCFIKRSKGGKYSVKDKEDTQVDSEARPMKDETFGEYRSLESDNEEKAFGSSQPSLNGD
IKPLGSDDSLADYGGSVDVQFNEDGSFIGQYSGKKEKEAAGGNDSSGATSPINPAVALE
>sp|P33724|CAV1_CANFA Caveolin-1 (Vesicular integral-membrane protein VIP21). 
MSGGKYVDSEGHLYTVPIREQGNIYKPNNKAMAEEMSEKQVYDAHTKEIDLVNRDPKHLN
DDVVKIDFEDVIAEPEGTHSFDGIWKASFTTFTVTKYWFYRLLSALFGIPMALIWGIYFA
ILSFLHIWAVVPCIKSFLIEIQCISRVYSIYVHTFCDPFFEAVGKIFSNIRINMQKET
>sp|P13869|CB12_PETHY Chlorophyll A-B binding protein, chloroplast precursor (LHCI type II 
MASACASSTIAAVAFSSPSSQKNGSIVGATKASFLGGKRLRVSKFIAPVGSRSVAVSAVA
ADPDRPLWFPGSTPPEWLDGSLPGDFGFDPLGLGSDPESLKWNAQAELVHSRWAMLGAAG
IFIPEFLTKIGVLNTPSWYTAGEQEYFTDTTTLFVIELVLIGWAEGRRWADIIKPGCVNT
DPIFPNNKLTGTDVGYPGGLWFDPLGWGSGSPAKIKELRTKEIKNGRLAMLAVMGAWFQH
IYTGTGPIDNLFAHLADPGHATIFAAFSPK
>sp|P27522|CB13_LYCES Chlorophyll A-B binding protein 8, chloroplast precursor (LHCI type 
MATQALISSSSISTSAEAARQIIGSRISQSVTRKASFVVRAASTPPVKQGANRQLWFASK
QSLSYLDGRLPGDFGFDPLGLSDPEGTGGFIEPKWLAYGEVINGRFAMLGAAGAIAPEIL
GKAGLIPQETALAWFQTGVIPPAGTYNYWADNYTLFVLEMALMGFAEHRRFQDWAKPGSM
GKQYFLGLEKGLGGSGDPAYPGGPLFNPLGFGKDEKSMKELKLKEIKNGRLAMLAILGYF
IQALVTGVGPYQNLLDHLADPVNNNVLTSLKFH
>sp|P27494|CB23_TOBAC Chlorophyll A-B binding protein 36, chloroplast precursor (LHCII type 
MATSAIEQSAFAGQTALKSQNELVRKIGSFNGGRATMRRTVKSAPQSIWYGEDRPKYLGP
FSEQTPSYLTGEFPGDYGWDTAGLSADPETFARNRELEVIHCRWAMLGALGCVFPEILSK
NGVKFGEAVWFKAGSQIFSEGGLDYLGNPNLIHAQSILAVWASQVVLMGLIEGYRVGGGP
LGEGLDKIYPGGAFDPLGLADDPEAFAELKVKEIKNGRLAMFSMFGFFVQAIVTGKGPIE
NLFDHVADPVANNAWAYATNFVPGK
>sp|P24006|CB2A_PYRPY Chlorophyll A-B binding protein 1A, chloroplast precursor (LHCII type 
MATTMASCGIGSRCAFAGAQLSSVKPQNNQLLGVGGAHGEARLTMRKATGRKSVAASIDS
PWYGPDRVMYLGPFSGEPPSYLTGEFPGDYGWDTAGLSADPETFAKNRELEVIHSRWAML
GALGCVFPELLARNGVKFGEAVWFKAGAQIFSEGGLDYLGSPQLIHAQSILAIWACQVIL
MGAIEGYRVAGGPLGEVTDPIYPGGNFDPLGLADDPDAFADVKVKEIKNGRLAMFSMFGF
FVQAIVTGKGPIENLADHLADPVNNNAWAYATNFVPGK
>sp|Q08857|CD36_MOUSE Platelet glycoprotein IV (GPIV) (GPIIIB) (CD36 antigen) (PAS IV) 
GCDRNCGLIAGAVIGAVLAVFGGILMPVGDMLIEKTIKREVVLEEGTTAFKNWVKTGTTV
YRQFWIFDVQNPDDVAKNSSKIKVKQRGPYTYRVRYLAKENITQDPEDHTVSFVQPNGAI
FEPSLSVGTEDDNFTVLNLAVAAAPHIYQNSFVQVVLNSLIKKSKSSMFQTRSLKELLWG
YKDPFLSLVPYPISTTVGVFYPYNDTVDGVYKVFNGKDNISKVAIIESYKGKRNLSYWPS
YCDMINGTDAASFPPFVEKSRTLRFFSSDICRSIYAVFGSEIDLKGIPVYRFVLPANAFA
SPLQNPDNHCFCTEKVISNNCTSYGVLDIGKCKEGKPVYISLPHFLHASPDVSEPIEGLH
PNEDEHRTYLDVEPITGFTLQFAKRLQVNILVKPARKIEALKNLKRPYIVPILWLNETGT
IGDEKAEMFKTQVTGKIKLLGMVEMALLGIGVVMFVAFMISYCACKSKNGK
>sp|P04234|CD3D_HUMAN T-cell surface glycoprotein CD3 delta chain precursor (T-cell receptor 
MEHSTFLSGLVLATLLSQVSPFKIPIEELEDRVFVNCNTSITWVEGTVGTLLSDITRLDL
GKRILDPRGIYRCNGTDIYKDKESTVQVHYRMCQSCVELDPATVAGIIVTDVIATLLLAL
GVFCFAGHETGRLSGAADTQALLRNDQVYQPLRDRDDAQYSHLGGNWARNK
>sp|P22646|CD3E_MOUSE T-cell surface glycoprotein CD3 epsilon chain precursor (T-cell 
MRWNTFWGILCLSLLAVGTCQDDAENIEYKVSISGTSVELTCPLDSDENLKWEKNGQELP
QKHDKHLVLQDFSEVEDSGYYVCYTPASNKNTYLYLKARVCEYCVEVDLTAVAIIIIVDI
CITLGLLMVIYYWSKNRKAKAKPVTRGTGAGSRPRGQNKERPPPVPNPDYEPIRKGQRDL
YSGLNQRAV
>sp|P11942|CD3G_MOUSE T-cell surface glycoprotein CD3 gamma chain precursor (T-cell receptor 
MEQRKGLAGLFLVISLLQGTVAQTNKAKNLVQVDGSRGDGSVLLTCGLTDKTIKWLKDGS
IISPLNATKNTWNLGNNAKDPRGTYQCQGAKETSNPLQVYYRMCENCIELNIGTISGFIF
AEVISIFFLALGVYLIAGQDGVRQSRASDKQTLLQNEQLYQPLKDREYDQYSHLQGNQLR
KK
>sp|P29020|CD3H_MOUSE T-cell surface glycoprotein CD3 eta chain precursor (T-cell receptor 
MKWKVSVLACILHVRFPGAEAQSFGLLDPKLCYLLDGILFIYGVIITALYLRAKFSRSAE
TAANLQDPNQLYNELNLGRREEYDVLEKKRARDPEMGGKQQRRRNPQEGVYNALQKDKMA
EAYSEIGTKGERRRGKGHDGLYQDSHFQAVQFGNRREREGSELTRTLGLRARPKGESTQQ
SSQSCASVFSIPTLWSPWPPSSSSQL
>sp|P24161|CD3Z_MOUSE T-cell surface glycoprotein CD3 zeta chain precursor (T-cell receptor 
MKWKVSVLACILHVRFPGAEAQSFGLLDPKLCYLLDGILFIYGVIITALYLRAKFSRSAE
TAANLQDPNQLYNELNLGRREEYDVLEKKRARDPEMGGKQQRRRNPQEGVYNALQKDKMA
EAYSEIGTKGERRRGKGHDGLYQGLSTATKDTYDALHMQTLAPR
>sp|P06800|CD45_MOUSE Leukocyte common antigen precursor (EC 3.1.3.48) (L-CA) (Lymphocyte 
MGLWLKLLAFGFALLDTEVFVTGQTPTPSDGASLTTLTPSTLGLASTDPPSTTIATTTKQ
TCAAMFGNITVNYTYESSNQTFKADLKDVQNAKCGNEDCENVLNNLEECSQIKNISVSND
SCAPATTIDLYVPPGTDKFSLHDCTPKEKANTSICLEWKTKNLDFRKCNSDNISYVLHCE
PENNTKCIRRNTFIPERCQLDNLRAQTNYTCVAEILYRGVKLVKNVINVQTDLGIPETPK
PSCGDPAARKTLVSWPEPVSKPESASKPHGYVLCYKNNSEKCKSLPNNVTSFEVESLKPY
KYYEVSLLAYVNGKIQRNGTAEKCNFHTKADRPDKVNGMKTSRPTDNSINVTCGPPYETN
GPKTFYILVVRSGGSFVTNTTKTNCQFYGDNLYYSTDYEFLVSFHNGVYEGDSVIRSEST
NFNAKALIIFLVFLIIVTSIALLVVLYKSYDLRKKRSSNLDEQQELVERDDEKQLMDVEP
IHSDILLETYKRKIADEGRLFLAEFQSIPRVFSKFPIKDARKPHNQNKNRYVDILPYDYN
RVELSEINGDAGSTYINASYIDGFKEPRKYIAAQGPRDETVDDFWRMIWEQKATVIVMVT
RCEEGNRNKCAEYWPSMEEGTRAFKDIVVTINDHKRCPDYIIQKLNVAHKKEKATGREVT
HIQFTSWPDHGVPEDPHLLLKLRRRVNAFSNFFSGPIVVHCSAGVGRTGTYIGIDAMLEG
LEAEGKVDVYGYVVKLRRQRCLMVQVEAQYILIHQALVEYNQFGETQVNLSELHSCLHNM
KKRDPPSDPSPREAEYQRLPSYRSWRTQHIGNQGENKKKKRNSNVVPYDFNRVPLKHELE
MSKESEPESDESSDDDSDSEETSKYINASFVMSYWKPEMMIAAQGPLKETIGDFWQMIFQ
RKVKVIVMLTELVNGDQEVCAQYWGEGKQTYGDMEVEMKDTNRASAYTLRTFELRHSKRK
EPRTVYQYQCTTWKGEELPAEPKDLVSMIQDLKQKLPKASPEGMKYHKHASILVHCRDGS
QQTGLFCALFNLLESAETEDVVDVFQVVKSLRKARPGVVCSYEQYQFLYDIIASIYPAQN
GQVKKTNSQDKIEFHNEVDGGKQDANCVRPDGPLNKAQEDSRGVGTPEPTNSAEEPEHAA
NGSASPAPTQSS
>sp|P06332|CD4_MOUSE T-cell surface glycoprotein CD4 precursor (T-cell surface antigen 
MCRAISLRRLLLLLLQLSQLLAVTQGKTLVLGKEGESAELPCESSQKKITVFTWKFSDQR
KILGQHGKGVLIRGGSPSQFDRFDSKKGAWEKGSFPLIINKLKMEDSQTYICELENRKEE
VELWVFKVTFSPGTSLLQGQSLTLTLDSNSKVSNPLTECKHKKGKVVSGSKVLSMSNLRV
QDSDFWNCTVTLDQKKNWFGMTLSVLGFQSTAITAYKSEGESAEFSFPLNFAEENGWGEL
MWKAEKDSFFQPWISFSIKNKEVSVQKSTKDLKLQLKETLPLTLKIPQVSLQFAGSGNLT
LTLDKGTLHQEVNLVVMKVAQLNNTLTCEVMGPTSPKMRLTLKQENQEARVSEEQKVVQV
VAPETGLWQCLLSEGDKVKMDSRIQVLSRGVNQTVFLACVLGGSFGFLGFLGLCILCCVR
CRHQQRQAARMSQIKRLLSEKKTCQCPHRMQKSHNLI
>sp|P13379|CD5_MOUSE T-cell surface glycoprotein CD5 precursor (Lymphocyte glycoprotein Ly- 
MDSHEVLLAATYLLGTLAAFCLGQSGRGGLDIQVMLSGSNSKCQGQVEIQMENKWKTVCS
SSWRLSQDHSKNAQQASAVCKQLRCGDPLALGPFPSLNRPQNQVFCQGSPWSISNCNNTS
SQDQCLPLSLICLEPQRTTPPPTTTPPTTVPEPTAPPRLQLVPGHEGLRCTGVVEFYNGS
WGGTILYKAKDRPLGLGNLICKSLQCGSFLTHLSGTEAAGTPAPAELRDPRPLPIRWEAP
NGSCVSLQQCFQKTTAQEGGQALTVICSDFQPKVQSRLVGGSSVCEGIAEVRQRSQWEAL
CDSSAARGRGRWEELCREQQCGDLISFHTVDADKTSPGFLCAQEKLSQCYHLQKKKHCNK
RVFVTCQDPNPAGLAPGTVASIILTLVLLVVLLAMCGPLVYKKLVKKFRQKKQRQWIGPT
GVNQNMSFHRSHTATVRSQVENPTASHVDNEYSQPPRNSHLSAYPALEGALHRSSTQPDN
SSDSDYDLQVAQRL
>sp|P37217|CD69_MOUSE Early activation antigen CD69. 
MDSENCSITENSSSHLERGQKDHGTSIHFEKHHEGSIQVSIPWAVLIVVLITSLIIALIA
LNVGKYNCPGLYEKLESSDHHVATCKNEWISYKRTCYFFSTTTKSWALAQRSCSEDAATL
AVIDSEKDMTFLKRYSGELEHWIGLKNEANQTWKWANGKEFNSWFNLTGSGRCVSVNHKN
VTAVDCEANFHWVCSKPSR
>sp|P30433|CD8A_PONPY T-cell surface glycoprotein CD8 alpha chain precursor (T-lymphocyte 
MALPVTALLLPLALLLHAARPSQFRVSPLDRTWNLGETVELKCQVLLSNPTSGCSWLFQP
RGAAASPTFLLYLSQNKPKAAEGLDTQRFSGKRLGDTFVLTLSDFRRENEGYYFCSALSN
SIMYFSHFVPVFLPVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCNHRNRRRVCKC
PRPVVKSGGKPSLSERYV
>sp|P23439|CNRB_BOVIN Rod cGMP-specific 3',5'-cyclic phosphodiesterase beta-subunit 
MSLSEGQVHRFLDQNPGFADQYFGRKLSPEDVANACEDGCPEGCTSFRELCQVEESAALF
ELVQDMQENVNMERVVFKILRRLCSILHADRCSLFMYRQRNGVAELATRLFSVQPDSVLE
DCLVPPDSEIVFPLDIGVVGHVAQTKKMVNVQDVMECPHFSSFADELTDYVTRNILATPI
MNGKDVVAVIMAVNKLDGPCFTSEDEDVFLKYLNFGTLNLKIYHLSYLHNCETRRGQVLL
WSANKVFEELTDIERQFHKAFYTVRAYLNCDRYSVGLLDMTKEKEFFDVWPVLMGEAQAY
SGPRTPDGREILFYKVIDYILHGKEDIKVIPSPPADHWALASGLPTYVAESGFICNIMNA
PADEMFNFQEGPLDDSGWIVKNVLSMPIVNKKEEIVGVATFYNRKDGKPFDEQDEVLMES
LTQFLGWSVLNTDTYDKMNKLENRKDIAQDMVLYHVRCDREEIQLILPTRERLGKEPADC
EEDELGKILKEVLPGPAKFDIYEFHFSDLECTELELVKCGIQMYYELGVVRKFQIPQEVL
VRFLFSVSKGYRRITYHNWRHGFNVAQTMFTLLMTGKLKSYYTDLEAFAMVTAGLCHDID
HRGTNNLYQMKSQNPLAKLHGSSILERHHLEFGKFLLSEETLNIYQNLNRRQHEHVIHLM
DIAIIATDLALYFKKRTMFQKIVDESKNYEDRKSWVEYLSLETTRKEIVMAMMMTACDLS
AITKPWEVQSKVALLVAAEFWEQGDLERTVLDQQPIPMMDRNKAAELPKLQVGFIDFVCT
FVYKEFSRFHEEILPMFDRLQNNRKEWKALADEYEAKVKALEEDQKKETTAKKVGTEICN
GGPAPRSSTCRIL
>sp|P05502|COX1_SORBI Cytochrome c oxidase polypeptide I (EC 1.9.3.1). 
MTNLVRWLFSTNHKDIGTLYFIFGAIAGVMGTCFSVLIRMELARPGDQILGGNHQLYNVL
ITAHAFLMIFFMVMPAMIGGFGNWFVPILIGAPDMAFPRLNNISFWLLPPSLLLLLSSAL
VEVGSGTGWTVYPPLSGITSHSGGAVDLAIFSLHLSGVSSILGSINFITTIFNMRGPGMT
MHRLPLFVWSVLVTAFLLLLSLPVLAGAITMLLTDRNFNTTFFDPAGGGDPILYQHLFWF
FGHPEVYILILPGFGIISHIVSTFSRKPVFGYLGMVYAMISIGVLGFLVWAHHMFTVGLD
VDTRAYFTAATMIIAVPTGIKIFSWIATMWGGSIQYKTPMLFAVGFIFLFTIGGLTGIVL
ANSGLDIALHDTYYVVAHFHYVLSMGAVFALFAGFYYWVGKIFGRTYPETLGQIHFWITF
FGVNLTFFPMHFLGLSGMPRRIPDYPDAYAGWNALSSFGSYISVVGIRRFFVVVAITSSS
GKNKRCAESPWAVEQNPTTLEWLVQSPPAFHTFGELPTIKETQGELQTRK
>sp|P13588|COX2_EMENI Cytochrome c oxidase polypeptide II (EC 1.9.3.1). 
MFLIMLKGHILMDAPTPWGIFFQDSASPQMEGIMELHNNIMFYLAIILFTVTWMMITIIR
NFVAKKSPIAHKYMNHGTLIELIWTITPAFILILIAFPSFKLLYLMDEVMDPSLVVYAEG
HQWYWSYQYPDFTNEDNEFIEFDSYIVPESDLEEGQFRMLEVDNRVIIPELTHTAFVISA
DVIHSYACPSLGIKADAYPGRLNQASVYINGPGTFFGQCSEICGILHSSMNIAIQSVSIK
DFLLWLRDQMEG
>sp|P21592|COXX_YEAST Protoheme IX farnesyltransferase, mitochondrial precursor (EC 2.5.1.-) 
MSYFPRTYAHLMRNVLAHNKGNIYLQIGTQLHDTQIKIRFNGVRYISRNHGGKQQHINTA
PIEFTPNFGYGDRTSNCNKKVESTAMKTLRCTDDISTSSGSEATTDASTQLPFNVKLVDP
MVRKSKRPSHAISEGLNMKTLKKKVIMPYLQLTKPRLTILVMLSAICSYALSPYPASVNE
LLCLTVGTTLCSGSANAINMGREPEFDRQMVRTQARPVVRGDVTPTQAFEFAALIGTLGV
SILYFGVNPTVAILGASNIALYGWAYTSMKRKHIINTWLGALVGMVPPLMGWAAASPLSH
PGSWCLAGLLFAWQFPHFNTLSHNIRNEYKNAGYVMTAWKNPLLNARVSLRYSILMFPLC
FGLSYFNITDWYYQIDSGLINAWLTFWAFKFYWQQRINYSAKTLKDNVKFNKGLSVANIY
ARKTFMASVLHLPAILILAIIHKKGRWDWIYPGEAKRPQERF
>sp|P20816|CP42_RAT Cytochrome P450 4A2 precursor (EC 1.14.15.3) (CYPIVA2) (Lauric acid 
MGFSVFSPTRSLDGVSGFFQGAFLLSLFLVLFKAVQFYLRRQWLLKALEKFPSTPSHWLW
GHNLKDREFQQVLTWVEKFPGACLQWLSGSTARVLLYDPDYVKVVLGRSDPKPYQSLAPW
IGYGLLLLNGKKWFQHRRMLTPAFHYDILKPYVKIMADSVSIMLDKWEKLDDQDHPLEIF
HYVSLMTLDTVMKCAFSHQGSVQLDVNSRSYTKAVEDLNNLIFFRVRSAFYGNSIIYNMS
SDGRLSRRACQIAHEHTDGVIKTRKAQLQNEEELQKARKKRHLDFLDILLFAKMEDGKSL
SDEDLRAEVDTFMFEGHDTTASGISWVFYALATHPEHQERCREEVQSILGDGTSVTWDHL
DQMPYTTMCIKEALRLYSPVPSVSRELSSPVTFPDGRSIPKGIRVTILIYGLHHNPSYWP
NPKVFDPSRFSPDSPRHSHAYLPFSGGARNCIGKQFAMNELKVAVALTLLRFELLPDPTR
IPVPMPRLVLKSKNGIHLRLKKLR
>sp|Q05047|CP72_CATRO Cytochrome P450 72A1 (EC 1.14.14.1) (CYPLXXII) (Secologanin synthase) 
MEMDMDTIRKAIAATIFALVMAWAWRVLDWAWFTPKRIEKRLRQQGFRGNPYRFLVGDVK
ESGKMHQEALSKPMEFNNDIVPRLMPHINHTINTYGRNSFTWMGRIPRIHVMEPELIKEV
LTHSSKYQKNFDVHNPLVKFLLTGVGSFEGAKWSKHRRIISPAFTLEKLKSMLPAFAICY
HDMLTKWEKIAEKQGSHEVDIFPTFDVLTSDVISKVAFGSTYEEGGKIFRLLKELMDLTI
DCMRDVYIPGWSYLPTKRNKRMKEINKEITDMLRFIINKRMKALKAGEPGEDDLLGVLLE
SNIQEIQKQGNKKDGGMSINDVIEECKLFYFAGQETTGVLLTWTTILLSKHPEWQERARE
EVLQAFGKNKPEFERLNHLKYVSMILYEVLRLYPPVIDLTKIVHKDTKLGSYTIPAGTQV
MLPTVMLHREKSIWGEDAMEFNPMRFVDGVANATKNNVTYLPFSWGPRVCLGQNFALLQA
KLGLAMILQRFKFDVAPSYVHAPFTILTVQPQFGSHVIYKKLES
>sp|Q05555|CPAA_RABIT Cytochrome P450 2A10 (EC 1.14.14.1) (CYPIIA10) (P450-IIA10). 
MLASGLLLAALLACLTVMILLSVWRQRKLWGKLPPGPTPLPFIGNYLQLNTEQMYDSLMK
ISERYGPVFTIHLGPRRIVVLCGQEAVKEALVDQAEDFSGRGELATFDWLFKGYGVVFSS
WERARPLRRFAISTLRDFGVGKRGIEERIQEEAGFLIEAFRDTRGAFIDPTFFLSRTVSN
VISSIVFGDRFDYEDKEFLSLLRMMLGSFQFTATPTGQLYEMFYSVMKHLPGPQQQAFKE
LEGLRDFIAKKVERNQRTLDPNSPRDFIDSFLIRMQEEKKDPKSEFHMKNLVMTTLNLFF
AGTETVSTTMRYGFLLLMKHPDVEAKVHEEIDRVIGRNRQPKFEDRAKMPYTEAVIHEIQ
RFTDMIPMGLAHRVTRDTKFRDFLLPKGAEVFPMLGSVLKDPKFFSKPREFYPQHFLDEK
GQFKKSDAFMPFSVGKRYCLGEGLARMELFLFFTTIMQNFRFRSQQAPQDIDVSPKHVGF
ATIPRTYTMSFVPR
>sp|Q05556|CPAB_RABIT Cytochrome P450 2A11 (EC 1.14.14.1) (CYPIIA11) (P450-IIA11). 
MLASGLLLAALLACLTVMILLSVWRQRKLWGKLPPGPTPLPFIGNYLQLNTEQMYDSLMK
IRDRYGPVFTIHLGPRRIVVLCGQEAVKEALVDQAEDFSGRGEQATFDWLFKGYGVAFST
WERARPLRRFAISTLRDFGVGKRGIEERIQEEAGFLIEAFRDTRGAFIDPTFFLSRTVSN
VISSIVFGDRFDYEDKEFLSLLRMMLGSFQFTATPTGQLYEMFYSVMKHLPGPQQQAFKE
LEGLRDFIAKKVERNQRTLDPNSPRDFIDSFLIRMQEEKKDPKSEFHMKNLVLTTLNLFF
AGTETVSTTMRYGFLLLMKHPDVEAKVHEEIDRVIGRNRQPKFEDRAKMPYTEAVIHEIQ
RFTDMIPMGLARRVTRDTKFRDFLLPKGTEVFPMLGSVLKDPKFFSKPREFYPQHFLDEK
GQFKKSDAFMPFSVGKRYCLGEGLARMELFLFFTTIMQNFRFRSQQAPQDIDVSPKHVGF
ATIPRTYTMSFVPR
>sp|P00176|CPB1_RAT Cytochrome P450 2B1 (EC 1.14.14.1) (CYPIIB1) (P450-B) (P450-PB1 and 
MEPTILLLLALLVGFLLLLVRGHPKSRGNFPPGPRPLPLLGNLLQLDRGGLLNSFMQLRE
KYGDVFTVHLGPRPVVMLCGTDTIKEALVGQAEDFSGRGTIAVIEPIFKEYGVIFANGER
WKALRRFSLATMRDFGMGKRSVEERIQEEAQCLVEELRKSQGAPLDPTFLFQCITANIIC
SIVFGERFDYTDRQFLRLLELFYRTFSLLSSFSSQVFEFFSGFLKYFPGAHRQISKNLQE
ILDYIGHIVEKHRATLDPSAPRDFIDTYLLRMEKEKSNHHTEFHHENLMISLLSLFFAGT
ETSSTTLRYGFLLMLKYPHVAEKVQKEIDQVIGSHRLPTLDDRSKMPYTDAVIHEIQRFS
DLVPIGVPHRVTKDTMFRGYLLPKNTEVYPILSSALHDPQYFDHPDSFNPEHFLDANGAL
KKSEAFMPFSTGKRICLGEGIARNELFLFFTTILQNFSVSSHLAPKDIDLTPKESGIGKI
PPTYQICFSAR
>sp|P12789|CPB5_RABIT Cytochrome P450 2B5 (EC 1.14.14.1) (CYPIIB5) (P450 type B2) (P450 form 
MEFSLLLLLAFLAGLLLLLFRGHPKAHGRLPPGPPPLPVLGNLLQMDRKGLLRSFLRLRE
KYGDVFTVYLGSRPVVVLCGTDAIREALVDQAEAFSGRGKIAVVDPIFQGYGVFFANGEH
WRALRRFSLATMRDFGMGKRSVEERIQEEARCLVEELRKSKGALLDNTLLFHSVTSNIIC
SIVFGKRFDYKDPVFLRLLDLFFQSFSLISSFSSQVFELFPGFLKHFPGTHRQIYRNLQE
INTFIGQTVEKHRATLDPSNPRDFIDVYLLRMEKDKSDPSSEFHHRNLILTVLTLFFAGT
ETTSTTLRYGFLLMLKYPHVTERVQKEIEQVIGSHRPPALDDRAKMPYTDAVIHEIQRLG
DLVPFGAPHMVTKDTQFRGYVIPKNTEVFPVLSSALHDPRYFETPNTFNPGHFLDADGAL
KRNEGFMPFSLGKRICLGEGIARTELFLFFTTILQNFSIASPVPPEDIDLTPRESGVGNV
PPSYQIRFLAR
>sp|P33272|CPBC_RAT Cytochrome P450 2B12 (EC 1.14.14.1) (CYPIIB12). 
MEFGVLLLLTLTVGFLLFLVSQSQPKTHGHLPPGPRPLPFLGNLLQMNRRGFLNSFMQLQ
EKYGDVFTVHLGPRPVVILCGTDTIREALVDQAEAFSGRGTVAVLHPVVQGYGVIFATGE
RWKTLRRFSLVTMKEFGMGKRSVDERIKEEAQCLVEELKKYKGAPLNPTFLFQSIAANTI
CSIVFGERFDYKDHQFLHLLDLVYKTSVLMGSLSSQVFELYSGFLKYFPGAHKQIFKNLQ
EMLNYIGHIVEKHRATLDPSAPRDFIDTYLLRMEKEKSNHHTEFNHQNLVISVLSLFFAG
TETTSTTLRCTFLIMLKYPHVAEKVQKEIDQVIGSHRLPTPDDRTKMPYTDAVIHEIQRF
ADLTPIGLPHRVTKDTVFRGYLLPKNTEVYPILSSALHDPRYFEQPDTFNPEHFLDANGA
LKKSEAFLPFSTGKRICLGEGIARNELFIFFTAILQNFTLASPVAPEDIDLTPINIGVGK
IPSPYQINFLSR
>sp|P05179|CPC7_RAT Cytochrome P450 2C7 (EC 1.14.14.1) (CYPIIC7) (P450F) (PTF1). 
MDLVTFLVLTLSSLILLSLWRQSSRRRKLPPGPTPLPIIGNFLQIDVKNISQSLTKFSKT
YGPVFTLYLGSQPTVILHGYEAIKEALIDNGEKFSGRGSYPMNENVTKGFGIVFSNGNRW
KEMRRFTIMNFRNLGIGKRNIEDRVQEEAQCLVEELRKTKGSPCDPSLILNCAPCNVICS
ITFQNHFDYKDKEMLTFMEKVNENLKIMSSPWMQVCNSFPSLIDYFPGTHHKIAKNINYM
KSYLLKKIEEHQESLDVTNPRDFVDYYLIKQKQANNIEQSEYSHENLTCSIMDLIGAGTE
TMSTTLRYALLLLMKYPHVTAKVQEEIDRVIGRHRSPCMQDRKHMPYTDAMIHEVQRFIN
FVPTNLPHAVTCDIKFRNYLIPKGTKVLTSLTSVLHDSKEFPNPEMFDPGHFLDENGNFK
KSDYFLPFSAGKRACVGEGLARMQLFLFLTTILQNFNLKSLVHPKDIDTMPVLNGFASLP
PTYQLCFIPS
>sp|P08683|CPCB_RAT Cytochrome P450 2C11 (EC 1.14.14.1) (CYPIIC11) (P-450(M-1)) (P450H) 
MDPVLVLVLTLSSLLLLSLWRQSFGRGKLPPGPTPLPIIGNTLQIYMKDIGQSIKKFSKV
YGPIFTLYLGMKPFVVLHGYEAVKEALVDLGEEFSGRGSFPVSERVNKGLGVIFSNGMQW
KEIRRFSIMTLRTFGMGKRTIEDRIQEEAQCLVEELRKSKGAPFDPTFILGCAPCNVICS
IIFQNRFDYKDPTFLNLMHRFNENFRLFSSPWLQVCNTFPAIIDYFPGSHNQVLKNFFYI
KNYVLEKVKEHQESLDKDNPRDFIDCFLNKMEQEKHNPQSEFTLESLVATVTDMFGAGTE
TTSTTLRYGLLLLLKHVDVTAKVQEEIERVIGRNRSPCMKDRSQMPYTDAVVHEIQRYID
LVPTNLPHLVTRDIKFRNYFIPKGTNVIVSLSSILHDDKEFPNPEKFDPGHFLDERGNFK
KSDYFMPFSAGKRICAGEALARTELFLFFTTILQNFNLKSLVDVKDIDTTPAISGFGHLP
PFYEACFIPVQRADSLSSHL
>sp|P11510|CPCC_RAT Cytochrome P450 2C12, female-specific (EC 1.14.14.1) (CYPIIC12) 
MDPFVVLVLSLSFLLLLYLWRPSPGRGKLPPGPTPLPIFGNFLQIDMKDIRQSISNFSKT
YGPVFTLYFGSQPTVVLHGYEAVKEALIDYGEEFSGRGRMPVFEKATKGLGISFSRGNVW
RATRHFTVNTLRSLGMGKRTIEIKVQEEAEWLVMELKKTKGSPCDPKFIIGCAPCNVICS
IIFQNRFDYKDKDFLSLIENVNEYIKIVSTPAFQVFNAFPILLDYCPGNHKTHSKHFAAI
KSYLLKKIKEHEESLDVSNPRDFIDYFLIQRCQENGNQQMNYTQEHLAILVTNLFIGGTE
TSSLTLRFALLLLMKYPHITDKVQEEIGQVIGRHRSPCMLDRIHMPYTNAMIHEVQRYID
LAPNGLLHEVTCDTKFRDYFIPKGTAVLTSLTSVLHARKEFPNPEMFDPGHFLDENGNFK
KSDYFMPFSAGKRKCVGEGLASMELFLFLTTILQNFKLKSLSDPKDIDINSIRSEFSSIP
PTFQLCFIPV
>sp|P33263|CPCQ_MESAU Cytochrome P450 2C26 (EC 1.14.14.1) (CYPIIC26) (P450 HSM2). 
MDAFVVLVFILSCLFLLSLWRQSSERGKLPPGPTPLPIIGNFLQIDVKDISGSLTNFSKV
YGPVFTLYLGMKPTVVLHGYEAVKEALIDHGEEFAGRGSFPVAERVNKGLGIVFSNGSRW
KETRRFSLMTLRNLGMGKRSIEDRVQEEAQCLVEELRKTNGSPCDPTFILGCAPCNVICS
IIFQNRFDYKDKDFLTFMKKLNENARILSSPWFQVCNNFPLLIDYCPGSHHRITKNINYI
RSYLSEKMKEHQESLDVANPRDFIDYYLIKLKQGNYNQQSEFSPENLATTVSDLFAAGTE
TTSTTLRYALLLLLKHPHVTAKVQEEIDQVVGRHRNPCMQDRSHMPYTDAMIHEVQRFID
LIPTNLPHAVTCDIKFRDYFIPKGTTIITSLSSVLHDSKEFPNPEVFDPGHFLDKNGNFK
KSDYFMPFSTGKRMCAGEGLARMELFLFLTTILQNFKLKSLVHPKDIDTTPVLNGFASLP
PSYQLCFIPV
>sp|P33265|CPCS_MESAU Cytochrome P450 2C28 (EC 1.14.14.1) (CYPIIC28) (P450 HSM4). 
MDPVLVLVLTLSCLLLFSVWRQSSGRGRLPPGPTPLPLIGNILQIDIKDISKSLANFSKV
YGPVFTLYFGTKPTVVVHGYEAVKEALEDLGEEFSGRGNFPIVERMNSGLGIIFSNGTKW
KELRRFSLMTLRNFGMGKRSIEDCIQEEARCLVEELRKTNGSPCDPTFFLSCAPSNVICS
VVFHNRFDYNDKNFLNLMEKLNENFEILNSPWLQVCNVIPAFLDYLPGSHNKALKNFAEI
KSYILKRVKEHQETLDMNNPRDFIDCFLIKMEKEKDNPHSEFTTESLMATVADVFVAGSE
TTSTTLRYGLLLLLKHKEVTAKVQKEIDHVIGRDRSPCMQDRTRMPYTDAMVHEVQRYVN
LIPNNVPHAATCNVKFRNYVIPKGTDLITSLTSVLHDDKEFPNPKIFDPAHFLDENGNFK
KSDYFMPFSIGKRMCMGEALARMELFLLLTTILQNFDLKSLADTKDIDTTPVASTFGCVP
PSYQLYFIPR
>sp|Q05421|CPE1_MOUSE Cytochrome P450 2E1 (EC 1.14.14.1) (CYPIIE1) (P450-J) (P450-ALC). 
MAVLGITVALLVWIATLLLVSIWKQIYRSWNLPPGPFPIPFFGNIFQLDLKDIPKSLTKL
AKRFGPVFTLHLGQRRIVVLHGYKAVKEVLLNHKNEFSGRGDIPVFQEYKNKGIIFNNGP
TWKDVRRFSLSILRDWGMGKQGNEARIQREAHFLVEELKKTKGQPFDPTFLIGCAPCNVI
ADILFNKRFDYDDKKCLELMSLFNENFYLLSTPWIQAYNYFSDYLQYLPGSHRKVMKNVS
EIRQYTLGKAKEHLKSLDINCPRDVTDCLLIEMEKEKHSQEPMYTMENISVTLADLFFAG
TETTSTTLRYGLLILMKYPEIEEKLHEEIDRVIGPSRAPAVRDRMNMPYMDAVVHEIQRF
INLVPSNLPHEATRDTVFRGYVIPKGTVVIPTLDSLLFDNYEFPDPETFKPEHFLNENGK
FKYSDYFKAFSAGKRVCVGEGLARMELFLLLSAILQHFNLKSLVDPKDIDLSPVTIGFGS
IPREFKLCVIPRS
>sp|P19070|CR2_MOUSE Complement receptor type 2 precursor (Cr2) (Complement C3d receptor). 
MLTWFLFYFSEISCDPPPEVKNARKPYYSLPIVPGTVLRYTCSPSYRLIGEKAIFCISEN
QVHATWDKAPPICESVNKTISCSDPIVPGGFMNKGSKAPFRHGDSVTFTCKANFTMKGSK
TVWCQANEMWGPTALPVCESDFPLECPSLPTIHNGHHTGQHVDQFVAGLSVTYSCEPGYL
LTGKKTIKCLSSGDWDGVIPTCKEAQCEHPGKFPNGQVKEPLSLQVGTTVYFSCNEGYQL
QGQPSSQCVIVEQKAIWTKKPVCKEILCPPPPPVRNGSHTGSFSENVPYGSTVTYTCDPS
PEKGVSFTLIGEKTINCTTGSQKTGIWSGPAPYCVLSTSAVLCLQPKIKRGQILSILKDS
YSYNDTVAFSCEPGFTLKGNRSIRCNAHGTWEPPVPVCEKGCQAPPKIINGQKEDSYLLN
FDPGTSIRYSCDPGYLLVGEDTIHCTPEGKWTPITPQCTVAECKPVGPHLFKRPQNQFIR
TAVNSSCDEGFQLSESAYQLCQGTIPWFIEIRLCKEITCPPPPVIHNGTHTWSSSEDVPY
GTVVTYMCYPGPEEGVKFKLIGEQTIHCTSDSRGRGSWSSPAPLCKLSLPAVQCTDVHVE
NGVKLTDNKAPYFYNDSVMFKCDDGYILSGSSQIRCKANNTWDPEKPLCKKEGCEPMRVH
GLPDDSHIKLVKRTCQNGYQLTGYTYEKCQNAENGTWFKKIEVCTVILCQPPPKIANGGH
TGMMAKHFLYGNEVSYECDEGFYLLGEKSLQCVNDSKGHGSWSGPPPQCLQSSPLTHCPD
PEVKHGYKLNKTHSAFSHNDIVHFVCNQGFIMNGSHLIRCHTNNTWLPGVPTCIRKASLG
CQSPSTIPNGNHTGGSIARFPPGMSVMYSCYQGFLMAGEARLICTHEGTWSQPPPFCKEV
NCSFPEDTNGIQKGFQPGKTYRFGATVTLECEDGYTLEGSPQSQCQDDSQWNPPLALCKY
RRWSTIPLICGISVGSALIILMSVGFCMILKHRESNYYTKTRPKEGALHLETREVYSIDP
YNPAS
>sp|P08198|CSG_HALHA Cell surface glycoprotein precursor (CSG). 
MTDTTGKLRAVLLTALMVGSVIGAGVAFTGGAAAANASDLNDYQRFNENTNYTYSTASED
GKTEGSVASGATIFQGEEDVTFRKLDNEKEVSPATLSRTGGSDEGVPLQMPIPEDQSTGS
YDSNGPDNDEADFGVTVQSPSVTMLEVRNNADNDVTGGVLNTQQDEFSIAVDYNYYAAED
LELTVEDEDGLDVTDEILAADQSGGAYEDGTGNNGPNTLRFDIDPNNVDAGDYTVSVEGV
EDLDFGDATESASVTISSSNKASLNLAEDEVVQGANLKYTIENSPEGNYHAVTIDSSDFR
DSSSGADAAKVMRSVGDTVDTGLVVDNDSTTEIVDDYENTSISDVDYAYAIVEIDDGNGV
GSIETQYLDDSSADIDLYPASDTEDAPDYVNSNEELTNGSALDGVSTDDDTDFDVTQGDI
TLDNPTGAYVVGSEVDINGTANEGTDDVVLYARDNNDFELVTVDGEKSIEVDSDDTFEEE
DITLSDGDKGGDDILGLPGTYRLGIIAKSDAVNSSGGVKDNIDTSDFNQGVSSTSSIRVT
DTELTASFETYNGQVADDDNQIDVEGTAPGKDNVAAIIIGSRGKVKFQSISVDSDDTFDE
EDIDISELRQGSASAHILSSGRDGKFGEDTANSISDLEDEVGNYTSGPPTGDQIRDRILS
NTVDDTASDDLIVTQQFRLVDGLTTIEATEGGEAGGSVTVMGTTNRKADDNTITVELLQG
DASIEINSTDEWNSDGQWSVDVPLSNVEPGNYTVEADDGDNTDRQNVEIVEELEEPDQTT
VDQPENNQTMTTTMTETTTETTTEMTTTQENTTENGSEGTSDGESGGSIPGFGVGVALVA
VLGAALLALRQN
>sp|P09793|CTL4_MOUSE Cytotoxic T-lymphocyte protein 4 precursor (Cytotoxic T-lymphocyte- 
MACLGLRRYKAQLQLPSRTWPFVALLTLLFIPVFSEAIQVTQPSVVLASSHGVASFPCEY
SPSHNTDEVRVTVLRQTNDQMTEVCATTFTEKNTVGFLDYPFCSGTFNESRVNLTIQGLR
AVDTGLYLCKVELMYPPPYFVGMGNGTQIYVIDPEPCPDSDFLLWILVAVSLGLFFYSFL
VSAVSLSKMLKKRSPLTTGVYVKMPPTEPECEKQFQPYFIPIN
>sp|Q03101|CYAG_DICDI Adenylate cyclase, germination specific (EC 4.6.1.1) (ATP 
MKKTFVKILSKSYVEGYPVGFFIGLIILAIFGSMVCIFSFMHYSEEENSNIQMDLERSSK
QIIHNIQMNAMYLLSSIDTLKALYYVNPNFDRNDFNVFLNTTLKNSEFQYLFWIKKINNN
DRNCFEEKFSKEIKDTFQIYSFDENTNSIHVAKNKSSYFPILHAFPDINKDIIGLDINST
DYMNETIKKSIFNKKPTVHLNKKVLLSKRNIDILIVSPIIVTKTLESTNETMEDMSHISS
GLFLMEKNVQASRIEVENGNDFTIFLSTTNGEIVYQENYLNFKTLYQVHESGLFEDRLKY
ESSLKIADCVLKLWIFTTEEYENNSKTYLPLLVSIISAVILVLLITYSVDQRKQKSLIAK
IMREKNNLINKILPLEVSVKLENGEDVVAERSNNACVFFLDIAGFTRFSSIHSPEQVIQV
LIKIFNSMDLLCAKHGIEKIKTIGDAYMATCGIFPKCDDIRHNTYKMLGFAMDVLEFIPK
EMSFHLGLQVRVGIHCGPVISGVISGYAKPHFDVWGDTVNVASRMESTGIAGQIHVSDRV
YQLGKEDFNFSERCDIIHVKGKGRMKTWYLMGKKSSDFSLKKDFSRSRVQPSLFNRKQSH
VHCIYPEFPSGLQALNIENNLNNTDAGCENCSKILKKTYAYSPDHSTSNYYYHGDDNSPP
PPSLNSNDLIDGSEYHDDPFPSDSNVGYHDTSKDIKEDENEQNETLLFNQEQLKKKQIEN
IQRDLSLNDSIEAIKILNNNNNNNINDNNINNTNFNNNNNDININNSDNVNNYENNNNFS
DKIENNDGDNNNINDNNYKSTNENNIKSKTLFKDSKSLINDIKMAKENCDNNDDNNNNNN
NNNNNNNNDENVESKKNK
>sp|P00169|CYB5_RABIT Cytochrome b5. 
AAQSDKDVKYYTLEEIKKHNHSKSTWLILHHKVYDLTKFLEEHPGGEEVLREQAGGDATE
NFEDVGHSTDARELSKTFIIGELHPDDRSKLSKPMETLITTVDSNSSWWTNWVIPAISAL
IVALMYRLYMADD
>sp|P11528|CYGR_ARBPU Resact receptor precursor (Guanylate cyclase) (EC 4.6.1.2). 
MATTRLLFLLVVAVMITMVRSATLHYNPTVINLDRGRPKLHIGMLTSWTNADNSQGTGFP
SAGAFPLAIQYANNDMDILHGYDINFEWVDTHCDINLGMAAISDWWKRGFLGVIGPGCGC
TYEGRLASALNFPMIDYACDENPVSNKEFYPTFLRTIPPSIQVVDSILLTLDMYDWNQVT
VVVENITKYRNVFNTMKEQFDMREEWEILHEEYYAGFDPWDPDAAEPFTDIIQRTKKTTR
IYVFFGDSGDLRQFAISALDVGILNSGDYAIVGAVIDLEIRDSQDYHSLEYTLEASDYLE
QINQAYEQMFKLREYTRTDDERALEAMKSVLIVTGEPVLRSQAWHIYSAIVIDNALDEPF
NGTLELKTDIDMASVYIFDATTELLKALDATLQAGGDMYDGSQVVSNLFNTSYRSKAKAD
YQFDENGDGVKSYVLLHRIPIPVGDGGMPPGSPGMYPIGTFVRAESGHWSFNKDPDLNPV
WHNRDDPPLDMPVCGFHGELCTNWGLYLGTLIPAFIIIFGGGLGYYIYRKRAYEAALDSL
VWKVDWKEVQTRESETNSQGFSMKSMVLSAISVISNAEKQQIFATIGTYRGTICAIHAVH
KNHIDLTRAVRTELKLMRDMRHDNICPFIGACIDRPHICILMHYCAKGSLQDIMENDDIK
LDSMFLASLIADLVKGLVYLHSSEIKSHGHLKSSNCVVDNRWVLQITDYGLHEFRKGQKE
DVDLGEHAKLARKLWTAPEHLREGKSMHPGGTPKGDIYSFSIILTEMYSRQEPFHENDLE
LADIIARVSKGEVPPYRPVLNAVNEAAPDCVLTAIRACWVEDPMERPNIIEVRTMLAPLQ
KGLKPNILDNMIAIMERYTNNLEELVDERTQELQKEKAKTEQLLHRMLPPSIASQLIKGI
SVLPETFDMVSIFFSDIVGFLIHFSLSSCRLFCSSQVLPLLVPWLHSLLTLPLHLPLIWM
NPLISSFAQPSWSALHSHSCSALHSS
>sp|P16065|CYGS_STRPU Speract receptor precursor (Guanylate cyclase) (EC 4.6.1.2). 
MAHARHLFLFMVAFTITMVIARLDFNPTIINEDRGRTKIHVGLLAEWTTADGDQGTLGFP
ALGALPLAISLANQDSNILNGFDVQFEWVDTHCDINIGMHAVSDWWKRGFVGVIGPGCGC
TYEGRLASALNIPMIDYVCDENPVSDKSIYPTFLRTIPPSIQVVEAIILTLQRYELDQVS
VVVENITKYRNIFNTMKDKFDERDYEILHEEYYAGFDPWDYEMDDPFSEIIQRTKETTRI
YVFFGDASDLRQFAMTALDEGILDSGDYVILGAVVDLEVRDSQDYHSLDYILDTSEYLNQ
INPDYARLFKNREYTRSDNDRALEALKSVIIVTGAPVLKTRNWDRFSTFVIDNALDAPFN
GELELRAEIDFASVYMFDATMQLLEALDRTHAAGGDIYDGEEVVSTLLNSTYRSKTDTFY
QFDENGDGVKPYVLLHLIPIPKGDGGATKDSLGMYPIGTFNRENGQWGFEEALDEDANVL
KPVWHNRDEPPLDMPPCGFHGELCTNWALYLGASIPTFLIIFGGLIGFFIYRKRAYEAAL
DSLVWKVDWSEVQTKATDTNSQGFSMKNMVMSAISVISNAEKQQIFATIGTYRGTVCALH
AVHKNHIDLTRAVRTELKIMRDMRHDNICPFIGACIDRPHISILMHYCAKGSLQDILEND
DIKLDSMFLSSLIADLVKGIVYLHSSEIKSHGHLKSSNCVVDNRWVLQITDYGLNEFKKG
QKQDVDLGDHAKLARQLWTSPEHLRQEGSMPTAGSPQGDIYSFAIILTELYSRQEPFHEN
EMDLADIIGRVKSGEVPPYRPILNAVNAAAPDCVLSAIRACWPEDPADRPNIMAVRTMLA
PLQKGLKPNILDNMIAIMERYTNNLEELVDERTQELQKEKTKTEQLLHRMLPPSIASQLI
KGIAVLPETFEMVSIFFSDIVGFTALSAASTPIQVVNLLNDLYTLFDAIISNYDVYKVET
IGDAYMLVSGLPLRNGDRHAGQIASTAHHLLESVKGFIVPHKPEVFLKLRIGIHSGSCVA
GVVGLTMPRYCLFGDTVNTASRMESNGLALRIHVSPWCKQVLDKLGGYELEDRGLVPMNG
KGEIHTFWLLGQDPSYKITKVKPPPQKLTQEAIEIAANRVIPDDV
>sp|P40321|CYRG_CANFA Cytokine receptor common gamma chain precursor (Gamma-C) 
MLKPPLPLRSLLFLQLSLLGVGLNSTVPMPNGNEDITPDFFLTATPSETLSVSSLPLPEV
QCFVFNVEYMNCTWNSSSEPRPTNLTLHYWYKNSNDDKVQECGHYLFSREVTAGCWLQKE
EIHLYETFVVQLRDPREPRRQSTQKLKLQNLVIPWAPENLTLHNLSESQLELSWSNRHLD
HCLEHVVQYRSDWDRSWTEQSVDHRNSFSLPSVDGQKFYTFRVRSRYNPLCGSAQRWSEW
SHPIHWGSNTSKENPLFASEAVLIPLGSMGLIISLICVYYWLERSIPRIPTLKNLEDLVT
EYHGNFSAWSGVSKGLAESLQPDYSEWLCHVSEIPPKGGAPGEGPGGSPCSQHSPYWAPP
CYTLKPETGALIP
>sp|P39653|DEXT_STRDO Dextranase precursor (EC 3.2.1.11) (Alpha-1,6-glucan-6- 
MNNRMLSFPSMLFLLAFGIVLSVSAGTTHADELANQTAKVADEASIVVSTSQAAVEQTQS
QEKEISPAMEEDTSNLSLKPNAQQESQSPDSSTELQDPAEQTPPETSDASAPATTSADSV
EKYAQDATQNQSSTSNGPGVIRATSAQVTATRSVVSSQSGDAIVDLSADKASYRQGEDVN
LSVDFKNTTDKEQDVTVYADVYYIDNKLGTYKFSKHLKAGEGYKMQSGDLKIPASQFENN
HGYLLKVRVRDADNNTLSEVNKAIAVESDWTKFPRYGIVGGSQDTNNSLLSKDADRYRAE
IEKMKNMNINSYFFYDVYKTATNPFPSDEATFKQDWNTWSGSEIDTQAVKDIVNQVHDGG
AVAMLYNMILAENTNTGEAPVLPETEYAYNSDDRGYGAQGQPMSYTVKIPKDGQEEDVEI
QRYYNPTSKLWQDYIADKMGQAMKNGGFDGWQGDTIGDNEVYSYADKDSNDPSKKFWLTE
GYAEFLRAIKEKLPNYYLTVNDVNGEQIYRLKDGNQDVIYNEIWPFGPALPSEMAAVKPN
TVTSRPVLTKVRQGDWKISIVGAYMEGSENGGSKADAEAGKSLQTDAVLLTSASIAAAGG
YHMSLAALANQQDETDGGQGIGVLQTAYYPTQSLKTSSELTRKNNDYQQFITAYENVLRD
GVENDDAQVNTFDSNGQKLSTDAKGITGNQVWTYGKKGDNFRTVQLLNLMGINSDWKNED
GSAANKTPDEQTNLTVKYALGDVSMEDAQRMANQTYVTSPDDWSKSNLQKVSASVKTDEN
GKPVLVINVPKLTLWDVVYISNANQESAPEADQAQTPAAQSSDDKVAENETSQPAAEDAK
EQTSEPAQDQAAPAEQGQAINQAESPATEPEAEVTPATAEPAKVDAPEANQAADQAVSPE
PASQEQAASQSQPEANQTPASNETPATQGNSEQPELNEPTAQTQPSSQVSPANTSVTPVA
EQPTNQGQAADKADQAPTNSTSTPESTSPVEPAATDQSSDTPIVTAGNLSVQPAETETPT
VPDKQGDSKANQSSTETPVADQVPAVAEQPQATEPNQAKPSVDKAAAPEALSLIQLKQQT
PAIQAKEADDPEVDETKSEVTPDSGTDKAPEAGQVDSDKAPTVKPSTPENNDNQPNNAND
ADKNKTNEADSNKANQDSTKGSSADQSGKSTTPEDGPDNSSPEDPETKPSDPNTDTSDQE
QVKPSLPVVPNQTVDDPKTDDTDTPANTDSAKSKKVADADKNKVATDSEGRQKSSEFPKE
ATDLEKVGQPASPQVAGVKSSVATSPEKKSEPVSKTSTTSSSDKLPKTGDHKTVVLIIVL
GLVFVGMTGLLARHEKK
>sp|P33560|DIP_ANTMA Probable tonoplast intrinsic protein DIP. 
MVKIAFGSIGDSFSVASIKAYVAEFIATLLFVFAGVGSAIAYNKLTSDAALDPAGLVAVA
VAHAFALFVGVSMAANVSGGHLNPAVTLGLAVGGNITILTGLFYWIAQCLGSTVACLLLK
FVTNGLSVPTHGVAAGMDAIQGVVMEIIITFALVYTVYATAADPKKGSLGVIAPIAIGFI
VGANILAAGPFSGGSMNPARSFGPAVASGDFSQNWIYWAGPLIGGALAGFIYGDVFITAH
APLPTSEDYA
>sp|P15101|DOPO_BOVIN Dopamine beta-monooxygenase precursor (EC 1.14.17.1) (Dopamine beta- 
MQVPSPSVREAASMYGTAVAVFLVILVAALQGSAPAESPFPFHIPLDPEGTLELSWNISY
AQETIYFQLLVRELKAGVLFGMSDRGELENADLVVLWTDRDGAYFGDAWSDQKGQVHLDS
QQDYQLLRAQRTPEGLYLLFKRPFGTCDPNDYLIEDGTVHLVYGFLEEPLRSLESINTSG
LHTGLQRVQLLKPSIPKPALPADTCTMEIRAPDVLIPGQQTTYWCYVTELPDGFPRHHIV
MYEPIVTEGNEALVHHMEVFQCAAEFRDHPHFSGPCDSKMKPQRLNFCRHVLAAWALGAK
AFYYPEEAGLAFGGPGSSRFLRLEVHYHNPLVITGRRDSSGIRLYYTAALRRFDAGIMEL
GLAYTPVMAIPPQETAFVLTGYCTDKCTQLALPASGIHIFASQLHTHLTGRKVVTVLARD
GRETEIVNRDNHYSPHFQEIRMLKKVVSVQPGDVLITSCTYNTEDRRLATVGGFGILEEM
CVNYVHYYPQTQLELCKSAVDPGFLHKYFRLVNRFNSEEVCTCPQASVPEQFASVPWNSF
NREVLKALYGFAPISMHCNRSSAVRFQGEWNRQPLPEIVSRLEEPTPQCPASQAQSPAGP
TVLNISGGKG
>sp|P15133|E310_ADE02 Early E3B 10.4 kDa protein precursor. 
MIPRVLILLTLVALFCACSTLAAVAHIEVDCIPPFTVYLLYGFVTLILICSLVTVVIAFI
QFIDWVCVRIAYLRHHPQYRDRTIADLLRIL
>sp|P15140|E3GL_ADE35 Early E3 18.5 kDa glycoprotein precursor (GP19K). 
MGPILVLLVLLSLLEPGSANYDPCLDFDPENCTLTFAPDTSRICGVLIKCGWECRSVEIT
HNNKTWNNTLSTTWEPGVPEWYTVSVRGPDGSIRISNNTFIFSEMCDLAMFMSKQYSLWP
PSKDNIVTFSIAYCLCACLLTALLCVCIHLLVTTRIKNANNKEKMP
>sp|P16573|ECTO_RAT Ecto-ATPase precursor (Cell-CAM 105) (C-CAM 105) (ATP-dependent 
MELASARLLRGQIPWRGLLLTASLLTYWSPLTTAQVTVDAVPPNVVEESSVLLLTHNLPQ
EFQVFYWYKVTTTGLNSEIARYIRSSNTSQTEPAYSGRVTIYSNGSLFFQNVNKTDEGPY
TLSVIDKQFNPIQTSVQFRVYPALQKPNVTGNNSNPMEGEPFVSLMCEPYTNNTSYLWSR
NGESLSEGDRVTFSEGNRTLTLLNVRRTDKGYYECEARNPATFNRSDPFNLDVIYGPDAP
VISPPDIYLHQGSNLNLSCHADSNPPAQYFWLINEKLQTSSQELFISNITTNNSGTYACF
VNNTVTGLSRTTVKNITVFEPVTQPSIQITNTTVKELGSVTLTCFSKDTGVSVRWLFNSQ
SLQLTDRMTLSQDNSTLRIDPIKREDAGDYQCEISNPVSFRISHPIKLDVIPDPTQGNSG
LSEGAIAGIVIGSVAGVALIAALAYFLYSRKTGGGSDHRDLTEHKPSTSSHNLGPSDDSP
NKVDDVSYSVLNFNAQQSKRPTSASSSPTETVYSVVKKK
>sp|P41047|FASL_MOUSE FAS antigen ligand. 
MQQPMNYPCPQIFWVDSSATSSWAPPGSVFPCPSCGPRGPDQRRPPPPPPPVSPLPPPSQ
PLPLPPLTPLKKKDHNTNLWLPVVFFMVLVALVGMGLGMYQLFHLQKELAELREFTNQSL
KVSSFEKQIANPSTPSEKKEPRSVAHLTGNPHSRSIPLEWEDTYGTALISGVKYKKGGLV
INETGLYFVYSKVYFRGQSCNNQPLNHKVYMRNSKYPEDLVLMEEKRLNYCTTGQIWAHS
SYLGAVFNLTSADHLYVNISQLSLINFEESKTFFGLYKL
>sp|P20693|FCE2_MOUSE Low affinity immunoglobulin epsilon FC receptor (Lymphocyte IGE 
MEENEYSGYWEPPRKRCCCARRGTQLMLVGLLSTAMWAGLLALLLLWHWETEKNLKQLGD
TAIQNVSHVTKDLQKFQSNQLAQKSQVVQMSQNLQELQAEQKQMKAQDSRLSQNLTGLQE
DLRNAQSQNSKLSQNLNRLQDDLVNIKSLGLNEKRTASDSLEKLQEEVAKLWIEILISKG
TACNICPKNWLHFQQKCYYFGKGSKQWIQARFACSDLQGRLVSIHSQKEQDFLMQHINKK
DSWIGLQDLNMEGEFVWSDGSPVGYSNWNPGEPNNGGQGEDCVMMRGSGQWNDAFCRSYL
DAWVCEQLATCEISAPLASVTPTRPTPKSEP
>sp|P20491|FCEG_MOUSE High affinity immunoglobulin epsilon receptor gamma-subunit precursor 
MISAVILFLLLLVEQAAALGEPQLCYILDAVLFLYGIVLTLLYCRLKIQVRKAAIASREK
ADAVYTGLNTRSQETYETLKHEKPPQ
>sp|P31995|FCGC_HUMAN Low affinity immunoglobulin gamma Fc region receptor II-C precursor 
MGILSFLPVLATESDWADCKSPQPWGHMLLWTAVLFLAPVAGTPAAPPKAVLKLEPQWIN
VLQEDSVTLTCRGTHSPESDSIQWFHNGNLIPTHTQPSYRFKANNNDSGEYTCQTGQTSL
SDPVHLTVLSEWLVLQTPHLEFQEGETIVLRCHSWKDKPLVKVTFFQNGKSKKFSRSDPN
FSIPQANHSHSGDYHCTGNIGYTLYSSKPVTITVQAPSSSPMGIIVAVVTGIAVAAIVAA
VVALIYCRKKRISANSTDPVKAAQFEPPGRQMIAIRKRQPEETNNDYETADGGYMTLNPR
APTDDDKNIYLTLPPNDHVNSNN
>sp|Q02769|FDFT_RAT Farnesyl-diphosphate farnesyltransferase (EC 2.5.1.21) (Squalene 
MEFVKCLGHPEEFYNLLRFRMGGRRNFIPKMDRNSLSNSLKTCYKYLDQTSRSFAAVIQA
LDGDIRHAVCVFYLILRAMDTVEDDMAISVEKKIPLLRNFHTFLYEPEWRFTESKEKHRV
VLEDFPTISLEFRNLAEKYQTVIADICHRMGCGMAEFLNKDVTSKQDWDKYCHYVAGLVG
IGLSRLFSASEFEDPIVGEDTECANSMGLFLQKTNIIRDYLEDQQEGRQFWPQEVWGKYV
KKLEDFVKPENVDVAVKCLNELITNALQHIPDVITYLSRLRNQSVFNFCAIPQVMAIATL
AACYNNHQVFKGVVKIRKGQAVTLMMDATNMPAVKAIIYQYIEEIYHRVPNSDPSASKAK
QLISNIRTQSLPNCQLISRSHYSPIYLSFIMLLAALSWQYLSTLSQVTEDYVQREH
>sp|Q04954|FLIF_CAUCR Flagellar M-ring protein. 
MLGVGAGVVAVLVALVMFMGKEPSELLYSNLDLKEASEVTQALDQAGIKYETKGDGSTIM
VPRDKVASARLMVAGKGLVSSGSIGYEIFDTNNALGQTDFVQQLNRQRALQGELERTIKA
MQGVNSVRVHLVLPKRQLFEEDAEQPSAAVTIGVGSREPSSDMVRAIQNLVSSSVPNMKA
EKVAVIDQHGKTLSAPSDESLAGKMAQDRKSEVEARIAKTVKDMIEGVLGPGKARVNVTA
ELDLNRVTTQEERFDPDGQVIRSESTTEASSQENKNDDNAGVTAAANVPGGQGANGFQQL
GSRTGQNDAVTNYEISKSVTTTVQEPGTIKKIAVAVAIDGVSAPMAADGKPGAYTPRTAQ
EIQQIEELVKTAVGFDAERGDQVRVTNIKFPQPEDQGLEEQGLLAGFDKNDIMRAAELGV
LAVVALLILLFAVRPFIKNLSAPAPGQIALAGPSGGPPVTRLVTLADGTQQQVVVDQSGE
PIALAGPPVSDIDQRIDIAKIEGQVKASSIKRVSEFVEKHPDESVAILRNWLHEST
>sp|P33133|FLIP_ECOLI Flagellar biosynthetic protein fliP precursor. 
MRRLLSVAPVLLWLITPLAFAQLPGITSQPLPGGGQSWSLPVQTLVFITSLTFIPAILLM
MTSFTRIIIVFGLLRNALGTPSAPPNQVLLGLALFLTFFIMSPVIDKIYVDAYQPFSEEK
ISMQEALEKGAQPLREFMLRQTREADLGLFARLANTGPLQGPEAVPMRILLPAYVTSELK
TAFQIGFTIFIPFLIIDLVIASVLMALGMMMVPPATIALPFKLMLFVLVDGWQLLVGSLA
QSFYS
>sp|P36888|FLT3_HUMAN FL cytokine receptor precursor (EC 2.7.1.112) (Tyrosine-protein kinase 
MPALARDAGTVPLLVVFSAMIFGTITNQDLPVIKCVLINHKNNDSSVGKSSSYPMVSESP
EDLGCALRPQSSGTVYEAAAVEVDVSASITLQVLVDAPGNISCLWVFKHSSLNCQPHFDL
QNRGVVSMVILKMTETQAGEYLLFIQSEATNYTILFTVSIRNTLLYTLRRPYFRKMENQD
ALVCISESVPEPIVEWVLCDSQGESCKEESPAVVKKEEKVLHELFGTDIRCCARNELGRE
CTRLFTIDLNQTPQTTLPQLFLKVGEPLWIRCKAVHVNHGFGLTWELENKALEEGNYFEM
STYSTNRTMIRILFAFVSSVARNDTGYYTCSSSKHPSQSALVTIVGKGFINATNSSEDYE
IDQYEEFCFSVRFKAYPQIRCTWTFSRKSFPCEQKGLDNGYSISKFCNHKHQPGEYIFHA
ENDDAQFTKMFTLNIRRKPQVLAEASASQASCFSDGYPLPSWTWKKCSDKSPNCTEEITE
GVWNRKANRKVFGQWVSSSTLNMSEAIKGFLVKCCAYNSLGTSCETILLNSPGPFPFIQD
NISFYATIGVCLLFIVVLTLLICHKYKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYD
LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMS
ELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFHRTWTEIFKE
HNFSFYPTFQSHPNSSMPGSREVQIHPDSDQISGLHGNSFHSEDEIEYENQKRLEEEEDL
NVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS
NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYK
LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEAMYQNVDG
RVSECPHTYQNRRPFSREMDLGLLSPQAQVEDS
>sp|P35917|VGR3_MOUSE Vascular endothelial growth factor receptor 3 precursor (EC 2.7.1.112) 
MQPGAALNLRLWLCLGLLQGLANGYSMTPPTLNITEDSYVIDTGDSLSISCRGQHPLEWT
WPGAQEVLTTGGKDSEDTRVVHDCEGTEARPYCKVLLLAQTHANNTGSYHCYYKYIKARI
EGTTAASTYVFVRDFKHPFINKPDTLLVNRKDSMWVPCLVSIPGLNITLRSQSSALHPDG
QEVLWDDRRGMRVPTQLLRDALYLQCETTWGDQNFLSNLFVVHITGNELYDIQLYPKKSM
ELLVGEKLVLNCTVWAEFDSGVTFDWDYPGKQAERAKWVPERRSQQTHTELSSILTIHNV
SQNDLGPYVCEANNGIQRFRESTEVIVHEKPFISVEWLKGPVLEATAGDELVKLPVKLAA
YPPPEFQWYKDRKAVTGRHNPHALVLKEVTEASAGVYTLALWNSAAGLRQNISLELVVNV
PPHIHEKEASSPSIYSRHSRQTLTCTAYGVPQPLSVQWHWRPWTPCKTFAQRSLRRRQQR
DGMPQCRDWKEVTTQDAVNPIESLDSWTEFVEGKNKTVSKLVIQDANVSAMYKCVVVNKV
GQDERLIYFYVTTIPDGFSIESEPSEDPLEGQSVRLSCRADNYTYEHLRWYRLNLSTLHD
AQGNPLLLDCKNVHLFATPLEANLEEAEPGARHATLSLNIPRVAPEDEGDYVCEVQDRRS
QDKHCHKKYLSVQALEAPRLTQNLTDLLVNVSDSLEMRCPVAGAHVPSIVWYKDERLLEK
ESGIDLADSNQRLSIQRVREEDAGRYLCSVCNAKGCVNSSASVAVEGSEDKGSMEIVILI
GTGVIAVFFWVLLLLIFCNMKRPAHADIKTGYLSIIMDPGEVPLEEQCEYLSYDASQWEF
PRERLHLGRVLGHGAFGKVVEASAFGINKGSSCDTVAVKMLKEGATASEHRALMSELKIL
IHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRVKRDTFNPYAEKSPEQRRRF
RAMVEGAKADRRRPGSSDRALFTRFLMGKGSARRAPLVQEAEDLWLSPLTMEDLVCYSFQ
VARGMEFLASRKCIHRDLAARNILLSESDIVKICDFGLARDIYKDPDYVRKGSARLPLKW
MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPELA
TPAIRHIMQSCWSGDPKARPAFSDLVEILGDLLQGGGWQEEEEERMALHSSQSSEEDGFM
QASTTALHITEADADDSPPSMHCHSLAARYYNCVSFPGRLARGTKTPGSSRMKTFEELPM
TPTTYKASMDNQTDSGMVLASEEFEELESRHRPEGSFSCKGPGQHMDIPRGHPDPQGRRR
RPTQGAQGGKVFYNNEYGEVSQPCTEGDCCPSAGSTFFADSSY
>sp|P18477|FM1_ACTVI Fimbrial subunit type 1 precursor. 
MHSLNTRRGLGLAAAMTLAAGALVAPTGAAAPADPNGSTIDPDAATTLTVHKCEQTDTNG
VKEGTGNEDPQAECKPVSDVEFTITKLNVDLTTYDGWKTLADLKGDVVKAGALKSTTVQK
ITTGANGLASFTDAQTEVGAYLVSETRTPDKVIPAEDFVVTLPMTNPQDTAKWNYNVHVY
PKNTLSGVDKQVTDKPAPGSGRDITYTITTSIPKVDYPGGARIKRYEVVDRLDKRIKKEA
LTPVVKIVGQNEVTLAETTDYTLITAEGKDHNWATIQLTEEGRRKASEARYNGNGETKLQ
VTLNAKFDAAVNLEGDLSNTAGLIPNDSPNFTWDPNNPGTTTDIPGIPTTPVLSKYGKVV
LTKTGTDDLADKTKYNGAQFQVYECTKTASGATLRDSDPSTQTVDPLTIGGEKTFTTAGQ
GTVEINYLRANDYVNGAKKDQLTDEDYYCLVETKAPEGYNLQADPLPFRVLAEKAEKKAA
TEVTVTDIPKNAGFRLPLTGANGVIFLTIAGALLVAGGAVVAYANKRRHVAKH
>sp|P36367|FMO4_RABIT Dimethylaniline monooxygenase [N-oxide forming] 4 (EC 1.14.13.8) 
AKKVAVIGAGVSGLTSIKCCLDEDLEPTCFERSNDIGGLWKYTETSKDGMTRIYWSLVTN
VCKEMSCYSDFPFQEDYPNFMSHSKFWNYLQEFAEHFDLLKYIQFKTTVCSVTKRPDFSK
TGQWDVVTETEGKQHRAVFDAVMVCTGKFLNPRLPLESFPGILKFRGQILHCQEYKIPEG
FRGQRVLVIGLGNSGGDVAVELSRVAAQVLLSTRTGTWVISRSSNGGYPFNMMITRRCLN
VIEQVLPSCFLRWINERQMNKRFNHENYGLSITKGKNPKFIVNDELPTCILCGTVTVKTS
VKEFTETSAIFEDGTVEENIDSVIFTTGYVFSFPFLEEPLRSLCMKKMFLYKHVFPSNLE
RASMAIIGLISLKGSILTGTELQARWATRVFKGLCKIPPPQQLMAEVTKKEELIKRGVIK
DTSEEKLSYIPYMDDLAACIGTKPNIPLLFLKDPRLAWEVFFGPCTPYQYRLMGPGKWDG
ARNAILTQWDRTLKPLKTRTVSSDSSKSASLSHYLKVWGAPLLLASVLLICKSSHFLKSV
RDKLQNRIFPYLVL
>sp|P23377|FURI_RAT Furin precursor (EC 3.4.21.75) (Paired basic amino acid residue 
MELRPWLLWVVAAAGALVLLAAEARGQKIFTNTWAVHISGGPAVADSVARKHGFHNLGQI
FGDYYHFWHRAVTKRSLSPHRPRHSRLQRVPQVKWLEQQVAKQRAKRDVYQEPTDPKFPQ
QWYLSGVTQRDLNVKEAWAQGFTGRGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDP
DPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSL
GLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREH
DSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKC
TESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKV
SHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIEILAEPKDIGKRLEVRKTVTACLGEPNH
ISRLEHVQARLTLSYNRRGDLAIHLISPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWD
EDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASEGLSAPPESSGCKTLTSSQACVVCE
EGFSLHQKSCVQRCPPGFTPQVLDTHYSTENDVEIIRASVCTPCHASCATCQGPAPTDCL
SCPSHASLDPVEQTCSRQSQSSRESRPQQPPPALRPEVEVEPRLRAGLASHLPEVLAGLS
CLIIALIFGIVFLFLHRCSGFSFRGVKVYTMDRGLISYKGLPPEAWQEECPSDSEEDEGR
GERTAFIKDQSAL
>sp|P30430|FURC_DROME Furin-like protease 1, isoforms 1-CRR/2 precursor (EC 3.4.21.75) 
MKNDVVRWSRQPTSNTTNSSSSSRSDSNSTHKHRSKSNKLNARQLGSNAARSCQQRSSVA
TTLEDEQQTIIECDIGNFNFDCNLFKTSFLTQHKQKRSGKSSSKSKSNRSRPLAKTKAVF
LLALQFSAVVFLCNINVGFVAGSVATAASSAGGSSPAAPSSAPSSPPTVAVPPPPPPSSA
LKVDPNGQSPVLPPYVLDYETGGKAKLTPNNGKFGQSGSSGSNNNHIVGHYTHTWAVHIP
NGDNGMADAVAKDHGFVNLGKIFDDHYHFAHHKVSKRSLSPATHHQTRLDDDDRVHWAKQ
QRAKSRSKRDFIRMRPSRTSSRAMSMVDAMSFNDSKWPQMWYLNRGGGLDMNVIPAWKMG
ITGKGVVVTILDDGLESDHPDIQDNYDPKASYDVNSHDDDPMPHYDMTDSNRHGTRCAGE
VAATANNSFCAVGIAYGASVGGVRMLDGDVTDAVEARSLSLNPQHIDIYSASWGPDDDGK
TVDGPGELASRAFIEGTTKGRGGKGSIFIWASGNGGREQDNCNCDGYTNSIWTLSISSAT
EEGHVPWYSEKCSSTLATTYSSGGQGEKQVVTTDLHHSCTVSHTGTSASAPLAAGIAALV
LQSNQNLTWRDLQHIVVRTAKPANLKDPSWSRNGVGRRVSHSFGYGLMDAAEMVRVARNW
KAVPEQQRCEINAPHVDKVIPPRTHITLQLTVNHCRSVNYLEHVQAKITLTSQRRGDIQL
FLRSPANTSVTLLTPRIHDNSRSGFNQWPFMSVHTWGESPQGNWQLEIHNEGRYMAQITQ
WDMIFYGTETPAQPDDVANPSQSNQFNLYGNDMAHNDVEYDSTGQWRNMQQVGEVGMTRD
HSNTAACLKWSDRKCLECNDSAYMFEDQCYDVCPVHTYPLDKFQAEEDEQDDEVTRGPVN
PYSSSPMDHSLLMSNSLDDKQDPLQAEDRRRRSSLTQLVEVPSRVCAACDRSCLECYGAL
ASQCSTCSPGSQLRKILNETFCYAYVVRSTGMASVVDISKMDDRDTQQYMTGTTVLLLVS
VIFTLMGVAVAGGIVYHRRAMARSNELYSRVSLVPGDESDSDEDELFTAHFPARKSGVNI
YRDEAPSEKIFEEDEISHLVP
>sp|Q02742|G6NT_HUMAN Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N- 
MLRTLLRRRLFSYPTKYYFMVLVLSLITFSVLRIHQKPEFVSVRHLELAGENPSSDINCT
KVLQGDVNEIQKVKLEILTVKFKKRPRWTPDDYINMTSDCSSFIKRRKYIVEPLSKEEAE
FPIAYSIVVHHKIEMLDRLLRAIYMPQNFYCVHVDTKSEDSYLAAVMGIASCFSNVFVAS
RLESVVYASWSRVQADLNCMKDLYAMSANWKYLINLCGMDFPIKTNLEIVRKLKLLMGEN
NLETERMPSHKEERWKKRYEVVNGKLTNTGTVKMLPPLETPLFSGSAYFVVSREYVGYVL
QNEKIQKLMEWAQDTYSPDEYLWATIQRIPEVPGSLPASHKYDLSDMQAVARFVKWQYFE
GDVSKGAPYPPCDGVHVRSVCIFGAGDLNWMLRKHHLFANKFDVDVDLFAIQCLDEHLRH
KALETLKH
>sp|P16422|TTD1_HUMAN Tumor-associated calcium signal transducer 1 precursor (Major 
MAPPQVLAFGLLLAAATATFAAAQEECVCENYKLAVNCFVNNNRQCQCTSVGAQNTVICS
KLAAKCLVMKAEMNGSKLGRRAKPEGALQNNDGLYDPDCDESGLFKAKQCNGTSTCWCVN
TAGVRRTDKDTEITCSERVRTYWIIIELKHKAREKPYDSKSLRTALQKEITTRYQLDPKF
ITSILYENNVITIDLVQNSSQKTQNDVDIADVAYYFEKDVKGESLFHSKKMDLTVNGEQL
DLDPGQTLIYYVDEKAPEFSMQGLKAGVIAVIVVVVMAVVAGIVVLVISRKKRMAKYEKA
EIKEMGEMHRELNA
>sp|P14769|GATR_BOVIN N-acetyllactosaminide alpha-1,3-galactosyltransferase (EC 2.4.1.151) 
MNVKGKVILSMLVVSTVIVVFWEYIHSPEGSLFWINPSRNPEVGGSSIQKGWWLPRWFNN
GYHEEDGDINEEKEQRNEDESKLKLSDWFNPFKRPEVVTMTKWKAPVVWEGTYNRAVLDN
YYAKQKITVGLTVFAVGRYIEHYLEEFLTSANKHFMVGHPVIFYIMVDDVSRMPLIELGP
LRSFKVFKIKPEKRWQDISMMRMKTIGEHIVAHIQHEVDFLFCMDVDQVFQDKFGVETLG
ESVAQLQAWWYKADPNDFTYERRKESAAYIPFGEGDFYYHAAIFGGTPTQVLNITQECFK
GILKDKKNDIEAQWHDESHLNKYFLLNKPTKILSPEYCWDYHIGLPADIKLVKMSWQTKE
YNVVRNNV
>sp|Q03555|GEPH_RAT Gephyrin (Putative glycine receptor-tubulin linker protein). 
MATEGMILTNHDHQIRVGVLTVSDSCFRNLAEDRSGINLKDLVQDPSLLGGTISAYKIVP
DEIEEIKETLIDWCDEKELNLILTTGGTGFAPRDVTPEATKEVIEREAPGMALAMLMGSL
NVTPLGMLSRPVCGIRGKTLIINLPGSKKGSQECFQFILPALPHAIDLLRDAIVKVKEVH
DELEDLPSPPPPLSPPPTTSPHKQTEDKGVQCEEEEEEKKDSGVASTEDSSSSHITAAAL
ARKIPDSIISRGVQVLPRDTASLSTTPSESPRAQATSRLSTASCPTPKVQSRCSSKENIL
RASHSAVDITKVARRHRMSPFPLTSMDKAFITVLEMTPVLGTEIINYRDGMGRVLAQDVY
AKDNLPPFPASVKDGYAVRAADGPGDRFIIGESQAGEQPTQTVMPGQVMRVTTGAPIPCG
ADAVVQVEDTELIRESDDGTEELEVRILVQARPGQDIRPIGHDIKRGECVLAKGTHMGPS
EIGLLATVGVTEVEVNKFPVVAVMSTGNELLNPEDDLLPGKIRDSNRSTLLATIQEHGYP
TINLGIVGDNPDDLLNALNEGISRADVIITSGGVSMGEKDYLKQVLDIDLHAQIHFGRVF
MKPGLPTTFATLDIDGVRKIIFALPGNPVSAVVTCNLFVVPALRKMQGILDPRPTIIKAR
LSCDVKLDPRPEYHRCILTWHHQEPLPWAQSTGNQMSSRLMSMRSANGLLMLPPKTEQYV
ELHKGEVVDVMVIGRL
>sp|P14221|GLP_MACFU Glycophorin MK. 
SSTTVPATHTSSSSLGPEQYVSSQSNDKHTSDSHPTPTSAHEVTTEFSGRTHYPPEEDDR
VQLVHEFSELVIALIIFGVMAGVIGTILFISYGSRRLIKKSESDVQPLPPPDAEVPLSSV
EIEDPEETDELNSFTKPNQERNES
>sp|P35052|GPC1_HUMAN Glypican-1 precursor. 
MELRARGWWLLCAAAALVACARGDPASKSRSCGEVRQIYGAKGFSLSDVPQAEISGEHLR
ICPQGYTCCTSEMEENLANRSHAELETALRDSSRVLQAMLATQLRSFDDHFQHLLNDSER
TLQATFPGAFGELYTQNARAFRDLYSELRLYYRGANLHLEETLAEFWARLLERLFKQLHP
QLLLPDDYLDCLGKQAEALRPFGEAPRELRLRATRAFVAARSFVQGLGVASDVVRKVAQV
PLGPECSRAVMKLVYCAHCLGVPGARPCPDYCRNVLKGCLANQADLDAEWRNLLDSMVLI
TDKFWGTSGVESVIGSVHTWLAEAINALQDNRDTLTAKVIQGCGNPKVNPQGPGPEEKRR
RGKLAPRERPPSGTLEKLVSEAKAQLRDVQDFWISLPGTLCSEKMALSTASDDRCWNGMA
RGRYLPEVMGDGLANQINNPEVEVDITKPDMTIRQQIMQLKIMTNRLRSAYNGNDVDFQD
ASDDGSGSGSGDGCLDDLCGRKVSRKSSSSRTPLTHALPGLSEQEGQKTSAASCPQPPTF
LLPLLLFLALTVARPRWR
>sp|P26572|GNT1_HUMAN Alpha-1,3-mannosyl-glycoprotein beta-1,2-N- 
MLKKQSAGLVLWGAILFVAWNALLLLFFWTRPAPGRPPSVSALDGDPASLTREVIRLAQD
AEVELERQRGLLQQIGDALSSQRGRVPTAAPPAQPRVPVTPAPAVIPILVIACDRSTVRR
CLDKLLHYRPSAELFPIIVSQDCGHEETAQAIASYGSAVTHIRQPDLSSIAVPPDHRKFQ
GYYKIARHYRWALGQVFRQFRFPAAVVVEDDLEVAPDFFEYFRATYPLLKADPSLWCVSA
WNDNGKEQMVDASRPELLYRTDFFPGLGWLLLAELWAELEPKWPKAFWDDWMRRPEQRQG
RACIRPEISRTMTFGRKGVSHGQFFDQHLKFIKLNQQFVHFTQLDLSYLQREAYDRDFLA
RVYGAPQLQVEKVRTNDRKELGEVRVQYTGRDSFKAFAKALGVMDDLKSGVPRAGYRGIV
TFQFRGRRVHLAPPPTWEGYDPSWN
>sp|Q02527|GNT3_RAT Beta-1,4-mannosyl-glycoprotein beta-1,4-N-acetylglucosaminyl- 
MRRYKLFLMFCMAGLCLISFLHFFKTLSYVTFPRELASLSPNLISSFFWNNAPVTPQASP
EPGDPDLLRTPLYSHSPLLQPLSPSKATEELHRVDFVLPEDTTEYFVRTKAGGVCFKPGT
RMLEKPSPGRTEEKTKVAEGSSVRGPARRPMRHVLSARERLGGRGTRRKWVECVCLPGWH
GPSCGVPTVVQYSNLPTKERLVPREVPRRVINAININHEFDLLDVRFHELGDVVDAFVVC
ESNFTAYGEPRPLKFREMLTNGTFEYIRHKVLYVFLDHFPPGGRQDGWIADDYLRTFLTQ
DGVSRLRNLRPDDVFIIDDADEIPARDGVLFLKLYDGWTEPFAFHMRKSLYGFFWKQPGT
LEVVSGCTIDMLQAVYGLDGIRLRRRQYYTMPNFRQYENRTGHILVQWSLGSPLHFAGWH
CSWCFTPEGIYFKLVSAQNGDFPRWGDYEDKRDLNYIRSLIRTGGWFDGTQQEYPPADPS
EHMYAPKYLLKNYDQFRYLLENPYREPKSTVEGGRRNQGSDGRSSAVRGKLDTTEG
>sp|Q08834|GNT5_RAT Alpha-1,3(6)-mannosylglycoprotein beta-1,6-N-acetyl- 
MAFFSPWKLSSQKLGFFLVTFGFIWGMMLLHFTIQQRTQPESSSMLREQILDLSKRYIKA
LAEENRNVVDGPYAGVMTAYDLKKTLAVLLDNILQRIGKLESKVDNLVNGTGANSTNSTT
AVPSLVSLEKINVADIINGVQEKCVLPPMDGYPHCEGKIKWMKDMWRSDPCYADYGVDGT
SCSFFIYLSEVENWCPRLPWRAKNPYEEADHNSLAEIRTDFNILYGMMKKHEEFRWMRLR
IRRMADAWIQAIKSLAEKQNLEKRKRKKILVHLGLLTKESGFKIAETAFSGGPLGELVQW
SDLITSLYLLGHDIRISASLAELKEIMKKVVGNRSGCPTVGDRIVELIYIDIVGLAQFKK
TLGPSWVHYQCMLRVLDSFGTEPEFNHASYAQSKGHKTPWGKWNLNPQQFYTMFPHTPDN
SFLGFVVEQHLNSSDIHHINEIKRQNQSLVYGKVDSFWKNKKIYLDIIHTYMEVHATVYG
SSTKNIPSYVKNHGILSGRDLQFLLRETKLFVGLGFPYEGPAPLEAIANGCAFLNPKFNP
PKSSKNTDFFIGKPTLRELTSQHPYAEVFIGRPHVWTVDLNNREEVEDAVKAILNQKIEP
YMPYEFTCEGMLQRINAFIEKQDFCHGQVMWPPLSALQVKLAEPGQSCKQVCQESQLICE
PSFFQHLNKEKDLLKYKVICQSSELYKDILVPSFYPKSKHCVFQGDLLLFSCAGAHPTHQ
RICPCRDFIKGQVALCKDCL
>sp|P07359|GPBA_HUMAN Platelet glycoprotein IB alpha chain precursor (GP-IB alpha) (GPIBA) 
MPLLLLLLLLPSPLHPHPICEVSKVASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLY
TFSLATLMPYTRLTQLNLDRCELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTV
LDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELP
AGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEILYFRRWLQDNA
ENVYVWKQGVDVKAMTSNVASVQCDNSDKFPVYKYPGKGCPTLGDEGDTDLYDYYPEEDT
EGDKVRATRTVVKFPTKAHTTPWGLFYSWSTASLDSQMPSSLHPTQESTKEQTTFPPRWT
PNFTLHMESITFSKTPKSTTEPTPSPTTSEPVPEPAPNMTTLEPTPSPTTPEPTSEPAPS
PTTPEPTPIPTIATSPTILVSATSLITPKSTFLTTTKPVSLLESTKKTIPELDQPPKLRG
VLQGHLESSRNDPFLHPDFCCLLPLGFYVLGLFWLLFASVVLILLLSWVGHVKPQALDSG
QGAALTTATQTTHLELQRGRQVTVPRAWLLFLRGSLPTFRSSLFLWVRPNGRVGPLVAGR
RPSALSQGRGQDLLSTVSIRYSGHSL
>sp|P40197|GPV_HUMAN Platelet glycoprotein V precursor (GPV) (CD42D). 
MLRGTLLCAVLGLLRAQPFPCPPACKCVFRDAAQCSGGDVARISALGLPTNLTHILLFGM
GRGVLQSQSFSGMTVLQRLMISDSHISAVAPGTFSDLIKLKTLRLSRNKITHLPGALLDK
MVLLEQLFLDHNALRGIDQNMFQKLVNLQELALNQNQLDFLPASLFTNLENLKLLDLSGN
NLTHLPKGLLGAQAKLERLLLHSNRLVSLDSGLLNSLGALTELQFHRNHIRSIAPGAFDR
LPNLSSLTLSRNHLAFLPSALFLHSHNLTLLTLFENPLAELPGVLFGEMGGLQELWLNRT
QLRTLPAAAFRNLSRLRYLGVTLSPRLSALPQGAFQGLGELQVLALHSNGLTALPDGLLR
GLGKLRQVSLRRNRLRALPRALFRNLSSLESVQLDHNQLETLPGDVFGALPRLTEVLLGH
NSWRCDCGLGPFLGWLRQHLGLVGGEEPPRCAGPGAHAGLPLWALPGGDAECPGPRGPPP
RPAADSSSEAPVHPALAPNSSEPWVWAQPVTTGKGQDHSPFWGFYFLLLAVQAMITVIIV
FAMIKIGQLFRKLIRERALG
>sp|P24524|GRA3_RAT Glycine receptor alpha-3 chain precursor. 
MAHVRHFRTLLSGFYFWEAALLLSLVATKETNSARSRSAPMSPSDFLDKLMGRTSGYDAR
IRPNFKGPPVNVTCNIFINSFGSIAETTMDYRVNIFLRQKWNDPRLAYSEYPDDSLDLDP
SMLDSIWKPDLFFANEKGANFHEVTTDNKLLRIFKNGNVLYSIRLTLTLSCPMDLKNFPM
DVQTCIMQLESFGYTMNDLIFEWQDEAPVQVAEGLTLPQFLLKEEKDLRYCTKHYNTGKF
TCIEVRFHLERQMGYYLIQMYIPSLLIVILSWVSFWINMDAAPARVALGITTVLTMTTQS
SGSRASLPKVSYVKAIDIWMAVCLLFVFSALLEYAAVNFVSRQHKELLRFRRKRKNKTEA
FALEKFYRFSDTDDEVRESRLSFTAYGMGPCLQAKDGVVPKGPNHAVQVMPKSADEMRKV
FIDRAKKIDTISRACFPLAFLIFNIFYWVIYKILRHEDIHHQQD
>sp|P41355|HEMA_RINDR Hemagglutinin-neuraminidase (EC 3.2.1.18). 
MSPPRDRVDAYYKDNFQFKNTRVVLNKEQLLIERPCMLLTVLFVMFLSLVGLLAIAGIRL
HRAAVNTAKINNDLTTSIDITKSIEYQVKDVLTPLFKIIGDEVGLRTPQRFTDLTKFISD
KIKFLNPDKEYDFRDINWCINPPERIKIDYDQYCAHTAAEDLITMLVNSSLTGTTVPRTS
LVNLGRNCTGPTTTKGQFSNISLTLSGIYSGRGYNISSMITITGKGMYGSTYLVGKYNQR
ARRPSKVWHQDYRVFEVGIIRELGVGTPGFHMTNYLELPRQPELETCMLALGESKLAALC
LADSPVALHYGRVGDDNKIRFVKLGVWASPADRDTLATLSAIDPTLDGLYITTHRGIIAA
GTAIWAVPVTRTDDQVKMGKCRLEACRDRPPPFCNSTDWEPLEAGRIPAYGVLTIKLGLA
DEPKVDIISEFGPLITHDSGMDLYTSFDGTKYWLTTPPLQNSALGTVNTLVLEPSLKISP
NILTLPIRSGGGDCYIPTYLSDRADDDVKLSSNLVILPSRDLQYVSATYDISRVEHAIVY
HIYSTGRLSSYYYPFKLPIKGDPVSLQIECFPWDRKLWCHHFCSVVDSGTGEQVTHIGVV
GIKITCNGK
>sp|P34135|HMD1_DICDI 3-hydroxy-3-methylglutaryl-coenzyme A reductase 1 (EC 1.1.1.34) (HMG- 
MLFAPPNLETKELFWIIYILILIPKVFAKVMSVRELFPFFKWGFNIRRSNFLVPILSNNV
IVTGEEAVQYEKPLPYIPQHNQQQQQKQQPSQDYIQQPQNDNNINSGKEQEQQQQQQQQQ
QQTPDITNQPTKTNKKIPIKELSNEEILIKLEKGEVLAYRLENELGDCSRAVEIRRMLLE
KQLSKKIEPIPHEGFDFAKVQGQCCENVIGYVPIPVGTAGPIQLNGQLVTIPMATTEGCL
VASTHRGCKAITESGGAKCTITSRGMTRAPVVRFSDIVKASEFVSWINDTDNYQALKAVF
DSTSRFARLSAIKCTIAGRSVYIRFKCDTGDAMGMNMVSKGVEAVLEHLKIIFDDMTLLS
ISGNMCTDKKPSSINWTEGRGRSVVCEAMITGDVVQRVLKTNVQALVDLNIAKNLIGSAM
AGSIGGFNAHASNIVTAIFLATGQDCAQNVESSNCITQMEACNDGQDLYITVTMPSIEVG
TVGGGTSLPAQSACLDIIGVKGSSSSKPGANADQLAKTIASAVMAGELSLMSALSAGHLM
KSHLQYNRAKTN
>sp|Q00583|HMD3_HEVBR 3-hydroxy-3-methylglutaryl-coenzyme A reductase 3 (EC 1.1.1.34) (HMG- 
MDEVRRRPPKHIVRKDHDGEVLNSFSHGHHLPPLKPSDYSLPLSLYLANALVFSLFFSVA
YFLLHRWREKIRKSTPLHIVTFPEIAALICLVASVIYLLGFFGIGFVHSFSRASTDSWDV
EEYDDDNIIIKEDTRPTGACAAPSLDCSLSLPTKIHAPIVSTTTTSTLSDDDEQIIKSVV
SGSIPSYSLESKLGNCKRAALIRRETLQRMSGRSLEGLPLDGFDYESILGQCCEMAIGYV
QIPVGIAGPLLLDGKEYTVPMATTEGCLVASANRGCKAIYASGGATSVLLRDGMTRAPVV
RFPTAKRAADLKFFMEDPDNFDTIAVVFNKSSRFARLQSVQCAIAGKNLYMRFSCSTGDA
MGMNMVSKAVQNVIDYLQNDFPDMDVIGLTGNFCADKKAAAVNWIEGRGKSVVCEAIIKE
EVVKKVLKTNVAALVELNMIKNLTGSAVAGSLGGFNAHASNMVTAVYIATGQDPAQNVES
SHCITMMEAVNDGKDLHISVSMPSIELGTVGGGTQLASQSACLNLLGVKGASKDSPGSNS
RLLATIVAGSVLAGELSLMSAIAAGQLVNSHMKYNRSAKDVSKITF
>sp|P16393|HMDH_STRPU 3-hydroxy-3-methylglutaryl-coenzyme A reductase (EC 1.1.1.34) (HMG-CoA 
MLSRLFLAQGRFCSSHPWEVIVCTLTLTICMLSMNYFTGLPRICGWNYECAPQVKESSLS
SDVLVMCIMRTLAVAYLYLQFTKLRTTGSKYILGIAGLFTIFSSFLFSSAVIHLFGLELT
GLNEALPFFLLLIDLTKASALTKFALSSTTQNEVVDNIARGMAILGPTITLDTVVTTLVI
SIGTMSSIRKMEVFCCFGILSLIANYFVFMTFFPACLSLVLELSNSNKYGRPVWHLGRFA
EVLEEEEDRKPNPVVQRVKMIMRTGLVLVHAHSYWLASNDTELMSRDMLYDGNLLTDKKI
DPTMPLWEFYATRLWPPTLDYILTAILATVLASHYIFFSDLATYPEKRVSIMEGHEVVNP
GSDHEDASEVETIGTLSSSPSTSDVRVIESMTSRTQACQTDPVTASPRNSRSSSPVSSHS
VKPARFTIGSSGSGSEDEEEEVIKEEEVEWVLETELKAPRPMPELLEILNVGKGPNALTD
DEVQLLVGAKHIPAYKLENILDNPERGVAVRRQIISKLLPITDALEKLPYASYDYSFVSG
ACCENVIGYMPVPVGVAGPLLLDGQEFQVPMATTEGCLVASTNRGCRALRSAGGIHSVLI
GDGMTRGPLVRLPSAQEAGAIKQWLEVPENFAAIKERFESTSRFAKLKSIQTALAGRYMF
LRFKALTGDAMGMNMISKGTEQALHALQTMFPNIEIMSLSGNYCTDKKVAAINWIEGRGK
SVVCEATVPAHIVQQVLKTSASALVDLNIHKNLVGSAMAGSIGGFNAHAANIVTAIYIAT
GQDAAQNIASSNCMTLMETRGPKGGDLYLSCTMPSIELGTVGGGTVLPPQSACLQMMDVK
GSNIHGSGLNASQLARIVCATVMAGELSLMSALAAGHLVKSHMKHNRSALNIASPLPSID
EVATHRRSKSVDFSALKESSAAAPGTCTANAS
>sp|P23897|HSER_RAT Heat-stable enterotoxin receptor precursor (GC-C) (Intestinal 
MTSLLGLAVRLLLFQPTLMFWASQVRQKCHNGTYEISVLMMDNSAYKEPLQNLRDAVEEG
LDIVRKRLREAELNVTVNATFIYSDGLIHKSGDCRSSTCEGLDLLREITRDRKMGCVLMG
PSCTYSTFQMYLDTELNYPMISAGSFGLSCDYKETLTRILPPARKLMYFLVDFWKVNNAP
FKTFSWNSSYVYKNGSEPEDCFWYLNALEAGVSYFSEVLSFKDVLRRSEQFQEILMGRNR
KSNVIVMCGTPETFYNVKGDLKVADDTVVILVDLFSNHYFEDDTRAPEYMDNVLVLTLPP
EKFIANASVSGRFPSERSDFSLAYLEGTLLFGHMLQTFLENGESVTTPKFARAFRNLTFQ
GLEGPVTLDDSGDIDNIMCLLYVSLDTRKYKVLMAYDTHKNQTIPVATSPNFIWKNHRLP
NDVPGLGPQILMIAVFTLTGIVVVLLLIALLVLRKYRRDHELRQKKWSHIPSENIFPLET
NETNHVSLKIDDDRRRDTIQRVRQCKYDKKKVILKDLKHCDGNFSEKQKIELNKLLQSDY
YNLTKFYGTVKLDTRIFGVVEYCERGSLREVLNDTISYPDGTFMDWEFKISVLNDIAKGM
SYLHSSKIEVHGRLKSTNCVVDSRMVVKITDFGCNSILPPKKDLWTAPEHLRQATISQKG
DVYSFSIIAQEIILRKETFYTLSCRDQNEKIFRVENSYGTKPFRPDLFLETADEKELEVY
LLVKSCWEEDPEKRPDFKKIESTLAKIFGLFHDQKNESYMDTLIRRLQLYSRNLEHLVEE
RTQLYKAERDRADHLNFMLLPRLVVKSLKEKGIVEPELYEEVTIYFSDIVGFTTICKYST
PMEVVDMLNDIYKSFDQIVDHHDVYKVETIGDAYVVASGLPMRNGNRHAVDISKMALDIL
SFMGTFELEHLPGLPVWIRIGVHSGPCAAGVVGIKMPRYCLFGDTVNTASRMESTGLPLR
IHMSSSTIAILRRTDCQFLYEVRGETYLKGRGTETTYWLTGMKDQEYNLPTPPTVENQQR
LQTEFSDMIVSALQKRQASGVKSRRPTRVASYKKGFLEYMQLNNSDHDSTYF
>sp|P27595|HXK1_BOVIN Hexokinase, type I (EC 2.7.1.1) (HK I) (Brain form hexokinase). 
MIAAQLLAYYFTELKDDQVKKIDKYLYAMRLSDETLLDIMNRFKKEMKNGLSRDFNPTAT
VKMLPTFVRSIPDGSEKGDFIALDLGGSSFRILRVQVNHEQNRPVHMESEVYDTPENIMH
GSGSQLFDHVLECLGDFMEKKKIKDKKLPVGFTFSFPCRQSKIDQAILITWTKRFKARGA
EGNYVVKLLDKAIKKRGDYDANIVAVVNDTVGTMIDCGYDDQHCEVGLIIGTGTNACYME
ELRQIDFGWGDDGRMCINTEWGDLGDDGSLEDIRKEFDREFRRGSLNPGKQRFEKMVSGR
YMEDVVRLVLVKMAKEGLLFEGRITPELLTRGKFNTSDVSAIEKDKEGLHNAKEILTRLG
VERSDDDCVSVQHVCTIVSFRSANLVAATLGAILNRLRDNKSTPRLRTTVRVDGSLYKTH
PQYSRRFHKTLRRLVPDSDVRFLLSESGTGKGAAMVTAVAYRLAEQHRQIEETLAHFRLS
KQTLMEVKKRLRTEMEMGLRKETNSNATVNMLPSFLRSIPDGTEDGDFLALDLGGTNFRV
LLVKIRSGKKSTVEMHNKIYRIPIEIMQGTGEELFDHIVSCISDFLDYMGIKGPRMPLGF
TFSFPCQQTSLDAGILITWTKGFKATDCVGHDVVTLLRDAVKRREEFDLDVVAVVNDTVG
TMMTCAYEEPTCEVGLIVGTGSNACYMEEMKNVEMVEGNQRQMCINMEWGAFGDNGCSDD
IRTDFDKVVDEYSLNSGNQRFENMISGIYLGEIVRNILIDFTKKGFLFRGQISEPLKTRG
IFETKFLSQIESDRLALLQVRAILQQLGLNSTCDDSILVKTVCGVVSKRAAQLCGAGMAA
VVEKIRENRGLDRLNVTVGVDGTLYKLHPQFSRIMHQTVKELSPKCNVSFLLSEDGSGKG
AALITAVGVRLRGESAIS
>sp|P27931|IL1S_MOUSE Interleukin-1 receptor, type II precursor (IL-1R-2). 
MFILLVLVTGVSAFTTPTVVHTGKVSESPITSEKPTVHGDNCQFRGREFKSELRLEGEPV
VLRCPLAPHSDISSSSHSFLTWSKLDSSQLIPRDEPRMWVKGNILWILPAVQQDSGTYIC
TFRNASHCEQMSVELKVFKNTEASLPHVSYLQISALSTTGLLVCPDLKEFISSNADGKIQ
WYKGAILLDKGNKEFLSAGDPTRLLISNTSMDDAGYYRCVMTFTYNGQEYNITRNIELRV
KGTTTEPIPVIISPLETIPASLGSRLIVPCKVFLGTGTSSNTIVWWLANSTFISAAYPRG
RVTEGLHHQYSENDENYVEVSLIFDPVTREDLHTDFKCVASNPRSSQSLHTTVKEVSSTF
SWSIALAPLSLIILVVGAIWMRRRCKRRAGKTYGLTKLRTDNQDFPSSPN
>sp|P12342|IL2A_BOVIN Interleukin-2 receptor alpha chain precursor (IL-2 receptor alpha 
MEPSLLMWRFFVFIVVPGCVTEACHDDPPSLRNAMFKVFRYEVGTMINCDCKTGFRRVSA
VMRCVGDSSHSAWENRCFCNSTSPAKNQVKQVTPAPEEHREKKHTDAQNQTQPPEEADLP
GHCEEPPPWEHEREPLKRVYHFTLGQTVHYQCAQGFRALQTSPAESTCMMINGELRWTRP
RLKCIREGEHGQASDDAEPQESTEAPPGSGTFLPTRMAGTTNFQKPTDEIATLDTFIFTT
EYQIAVAGCTLLLASILLLSCLTWQRKWKKNRRTI
>sp|P26896|IL2B_RAT Interleukin-2 receptor beta chain precursor (IL-2 receptor) (P70-75) 
MATVDLSWRLPLYILLLLLATTWVSAAVNDCSHLKCFYNSRANVSCMWSPEEALNVTSCH
IHAKSDMRHWNKTCELTPVRQASWACNLILGPLPDSQSLTSVDLLSLSVVCWEEKGWRRV
KTCTFHPFDNLRLIAPHSLQVLHIETRRCNISWEVSQVSHYVNPYLEFEARRRLLDRSWE
DASVFSLKQRQQWIFLETLTPDTSYELQVRVIAQRGKTRTWSPWSQPMAFRTRPADPKEI
FPLPWLRCLLLVLGCFFGFLSCVCVLVKCRYLGPWLKTLLKCHIPDPSEFFSQLSSQHGG
DLQKWLSSPVPQSFFSPTGSAPEISPLEVLDRDSKTMQMLLFQKEKASSPSPSGHSQASC
FTNQGYFFFHLSNALEIESCQVYFTYDPCMEEDVEEDGPRLPEESPLPPLLPFTGEQDDY
CAFPPRDDLLLFSPSMSTPNTAYGNSITPEERPPLSLQEGLPSLASPDLMGLQHPLELEL
GDDGEGMSTNSSGQQASVPEAALMGTTKTEARPVLTLNTDAYLSLQELQAQDSAHLI
>sp|Q00560|IL6B_MOUSE Interleukin-6 receptor beta chain precursor (IL-6R-beta) (Interleukin 
MSAPRIWLAQALLFFLTTESIGQLLEPCGYIYPEFPVVQRGSNFTAICVLKEACLQHYYV
NASYIVWKTNHAAVPREQVTVINRTTSSVTFTDVVLPSVQLTCNILSFGQIEQNVYGVTM
LSGFPPDKPTNLTCIVNEGKNMLCQWDPGRETYLETNYTLKSEWATEKFPDCQSKHGTSC
MVSYMPTYYVNIEVWVEAENALGKVSSESINFDPVDKVKPTPPYNLSVTNSEELSSILKL
SWVSSGLGGLLDLKSDIQYRTKDASTWIQVPLEDTMSPRTSFTVQDLKPFTEYVFRIRSI
KDSGKGYWSDWSEEASGTTYEDRPSRPPSFWYKTNPSHGQEYRSVRLIWKALPLSEANGK
ILDYEVILTQSKSVSQTYTVTGTELTVNLTNDRYVASLAARNKVGKSAAAVLTIPSPHVT
AAYSVVNLKAFPKDNLLWVEWTPPPKPVSKYILEWCVLSENAPCVEDWQQEDATVNRTHL
RGRLLESKCYQITVTPVFATGPGGSESLKAYLKQAAPARGPTVRTKKVGKNEAVLAWDQI
PVDDQNGFIRNYSISYRTSVGKEMVVHVDSSHTEYTLSSLSSDTLYMVRMAAYTDEGGKD
GPEFTFTTPKFAQGEIEAIVVPVCLAFLLTTLLGVLFCFNKRDLIKKHIWPNVPDPSKSH
IAQWSPHTPPRHNFNSKDQMYSDGNFTDVSVVEIEANNKKPCPDDLKSVDLFKKEKVSTE
GHSSGIGGSSCMSSSRPSISSNEENESAQSTASTVEYSTVVHSGYRHQVPSVQVFSRSES
TQPLLDSEERPEDLQLVDSVDGGDEILPRQPYFKQNCSQPEACPEISHFERSNQVLSGNE
EDFVRLKQQQVSDHISQPYGSEQRRLFQEGSTADALGTGADGQMERFESVGMETTIDEEI
PKSYLPQTVRQGGYMPQ
>sp|P35344|IL8B_RABIT High affinity interleukin-8 receptor B (IL-8R B) (CXCR-2) (GRO/MGSA 
MQEFTWENYSYEDFFGDFSNYSYSTDLPPTLLDSAPCRSESLETNSYVVLITYILVFLLS
LLGNSLVMLVILYSRSTCSVTDVYLLNLAIADLLFATTLPIWAASKVHGWTFGTPLCKVV
SLVKEVNFYSGILLLACISVDRYLAIVHATRTMIQKRHLVKFICLSMWGVSLILSLPILL
FRNAIFPPNSSPVCYEDMGNSTAKWRMVLRILPQTFGFILPLLVMLFCYVFTLRTLFQAH
MGQKHRAMRVIFAVVLIFLLCWLPYNLVLLTDTLMRTHVIQETCERRNDIDRALDATEIL
GFLHSCLNPIIYAFIGQKFRYGLLKILAAHGLISKEFLAKESRPSFVASSSGNTSTTL
>sp|P15261|INGR_MOUSE Interferon-gamma receptor alpha chain precursor. 
MGPQAAAGRMILLVVLMLSAKVGSGALTSTEDPEPPSVPVPTNVLIKSYNLNPVVCWEYQ
NMSQTPIFTVQVKVYSGSWTDSCTNISDHCCNIYGQIMYPDVSAWARVKAKVGQKESDYA
RSKEFLMCLKGKVGPPGLEIRRKKEEQLSVLVFHPEVVVNGESQGTMFGDGSTCYTFDYT
VYVEHNRSGEILHTKHTVEKEECNETLCELNISVSTLDSRYCISVDGISSFWQVRTEKSK
DVCIPPFHDDRKDSIWILVVAPLTVFTVVILVFAYWYTKKNSFKRKSIMLPKSLLSVVKS
ATLETKPESKYSLVTPHQPAVLESETVICEEPLSTVTAPDSPEAAEQEELSKETKALEAG
GSTSAMTPDSPPTPTQRRSFSLLSSNQSGPCSLTAYHSRNGSDSGLVGSGSSISDLESLP
NNNSETKMAEHDPPPVRKAPMASGYDKPHMLVDVLVDVGGKESLMGYRLTGEAQELS
>sp|P38484|INGS_HUMAN Interferon-gamma receptor beta chain precursor (Interferon-gamma 
MRPTLLWSLLLLLGVFAAAAAAPPDPLSQLPAPQHPKIRLYNAEQVLSWEPVALSNSTRP
VVYRVQFKYTDSKWFTADIMSIGVNCTQITATECDFTAASPSAGFPMDFNVTLRLRAELG
ALHSAWVTMPWFQHYRNVTVGPPENIEVTPGEGSLIIRFSSPFDIADTSTAFFCYYVHYW
EKGGIQQVKGPFRSNSISLDNLKPSRVYCLQVQAQLLWNKSNIFRVGHLSNISCYETMAD
ASTELQQVILISVGTFSLLSVLAGACFFLVLKYRGLIKYWFHTPPSIPLQIEEYLKDPTQ
PILEALDKDSSPKDDVWDSVSIISFPEKEQEDVLQTL
>sp|P25146|INLA_LISMO Internalin A precursor. 
MRKKRYVWLKSILVAILVFGSGVWINTSNGTNAQAATITQDTPINQIFTDTALAEKMKTV
LGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITPLKNLT
KLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDIS
ALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQ
ISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAPLSGLTKLTEL
KLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSL
TKLQRLFFYNNKVSDVSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWTNA
PVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIG
KGTTTFSGTVTQPLKAIFNVKFHVDGKETTKEVEAGNLLTEPAKPVKEGHTFVGWFDAQT
GGTKWNFSTDKMPTNDINLYAQFSINSYTATFDNDGVTTSQTVDYQGLLQEPTAPTKEGY
TFKGWYDAKTGGDKWDFATSKMPAKNITLYAQYSANSYTATFDVDGKSTTQAVDYQGLLK
EPKAPTKAGYTFKGWYDEKTDGKKWDFATDKMPANDITLYAQFTKNPVAPPTTGGNTPPT
TNNGGNTTPPSANIPGSDTSNTSTGNSASTTSTMNAYDPYNSKEASLPTTGDSDNALYLL
LGLLAVGTAMALTKKARASK
>sp|P15208|INSR_MOUSE Insulin receptor precursor (EC 2.7.1.112) (IR). 
MGFGRGCETTAVPLLVAVAALLVGTAGHLYPGEVCPGMDIRNNLTRLHELENCSVIEGHL
QILLMFKTRPEDFRDLSFPKLIMITDYLLLFRVYGLESLKDLFPNLTVIRGSRLFFNYAL
VIFEMVHLKELGLYNLMNITRGSVRIEKNNELCYLATIDWSRILDSVEDNYIVLNKDDNE
ECGDVCPGTAKGKTNCPATVINGQFVERCWTHSHCQKVCPTICKSHGCTAEGLCCHKECL
GNCSEPDDPTKCVACRNFYLDGQCVETCPPPYYHFQDWRCVNFSFCQDLHFKCRNSRKPG
CHQYVIHNNKCIPECPSGYTMNSSNLMCTPCLGPCPKVCQILEGEKTIDSVTSAQELRGC
TVINGSLIINIRGGNNLAAELEANLGLIEEISGFLKIRRSYALVSLSFFRKLHLIRGETL
EIGNYSFYALDNQNLRQLWDWSKHNLTITQGKLFFHYNPKLCLSEIHKMEEVSGTKGRQE
RNDIALKTNGDQASCENELLKFSFIRTSFDKILLRWEPYWPPDFRDLLGFMLFYKEAPYQ
NVTEFDGQDACGSNSWTVVDIDPPQRSNDPKSQTPSHPGWLMRGLKPWTQYAIFVKTLVT
FSDERRTYGAKSDIIYVQTDATNPSVPLDPISVSNSSSQIILKWKPPSDPNGNITHYLVY
WERQAEDSELFELDYCLKGLKLPSRTWSPPFESDDSQKHNQSEYDDSASECCSCPKTDSQ
ILKELEESSFRKTFEDYLHNVVFVPRPSRKRRSLEEVGNVTATTLTLPDFPNVSSTIVPT
SQEEHRPFEKVVNKESLVISGLRHFTGYRIELQACNQDSPDERCSVAAYVSARTMPEAKA
DDIVGPVTHEIFENNVVHLMWQEPKEPNGLIVLYEVSYRRYGDEELHLCVSRKHFALERG
CRLRGLSPGNYSVRVRATSLAGNGSWTEPTYFYVTDYLDVPSNIAKIIIGPLIFVFLFSV
VIGSIYLFLRKRQPDGPMGPLYASSNPEYLSASDVFPSSVYVPDEWEVPREKITLLRELG
QGSFGMVYEGNAKDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLL
GVVSKGQPMLVVMELMAHGDLKSHLRSLRPDAENNPGRPPPTLQEMIQMTAEIADGMAYL
NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD
GVFTASSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDPPDNCPERLTDLMR
MCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSFFYSEENKAPESEELEMEFEDMENVPLD
RSSHCQREEAGGREGGSSLSIKRTYDEHIPYTHMNGGKKNGRVLTLPRSNPS
>sp|P14617|IRR_CAVPO Insulin receptor-related protein precursor (EC 2.7.1.112) (IRR) 
MARPKLWPWGILLLVSLLSAGFNLDTMNVCPSLDIRSEVAELRRLENCSVVEGHLQILLM
FTATGEDFRSLSFPHLTQVTDYLLLFRVYGLESLRDLFPNLAVIRGAHLFLGYALVIFEM
PHLRDVGLPALGAVLHGSVRVEKNQELCHLSTIDWGLLQPTPSTNYIVGNKLGEECADVC
PGTLGAAGEPCARTTFNGHTDYRCWTSSHCQRVCPCPQGLACTISGECCHTECLGGCSQP
EDPRACVACRHFYYQSACHRACPLGTYEHESWRCVTAESCANLRSVPGRASTFGIHQGKC
LAQCPPGFTRNGSSIFCHKCEGLCPKECKVGTKTIDSVQAAQDLVGCTHVEGSLILNLRR
GYNLEPELQRSLGLVETITGFLKIKHSFALVSLSFFKNLKLIRGDTMVDGNYTLYVLDNQ
NLQQLGPWVSAGLTIPVGKIYFAFNPRLCLEHIYRLEEVTGTRGRQNKAEINPRTNGDRA
ACQTRTLRFVSNVTEADRILLRWERYEPLEARDLLSFIVYYKESPFQNATEHVGPDACGS
QSWNLLDVELPLSRTQEPGVILAPLKPWTQYAVFVRAITLTTAEDSPHQGAQSPIVYLWT
LPAAPTVPQDVISSSNSSSHLLVRWKPPTQRNGNITYYLVLWQRLAEDGDLYLNDYCHRG
LRLPTSNHDPRFDREDGDLEAELELGCCPCQHAPPGQVLPALEAQEASFQKKFENFLHNA
ITIPKPPWKVTSIHRNLQRDAGRHRRAIGSPRPGGNSSDFEIQEDKVPRERAVLGGLRHF
TEYRIDIHACNHAAHIVGCSAATFVFARTMPRREADDIPGKLSWEAASKSSVLLRWFEPP
DPNGLILKYEIKYRRLGEEATVLCVSRLRYAKVGGVQLALLPPGNYSARVRATSLAGNGS
WTDSVAFYIPGPEEEDSGGLHILLTVTPAGLMLLIILAALGFFYSRKRNGTLYTSVNPEY
LSASDMYIPDEWEVPREQISIIRELGQGSFGMVYEGVAKGLEAGEESTPVALKTVNELAS
PRERIEFLKEASVMKAFQCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSHLRSLRPEAEN
NPGIPRPALGDMIQMAGEIADGMAYLAANKFVHRDLAARNCMVSQDFTVKIGDFGMTRDV
YETDYYRKGGKGLLPVRWMAPESLKDGIFTTHSDVWSFGVVLWEIVTLAEQPYQGLSNEQ
VLKFVMDGGVLEELEDCPHQLQELMSSCWQQNPRLRPTFTQILNSIQKELRPSFRLLSFY
HSPECQGGCGLQPTTDAESSSPPTSKGASDCSLQNGGPEH
>sp|P18614|ITA1_RAT Integrin alpha-1 precursor (Laminin and collagen receptor) (VLA-1) 
MVPRRPASLEVTVACIWLLTVILGFCVSFNVDVKNSMSFSGPVEDMFGYTVQQYENEEGK
WVLIGSPLVGQPKARTGDVYKCPVGRERAMPCVKLDLPVNTSIPNVTEIKENMTFGSTLV
TNPNGGFLACGPLYAYRCGHLHYTTGICSDVSPTFQVVNSFAPVQECSTQLDIVIVLDGS
NSIYPWESVIAFLNDLLKRMDIGPKQTQVGIVQYGENVTHEFNLNKYSSTEEVLVAANKI
GRQGGLQTMTALGIDTARKEAFTEARGARRGVKKVMVIVTDGESHDNYRLKQVIQDCEDE
NIQRFSIAILGHYNRGNLSTEKFVEEIKSIASEPTEKHFFNVSDELALVTIVKALGERIF
ALEATADQSAASFEMEMSQTGFSAHYSQDWVMLGAVGAYDWNGTVVMQKANQMVIPHNTT
FQTEPAKMNEPLASYLGYTVNSATIPGDVLYIAGQPRYNHTGQVVIYKMEDGNINILQTL
GGEQIGSYFGSVLTTIDIDKDSYTDLLLVGAPMYMGTEKEEQGKVYVYAVNQTRFEYQMS
LEPIRQTCCSSLKDNSCTKENKNEPCGARFGTAIAAVKDLNVDGFNDVVIGAPLEDDHAG
AVYIYHGSGKTIREAYAQRIPSGGDGKTLKFFGQSIHGEMDLNGDGLTDVTIGGLGGAAL
FWARDVAVVKVTMNFEPNKVNIQKKNCRVEGKETVCINATMCFHVKLKSKEDSIYEADLQ
YRVTLDSLRQISRSFFSGTQERKIQRNITVRESECIRHSFYMLDKHDFQDSVRVTLDFNL
TDPENGPVLDDALPNSVHEHIPFAKDCGNKERCISDLTLNVSTTEKSLLIVKSQHDKFNV
SLTVKNKGDSAYNTRTVVQHSPNLIFSGIEEIQKDSCESNQNITCRVGYPFLRAGETVTF
KIIFQFNTSHLSENAIIHLSATSDSEEPLESLNDNEVNISIPVKYEVGLQFYSSASEHHI
SVAANETIPEFINSTEDIGNEINVFYTIRKRGHFPMPELQLSISFPNLTADGYPVLYPIG
WSSSDNVNCRPRSLEDPFGINSGKKMTISKSEVLKRGTIQDCSSTCGVATITCSLLPSDL
SQVNVSLLLWKPTFIRAHFSSLNLTLRGELKSENSSLTLSSSNRKRELAIQISKDGLPGR
VPLWVILLSAFAGLLLLMLLILALWKIGFFKRPLKKKMEK
>sp|P26007|ITA6_CHICK Integrin alpha-6 precursor (VLA-6). 
MAAALLLYLPLLPGLAGAFNLDAENVIGRRGEPGSLFGFSLAMHRQLQPQEKRLLLVGAP
REKAFPSQQANRTGGLYSCDITSSDTRCTRVVFDEDTDPKMESKEDQWMGVTVQSQGPGG
NVVTCAHRYEKRQYVNTVQETRDIIGRCYVLSQDLTIKDDMDNGVWSFCDGRLRGHEKFG
SCQQGVAATFTRDYHYIVFGAPGTYNWKGVVRAEQKNQTFYDLGIFDDGPYEVGDESRQD
KNLVPVPANSYLGFSLDSGKGIVSQDEMTFVSGAPRANHSGAVVLLKKEKNQRALSLEHM
FEGEGLASSFGYDVAVVDLNSDGWQDIVVGAPQYFDRSGDIGGAVYIYINQRGKWEGIKP
IRLNGTADSMFGLAVENVGDINQDGYPDIAVGAPYDGFGKVYIYHGSKNGINTEPAQILD
GEKTGTNFFGYSIAGNMDLDKNSYPDIAVGSLSDSVSVFRSRPVISITKSITVQPDKLDL
KKKNPEDPSEIWMDVKACFQYTANPRNLNPRIKINYTFEAENERRQLGLPSRVRFKDYLS
DQFTASTTLIGQNSKRCVTAKLVLQEKIKDKLRPIPIAVSVNIAGLESGSSSTRKERALP
DLIPILNSNESETKITKVEFLKEGCGEDNECHSNLKLQYRFCTREGNEDRFTYLPIENGI
PVLVLKDQKDIALEITVTNNPSDARNPQKDGEDAYEAKLIATFPDSLTYSAFREMRGYPE
KQLTCGANQNGSQAECELGNPFKRNSNVTFYLILSTTKVNVDTTDLDINLKLETTSTQVN
STAITASAKVVLELLLSLTGVAKPSQVYFGGNIVGESAMKSEDNIGNLIEYEFRVTNLGR
PLKTFGTASLDIQWPKEISNGKWLLYLMKIESKGLEKVSCQPQNEINVLHVAESHNSRRK
REIAEKQLTDSKTFSLFSERKYKTLDCKVNAQCVDIRCPLKGFDSKASILLRSRLWNSTF
LEEFSKMNYLDILVRASISVPAAAKNVKLTNEAAQVRVTVFPAKPVALYTGVPWWIIAVA
IFAGVLMLALLVFLLWKCGFFKRSKKDHYDATYHKAEIHAQPSDKERLTSDA
>sp|P08514|ITAB_HUMAN Integrin alpha-IIb precursor (Platelet membrane glycoprotein IIb) 
MARALCPLQALWLLEWVLLLLGPCAAPPAWALNLDPVQLTFYAGPNGSQFGFSLDFHKDS
HGRVAIVVGAPRTLGPSQEETGGVFLCPWRAEGGQCPSLLFDLRDETRNVGSQTLQTFKA
RQGLGASVVSWSDVIVACAPWQHWNVLEKTEEAEKTPVGSCFLAQPESGRRAEYSPCRGN
TLSRIYVENDFSWDKRYCEAGFSSVVTQAGELVLGAPGGYYFLGLLAQAPVADIFSSYRP
GILLWHVSSQSLSFDSSNPEYFDGYWGYSVAVGEFDGDLNTTEYVVGAPTWSWTLGAVEI
LDSYYQRLHRLRAEQMASYFGHSVAVTDVNGDGRHDLLVGAPLYMESRADRKLAEVGRVY
LFLQPRGPHALGAPSLLLTGTQLYGRFGSAIAPLGDLDRDGYNDIAVAAPYGGPSGRGQV
LVFLGQSEGLRSRPSQVLDSPFPTGSAFGFSLRGAVDIDDNGYPDLIVGAYGANQVAVYR
AQPVVKASVQLLVQDSLNPAVKSCVLPQTKTPVSCFNIQMCVGATGHNIPQKLSLNAELQ
LDRQKPRQGRRVLLLGSQQAGTTLNLDLGGKHSPICHTTMAFLRDEADFRDKLSPIVLSL
NVSLPPTEAGMAPAVVLHGDTHVQEQTRIVLDCGEDDVCVPQLQLTASVTGSPLLVGADN
VLELQMDAANEGEGAYEAELAVHLPQGAHYMRALSNVEGFERLICNQKKENETRVVLCEL
GNPMKKNAQIGIAMLVSVGNLEEAGESVSFQLQIRSKNSQNPNSKIVLLDVPVRAEAQVE
LRGNSFPASLVVAAEEGEREQNSLDSWGPKVEHTYELHNNGPGTVNGLHLSIHLPGQSQP
SDLLYILDIQPQGGLQCFPQPPVNPLKVDWGLPIPSPSPIHPAHHKRDRRQIFLPEPEQP
SRLQDPVLVSCDSAPCTVVQCDLQEMARGQRAMVTVLAFLWLPSLYQRPLDQFVLQSHAW
FNVSSLPYAVPPLSLPRGEAQVWTQLLRALEERAIPIWWVLVGVLGGLLLLTILVLAMWK
VGFFKRNRPPLEEDDEEGE
>sp|P38570|ITAE_HUMAN Integrin alpha-E precursor (Mucosal lymphocyte-1 antigen) (HML-1 
MWLFHTLLCIASLALLAAFNVDVARPWLTPKGGAPFVLSSLLHQDPSTNQTWLLVTSPRT
KRTPGPLHRCSLVQDEILCHPVEHVPIPKGRHRGVTVVRSHHGVLICIQVLVRRPHSLSS
ELTGTCSLLGPDLRPQAQANFFDLENLLDPDARVDTGDCYSNKEGGGEDDVNTARQRRAL
EKEEEEDKEEEEDEEEEEAGTEIAIILDGSGSIDPPDFQRAKDFISNMMRNFYEKCFECN
FALVQYGGVIQTEFDLRDSQDVMASLARVQNITQVGSVTKTASAMQHVLDSIFTSSHGSR
RKASKVMVVLTDGGIFEDPLNLTTVINSPKMQGVERFAIGVGEEFKSARTARELNLIASD
PDETHAFKVTNYMALDGLLSKLRYNIISMEGTVGDALHYQLAQIGFSAQILDERQVLLGA
VGAFDWSGGALLYDTRSRRGRFLNQTAAAAADAEAAQYSYLGYAVAVLHKTCSLSYVAGA
PQYKHHGAVFELQKEGREASFLPVLEGEQMGSYFGSELCPVDIDMDGSTDFLLVAAPFYH
VHGEEGRVYVYRLSEQDGSFSLARILSGHPGFTNARFGFAMAAMGDLSQDKLTDVAIGAP
LEGFGADDGASFGSVYIYNGHWDGLSASPSQRIRASTVAPGLQYFGMSMAGGFDISGDGL
ADITVGTLGQAVVFRSRPVVRLKVSMAFTPSALPIGFNGVVNVRLCFEISSVTTASESGL
REALLNFTLDVDVGKQRRRLQCSDVRSCLGCLREWSSGSQLCEDLLLMPTEGELCEEDCF
SNASVKVSYQLQTPEGQTDHPQPILDRYTEPFAIFQLPYEKACKNKLFCVAELQLATTVS
QQELVVGLTKELTLNINLTNSGEDSYMTSMALNYPRNLQLKRMQKPPSPNIQCDDPQPVA
SVLIMNCRIGHPVLKRSSAHVSVVWQLEENAFPNRTADITVTVTNSNERRSLANETHTLQ
FRHGFVAVLSKPSIMYVNTGQGLSHHKEFLFHVHGENLFGAEYQLQICVPTKLRGLQVAA
VKKLTRTQASTVCTWSQERACAYSSVQHVEEWHSVSCVIASDKENVTVAAEISWDHSEEL
LKDVTELQILGEISFNKSLYEGLNAENHRTKITVVFLKDEKYHSLPIIIKGSVGGLLVLI
VILVILFKCGFFKRKYQQLNLESIRKAQLKSENLLEEEN
>sp|P24063|ITAL_MOUSE Integrin alpha-L precursor (Leukocyte adhesion glycoprotein LFA-1 
MSFRIAGPRLLLLGLQLFAKAWSYNLDTRPTQSFLAQAGRHFGYQVLQIEDGVVVGAPGE
GDNTGGLYHCRTSSEFCQPVSLHGSNHTSKYLGMTLATDAAKGSLLACDPGLSRTCDQNT
YLSGLCYLFPQSLEGPMLQNRPAYQECMKGKVDLVFLFDGSQSLDRKDFEKILEFMKDVM
RKLSNTSYQFAAVQFSTDCRTEFTFLDYVKQNKNPDVLLGSVQPMFLLTNTFRAINYVVA
HVFKEESGARPDATKVLVIITDGEASDKGNISAAHDITRYIIGIGKHFVSVQKQKTLHIF
ASEPVEEFVKILDTFEKLKDLFTDLQRRIYAIEGTNRQDLTSFNMELSSSGISADLSKGH
AVVGAVGAKDWAGGFLDLREDLQGATFVGQEPLTSDVRGGYLGYTVAWMTSRSSRPLLAA
GAPRYQHVGQVLLFQAPEAGGRWNQTQKIEGTQIGSYFGGELCSVDLDQDGEAELLLIGA
PLFFGEQRGGRVFTYQRRQSLFEMVSELQGDPGYPLGRFGAAITALTDINGDRLTDVAVG
APLEEQGAVYIFNGKPGGLSPQPSQRIQGAQVFPGIRWFGRSIHGVKDLGGDRLADVVVG
AEGRVVVLSSRPVVDVVTELSFSPEEIPVHEVECSYSAREEQKHGVKLKACFRIKPLTPQ
FQGRLLANLSYTLQLDGHRMRSRGLFPDGSHELSGNTSITPDKSCLDFHFHFPICIQDLI
SPINVSLNFSLLEEEGTPRDQKGRAMQPILRPSIHTVTKEIPFEKNCGEDKKCEANLTLS
SPARSGPLRLMSSASLAVEWTLSNSGEDAYWVRLDLDFPRGLSFRKVEMLQPHSRMPVSC
EELTEGSSLLTKTLKCNVSSPIFKAGQEVSLQVMFNTLLNSSWEDFVELNGTVHCENENS
SLQEDNSAATHIPVLYPVNILTKEQENSTLYISFTPKGPKTQQVQHVYQVRIQPSAYDHN
MPTLEALVGVPRPHSEDLITYTWSVQTDPLVTCHSEDLKRPSSEAEQPCLPGVQFRCPIV
FRWEILIQVTGTVELSKEIKASSTLSLCSSLSVSFNSSKHFHLYGSKASEAQVLVKVDLI
HEKEMLHVYVLSGIGGLVLLFLIFLALYKVGFFKRNLKEKMEADGGVPNGSPPEDTDPLA
VPGEETKDMGCLEPSGRVTRTKA
>sp|P05555|ITAM_MOUSE Integrin alpha-M precursor (Cell surface glycoprotein MAC-1 alpha 
MTLKALLVTALALCHGFNLDTEHPMTFQENAKGFGQNVVQLGGTSVVVAAPQEAKAVNQT
GALYQCDYSTSRCHPIPLQVPPEAVNMSLGLSLAVSTVPQQLLACGPTVHQNCKENTYVN
GLCYLFGSNLLRPPQQFPEALRECPQQESDIVFLIDGSGSINNIDFQKMKEFVSTVMEQF
KKSKTLFSLMQYSDEFRIHFTFNDFKRNPSPRSHVSPIKQLNGRTKTASGIRKVVRELFH
KTNGARENAAKILVVITDGEKFGDPLDYKDVIPEADRAGVIRYVIGVGNAFNKPQSRREL
DTIASKPAGEHVFQVDNFEALNTIQNQLQEKIFAIEGTQTGSTSSFEHEMSQEGFSASIT
SNGPLLGSVGSFDWAGGAFLYTSKDKVTFINTTRVDSDMNDAYLGYASAVILRNRVQSLV
LGAPRYQHIGLVVMFRENFGTWEPHTSIKGSQIGSYFGASLCSVDMDADGNTNLILIGAP
HYYEKTRGGQVSVCPLPRGRARWQCEALLHGDQGHPWGRFGAALTVLGDVNGDKLTDVAI
GAPGEQENQGAVYIFYGASIASLSASHSHRIIGAHFSPGLQYFGQSLSGGKDLTMDGLMD
LAVGAQGHLLLLRAQPVLRLEATMEFSPKKVARSVFACQEQVLKNKDAGEVRVCLRVRKN
TKDRLREGDIQSTVTYDLALDPVRSRIRAFFDETKNNTRRRTQVFGLMQKCETLKLILPD
CVDDSVSPIILRLNYTLVGEPLRSFGNLRPVLAMDAQRFFTAMFPFEKNCGNDSICQDDL
SITMSAMGLDTLVVGGPQDFNMSVTLRNDGEDSYGTQVTVYYPSGLSYRKDSASQNPLTK
KPWFVKPAESSSSSEGHGALKSTTWNINHPIFPANSEVTFNVTFDVDSHASFGNKLLLKA
IVASENNMSRTHKTKFQLELPVKYAIYMIVTSDESSIRYLNFTASEMTSKVIQHQYQFNN
LGQRSLPVSVVFWIPVQINNVTVWDHPQVIFSQNLSSACHTEQKSPPHSNFRDQLERTPV
LNCSVAVCKRIQCDLPSFNTQEIFNVTLKGNLSFDWYIKTSHGHLLLVSSTEILFNDSAF
ALLPGQESYVRSKTETKVEPYEVHNPVPLIVGSSIGGLVLLALITAGLYKLGFFKRQYKD
MMNEAAPQDAPPQ
>sp|P26008|ITAV_CHICK Integrin alpha-V precursor (Vitronectin receptor alpha subunit) 
MAALRASLLLSCALTAARAFNLDAERPAVYSGAEGSYFGFAVDFFAPDASSMFLLVGAPK
ANTSQSNVVEGGQVLQCNWNSNRNCQPIIFDSTGNRDFAPDDPLEFKSHQWFGASVRSKN
DKILACAPLYHWRTETKQEREPVGTCYLFDGSKSVEYAPCRSTTIDADGQGFCQGGFSID
FTKGDRVLLGGPGSFYWQGQLISDRVAEILAKYDSKVYSTKYDDQLATRPASAAFDDSYL
GYSVAVGDFSGDGIEDFVSGVPRAARTLGMVSIYNGKNMSSMYNFTGEQMAAYFGYSVAT
TDINGDDYTDLFIGAPLFMDRGSDGKLQEVGQVSICLQRASGGFQIAKLNGFEIFARFGS
AIAPLGDLDQDGFNDIAVAAPYGGEDKRGLVYIYNGRATGLNAVPSRILEGQWAARTMPP
SFGYSLKGATDVDKNGYPDLIVGAFGVDTAVLYRARPVIRVNAALEVNPTILNPENKACS
LADVKVSCFKVKFCLKADGKGKLPNSLNFQVELLLDKLKQKGAIRRALFLHSKQPSHSKN
MTITKGGKMNCEELDAFLRDESEFRDKLTPITIFMEYRLDYKTAVDATGLHPILNQFIPA
NMSRQAHILLDCGEDNICKPKLEVSVRSDQKKIYIGDDNPLTLIVTAENQGEGAYEAELF
VIVPPQADFIGVVRNNEALARLSCAFKTENQTRMVVCDLGNPMKAGTKLLAGLRFSVHQQ
SEMDTSVKFDLQIRSSNLFDNLSPVAFYQVDLAISAAVEIRGVSSPDHIFLPIANWQPKE
NPETEDDIGPLVQHIYELRNNGPSAFSKVMMTLQWPYKYKNYTLLYIVQYDIDGPMNCTS
DMEINPLKIKISAPKEDEKNETFSREDNRNHRISRRDLTAIEGDVQTLGCGNADCLKIVC
QVGHLERGKSAILYLKSRLWTQTFMNKENQNHSYSLQSSASFNVIEFPYKNLSFEDIHNS
TVVTTNITWGIQPQPMPVPVWVIILAVLAGLLLLAVLVLVMYRMGFFKRVRPPQEEQERE
QLQPHENGEGTSEA
>sp|P07228|ITB1_CHICK Integrin beta-1 precursor (CSAT antigen) (JG22 antigen) (RGD- 
MAETNLTLLTWAGILCCLIWSGSAQQGGSDCIKANAKSCGECIQAGPNCGWCKKTDFLQE
GEPTSARCDDLAALKSKGCPEQDIENPRGSKRVLEDREVTNRKIGAAEKLKPEAITQIQP
QKLVLQLRVGEPQTFSLKFKRAEDYPIDLYYLMDLSYSMKDDLENVKSLGTALMREMEKI
TSDFRIGFGSFVEKTVMPYISTTPAKLRNPCTGDQNCTSPFSYKNVLSLTSEGNKFNELV
GKQHISGNLDSPEGGFDAIMQVAVCGDQIGWRNVTRLLVFSTDAGFHFAGDGKLGGIVLP
NDGKCHLENNMYTMSHYYDYPSIAHLVQKLSENNIQTIFAVTEEFQAVYKELKNLIPKSA
VGTLSSNSSNVIQLIIDAYNSLSSEVILENSKLPKEVTISYKSYCKNGVNDTQEDGRKCS
NISIGDEVRFEINVTANECPKKGQNETIKIKPLGFTEEVEIHLQFICDCLCQSEGEPNSP
ACHDGNGTFECGACRCNEGRIGRLCECSTDEVNSEDMDAYCRRENSTEICSNNGECICGQ
CVCKKRENTNEVYSGKYCECDNFNCDRSNGLICGGNGICKCRVCECFPNFTGSACDCSLD
TTPCMAGNGQICNGRGTCECGTCNCTDPKFQGPTCEMCQTCLGVCAEHKDCVQCRAFEKG
EKKETCSQECMHFNMTRVESRGKLPQPVHPDPLSHCKEKDVGDCWFYFTYSVNSNGEASV
HVVETPECPSGPDIIPIVAGVVAGIVLIGLALLLIWKLLMIIHDRREFAKFEKEKMNAKW
DTGENPIYKSAVTTVVNPKYEGK
>sp|P11835|ITB2_MOUSE Integrin beta-2 precursor (Cell surface adhesion glycoproteins LFA- 
MLGLRPSLLLALAGLFFLGSAVSQECTKYKVSSCRDCIQSGPGCSWCQKLNFTGPGEPDS
LRCDTRAQLLLKGCPADDIMDPRSIANPEFDQRGQRKQLSPQKVTLYLRPGQAAAFNVTF
RRAKGYPIDLYYLMDLSYSMLDDLNNVKKLGGDLLQALNEITESGRIGFGSFVDKTVLPF
VNTHPEKLRNPCPNKEKACQPPFAFRHVLKLTDNSNQFQTEVGKQLISGNLDAPEGGLDA
IMQVAACPEEIGWRNVTRLLVFATDDGFHFAGDGKLGAILTPNDGRCHLEDNMYKRSNEF
DYPSVGQLAHKLSESNIQPIFAVTKKMVKTYEKLTEIIPKSAVGELSDDSSNVVQLIKNA
YYKLSSRVFLDHSTLPDTLKVTYDSFCSNGASSIGKSRGDCDGVQINNPVTFQVKVMASE
CIQEQSFVIRALGFTDTVTVQVRPQCECQCRDQSREQSLCGGKGVMECGICRCESGYIGK
NCECQTQGRSSQELERNCRKDNSSIVCSGLGDCICGQCVCHTSDVPNKEIFGQYCECDNV
NCERYNSQVCGGSDRGSCNCGKCSCKPGYEGSACQCQRSTTGCLNARLVECSGRGHCQCN
RCICDEGYQPPMCEDCPSCGSHCRDNHTSCAECLKFDKGPFEKNCSVQCAGMTLQTIPLK
KKPCKERDSEGCWITYTLQQKDGRNIYNIHVEDSLECVKGPNVAAIVGGTVVGVVLIGVL
LLVIWKALTHLTDLREYRRFEKEKLKSQWNNDNPLFKSATTTVMNPKFAES
>sp|P26013|ITB8_RABIT Integrin beta-8 precursor. 
MCGSALGLPPAAFVRLRSCRPGPAAFLRAAWVLSLVLGLGRSENSRCASSHAVSCSECLA
LGPDCGWCVHEDFISGGPRSERCDIVSNLISKGCPVDSIEYPSVHVTIPSENEVNTQVTP
GEVSIQLRPGAAANFMLKIHPLKKYPVDLYYLVDVSASMHNNIEKLNSVGNDLSRKMAFF
SRDFRLGFGSYVDKTVSPYISIHPERIHNQCSDYNLDCMPPHGYIHVLSLTENITEFERA
VHRQKISGNIDTPEGGFDAMLQAAVCESHIGWRKEAKRLLLVMTDQTSHLALDSKLAGIV
VPNDGNCHLRNNVYVKSTTMEHPSLGQLSEKLIDNNINVIFAVQGKQFHWYKDLLPLLPG
TIAGEIESKAANLNNLVVEAYQKLISEVKVQVESKVPGVYFNVTAICPDGARKLGMEGCS
NVTSSDEVLFNVTVTMEKCSVTGGKNYAIIKPIGFNETSKIHIHQNCGCECEASRGGAAK
CAEEAPLDSTCPQCQESQCHQEEAQSPSQGCKAHEDQPVCSGRGVCVCGKCLCHKMKLGK
VYGKYCEKDDFSCPYHHGSLCAGHGECEAGRCQCFSGWEGDRCQCPSAAAQHCVNSKGQV
CSGRGTCVCGRCECSDPRSIGRFCEHCPTCPTACSENWNCVQCLHPHNLSQAILDQCRTS
CASMEQPYVEQASECFSSPSYLRIFFIIFIVTFLIGLLKILIIRQVILQWNSSKIKSSSD
YRVSASKKDKLILQSVCTRAVTYRREKPEEIKLDISKLNAHETFRCNF
>sp|P36937|KDPF_ECOLI Protein kdpF. 
MSAGVITGVLLVFLLLGYLVYALINAEAF
>sp|P29323|EPB2_HUMAN Ephrin type-B receptor 2 precursor (EC 2.7.1.112) (Tyrosine-protein 
MALRRLGAALLLLPLLAAVEETLMDSTTATAELGWMVHPPSGWEEVSGYDENMNTIRTYQ
VCNVFESSQNNWLRTKFIRRRGAHRIHVEMKFSVRDCSSIPSVPGSCKETFNLYYYEADF
DSATKTFPNWMENPWVKVDTIAADESFSQVDLGGRVMKINTEVRSFGPVSRSGFYLAFQD
YGGCMSLIAVRVFYRKCPRIIQNGAIFQETLSGAESTSLVAARGSCIANAEEVDVPIKLY
CNGDGEWLVPIGRCMCKAGFEAVENGTVCRGCPSGTFKANQGDEACTHCPINSRTTSEGA
TNCVCRNGYYRADLDPLDMPCTTIPSAPQAVISSVNETSLMLEWTPPRDSGGREDLVYNI
ICKSCGSGRGACTRCGDNVQYAPRQLGLTEPRIYISDLLAHTQYTFEIQAVNGVTDQSPF
SPQFASVNITTNQAAPSAVSIMHQVSRTVDSITLSWSQPDQPNGVILDYELQYYEKELSE
YNATAIKSPTNTVTVQGLKAGAIYVFQVRARTVAGYGRYSGKMYFQTMTEAEYQTSIQEK
LPLIIGSSAAGLVFLIAVVVIAIVCNRRGFERADSEYTDKLQHYTSGHMTPGMKIYIDPF
TYEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT
EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV
IQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY
TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE
QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLKAMAPLSSGI
NLPLLDRTIPDYTSFNTVDEWLEAIKMGQYKESFANAGFTSFDVVSQMMMEDILRLGVTL
AGHQKKILNSIQVMRAQMNQIQSVEGQPLARRPRATGRTKRCQPRDVTKKTCNSNDGKKK
GMGKKKTDPGRGREIQGIFFKEDSHKESNDCSCGG
>sp|P37172|AVR1_MOUSE Activin receptor type I precursor (EC 2.7.1.37) (ACTR-I) 
MVDGVMILPVLMMMAFPSPSVEDEKPKVNQKLYMCVCEGLSCGNEDHCEGQQCFSSLSIY
DGFHVYQKGCFQVYEQGKMTCKTPPSPGQAVECCQGDWCNRNITAQLPTKGKSFPGTQNF
HLEVGLIILSVVFAVCLLACILGVALRKFKRRNQERLNPRDVEYGTIEGLITTNVGDSTL
AELLDHSCTSGSGSGLPFLVQRTVARQITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR
DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTL
DTVSCLRIVLSIASGLAHLHIEIFGTQGKSAIAHRDLKSKNILVKKNGQCCIADLGLAVM
HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS
NGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQ
NPSARLTALRIKKTLTKIDNSLDKLKTDC
>sp|P80203|KIR3_RAT Serine/threonine-protein kinase receptor R3 precursor (EC 2.7.1.37) 
MTLGIFRRVFLMLSVALGLTKGDLVKPSRGQLVNCTCENPHCKRPICQGAWCTVVLVREQ
GRHPQVYRGCGSLNQELCLGRPTEFVNHHCCYRSFCNHNVSLMLEATQTPSEEPEVDAHL
PLILGPVLALLVLVALGTLGLWRVRRRQEKQRGLHSDLGESSLILKASEQGDSMLGDFLV
SDCTTGSGSGLPFLVQRTVARQVALVECVGKGRYGEVWRGSWHGESVAVKIFSSRDEQSW
FRETEIYNTVLLRHDNILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPQLA
LRLAVSAACAGLAHLHVEIFGTQGKPAIAHRDLKSRNVLVKSNLQCCIADLGLAVMHSQS
SDYLDIGNNPRVGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIINGIV
EDYRPPFYDMVPNDPSFEDMKKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSA
RLTALRIKKTLQKLSQNPEKPKVIH
>sp|P36897|TGR1_HUMAN TGF-beta receptor type I precursor (EC 2.7.1.37) (TGFR-1) (TGF-beta 
MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTE
TTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPG
LGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDL
IYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER
SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE
GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS
ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI
HEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA
ARLTALRIKKTLSQLSQQEGIKM
>sp|Q08156|KIT_CHICK Mast/stem cell growth factor receptor precursor (EC 2.7.1.112) (SCFR) 
MEGAHLAWELAHAVLLLSLIPAGGSVPHEESSLVVNKGEELRLKCNEEGPVTWNFQNSDP
SAKTRISNEKEWHTKNATIRDIGRYECKSKGSIVNSFYVFVKDPNVLFLVDSLIYGKEDS
DILLVCPLTDPDVLNFTLRKCDGKPLPKNMTFIPNPQKGIIIKNVQRSFKGCYQCLAKHN
GVEKISEHIFLNVRPVHKALPVITLSKSYELLKEGEEFEVTCIITDVDSSVKASWISYKS
AIVTSKSRNLGDYGYERKLTLNIRSVGVNDSGEFTCQAENPFGKTNATVTLKALAKGFVR
LFATMNTTIDINAGQNGNLTVEYEAYPKPKEEVWMYMNETLQNSSDHYVKFKTVGNNSYT
SELHLTRLKGTEGGIYTFFVSNSDASSSVTFNVYVKTKPEILTLDMLGNDILQCVATGFP
APTIYWYFCPGTEQRCLDSPTISPMDVKVSYTNSSVPSFERILVESTVNASMFKSTGTIC
CEASSNGDKSSVFFNFAIKEQIRTHTLFTPLLIAFGVAAGLMCIIVMILVYIYLQKPKYE
VQWKVVEEINGNNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKS
DAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTIGGPTLVITEYCC
YGDLLNFLRRKRDSFICPKHEEHAEAAVYENLLHQAEPTADAVNEYMDMKPGVSYAVPPK
ADKKRPVKSGSYTDQDVTLSMLEDDELALDVEDLLSFSYQVAKGMSFLASKNCIHRDLAA
RNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY
GILLWELFSLGSSPYPGMPVDSKFYKMIKEGYRMFSPECSPPEMYDIMKSCWDADPLQRP
TFKQIVQLIEQQLSDNAPRVYANFSTPPSTQGNATDHSVRINSVGSSASSTQPLLVREDV
>sp|Q03137|EPA4_MOUSE Ephrin type-A receptor 4 precursor (EC 2.7.1.112) (Tyrosine-protein 
MAGIFYFILFSFLFGICDAVTGSRVYPANEVTLLDSRSVQGELGWIASPLEGGWEEVSIM
DEKNTPIRTYQVCNVMEASQNNWLRTDWITREGAQRVYIEIKFTLRDCNSLPGVMGTCKE
TFNLYYYESDNDKERFIRESQFGKTDTIAADESFTQVDIGDRIMKLNTEIRDVGPLSKKG
FYLAFQDVGACIALVSVRVFYKKCPLTVRNLAQFPDTITGADTSSLVEVRGSCVNNSEEK
DVPKMYCGADGEWLVPIGNCLCNAGHEEQNGECQACKIGYYKALSTDASCAKCPPHSYSV
WEGATSCTCDRGFFRADNDAASMPCTRPPSAPLNLISNVNETSVNLEWSSPQNTGGRQDI
SYNVVCKKCGAGDPSKCRPCGSGVHYTPQQNGLKTTRVSITDLLAHTNYTFEIWAVNGVS
KYNPSPDQSVSVTVTTNQAAPSSIALVQAKEVTRYSVALAWLEPDRPNGVILEYEVKYYE
KDQNERSYRIVRTAARNTDIKGLNPLTSYVFHVRARTAAGYGDFSEPLEVTTNTVPSRII
GDGANSTVLLVSVSGSVVLVVILIAAFVISRRRSKYSKAKQEADEEKHLNQGVRTYVDPF
TYEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYT
DKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV
IQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT
TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEG
YRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIRNPNSLKRTGSESSRPNT
ALLDPSSPEFSAVVSVGDWLQAIKMDRYKDNFTAAGYTTLEAVVHMSQDDLARIGITAIT
HQNKILSSVQAMRTQMQQMHGRMVPV
>sp|P27810|KTR1_YEAST Alpha-1,2 mannosyltransferase KTR1 (EC 2.4.1.131). 
MAKIMIPASKQPVYKKLGLLLVAVFTVYVFFHGAQYARGSAPSPKYSTVLSSGSGYKYSK
VELPKYTGPREKATFVTLVRNRDLYSLAESIKSVEDRFNSKFNYDWVFLNDEEFTDEFKN
VTSALVSGTTKYGVIPKEHWSFPEWIDEEKAAQVRKEMGEKRIIYGDSISYRHMCRFESG
FFYRHPLMDDYDWYWRVEPDIKLHCDIDYDVFKFMKDNKKKYAFAISIKEYEATIPTLWE
TTRKFMEAHPELIHENNMLDFVSDDQGLSYNLCHFWSNFEIAALDLWRSPAYSAYFDYLD
REGGFFYERWGDAPVHSIGAALFLDRSEIHHFGDIGYYHVPFHSCPIDTSIRLANKCDCD
PSKDFTWHSYSCTTKFYNINKLPKPAGWQNHIG
>sp|P10716|KUCR_RAT Kupffer cell receptor. 
MKEAELNRDVAKFCTDNQCVILQPQGLGPKSAAPMAPRTLRHVQAIVALVVVTVFFSLLA
LFVVVLQPWRQKQNEDHPVKAGLHGGNYSGSDNCSQFVRRAEMQEAIQSLRASGNSSSCH
KEIQTLKYQMDNVSSQVQLLGGHLEEANADIQQAKDVLKGTGALASETQALRSSLEVASA
DIHSLRGDLEKANAMTSQTQGLLKSSTDNTSAELHVLGRGLEEAQSEIQALRGSLQSSND
LGSRTQNFLQHSMDNISAEIQAMRDGMQRAGEEMTSLKKDLETLTAQIQNANGHLEQTDT
QIQGLKAQLKSTSSLNSQIEVVNGKLKDSSRELQTLRRDLSDVSALKSNVQMLQSNLQKA
KAEVQSLKTGLEATKTLAAKIQGQQSDLEALQKAVAAHTQGQKTQNQVLQLIMQDWKYFN
GKFYYFSRDKKSWHEAENFCVSQGAHLASVTSQEEQAFLVQITNAVDHWIGLTDQGTEGN
WRWVDGTPFDYVQSRRFWRKGQPDNWRHGNGEREDCVHLQRMWNDMACGTAYNWVCKKST
DWSVARTDQS
>sp|P40970|LCB2_YEAST Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base 
MSTPANYTRVPLCEPEELPDDIQKENEYGTLDSPGHLYQVKSRHGKPLPEPVVDTPPYYI
SLLTYLNYLILIILGHVHDFLGMTFQKNKHLDLLEHDGLAPWFSNFESFYVRRIKMRIDD
CFSRPTTGVPGRFIRCIDRISHNINEYFTYSGAVYPCMNLSSYNYLGFAQSKGQCTDAAL
ESVDKYSIQSGGPRAQIGTTDLHIKAEKLVARFIGKEDALVFSMGYGTNANLFNAFLDKK
CLVISDELNHTSIRTGVRLSGAAVRTFKHGDMVGLEKLIREQIVLGQPKTNRPWKKILIC
AEGLFSMEGTLCNLPKLVELKKKYKCYLFIDEAHSIGAMGPTGRGVCEIFGVDPKDVDIL
MGTFTKSFGAAGGYIAADQWIIDRLRLDLTTVSYSESMPAPVLAQTISSLQTISGEICPG
QGTERLQRIAFNSRYLRLALQRLGFIVYGVADSPVIPLLLYCPSKMPAFSRMMLQRRIAV
VVVAYPATPLIESRVRFCMSASLTKEDIDYLLRHVSEVGDKLNLKSNSGKSSYDGKRQRW
DIEEVIRRTPEDCKDDKYFVN
>sp|Q99088|LDL2_XENLA Low-density lipoprotein receptor 2 precursor (LDL receptor 2). 
MMKPAVSFPLLLLGLCHVSAFSGIGKCDRNEFQCGDGKCIPYKWICDGSAECKDGSDESS
ETCRALTCGADQFSCGGRLNRCIPMSWKCDGQTDCENGSDENDCTRKVCADDQFTCRSGK
CISLDFVCDQDQDCDDGSDESYCPAPTCNPAMFQCKDKGICIPKLWACDGDRDCEDGSDE
DHCEGREPIKTDKPCAPLEFHCGSGECIHMSWKCDAGYDCKHKSDDKDCVKPTCRPDQFQ
CNDGTCIHGSRQCDREYDCKDLSDEEGCVNVTKCQGPDVFKCRSGECITMDKVCHKKRDC
RDWTDEPIKECGENECLRNNGGCSHICNDLKIGYECLCNEGYRLVDQKRCEDINECENPN
TCTQICINLHGGYKCECREGYQMDPVTASCKSIGTVAYLFFTNRHEVRKMTLDRSEYTSF
IPRLKNVVALDMEIASNKIYWSDLTQRKIYSASMDKADNTSHHETVISNQIQAPDGIAVD
WIHGNIYWTDSKFSTISVANTEGSKRKTLFTDDLAKPRDIVVDPSQGFMYWTDWGLPAKI
EKGGLNGVDRYPLVTDNIEWPNGITLDLISQRLYWVDSKLHSLSCIDITGENRRTVLSDE
THLAHPFGLTIFEDLVFWTDIENEAIFSAKRLTGENIMKVAEHLLSPEDIVLYHNLRQPK
AENWCESHHLGNGGCGYLCLPAPHVNARSPKFTCACPDGMHLGTDMRNCMKEPVTQEATT
STTTSAPVTTTSTARPSSRITTLAKIASTTSTLAPQRPKMVSTTVPPRRPTTNSPKTTLR
MNTEKVPAHTTQEPMTHSQLARNKFAEAGVVESARSHPTALYIVLPILILCLVSFGGFLL
WKNWRLKNTNSINFDNPVYQKTTEEDQVHICRSQDGYTYPSRQMVSLEDHIA
>sp|P35953|LDVR_RABIT Very low-density lipoprotein receptor precursor (VLDL receptor). 
MGTSARRALWLLLALCWALRESGATATGRKTKCEASQFQCTNGRCITQLWKCDGDEDCVD
GSDEKNCVKKTCAESDFVCNNGQCIPNRWQCDGDPDCEDGSDESPEQCHMRTCRINEISC
GARSTQCIPVSWRCDGESDCDSGEDEENCGNVTCSSDEFTCSSGRCISRNFVCNGQDDCS
DGSDELDCAPPTCGAHEFQCSTSSCIPISWVCDDDADCSDQSDESLEQCGRQPVIHTKCP
ASEIQCGSGECIHKKWRCDGDPDCKDGSDEVNCPSRTCRPDQFECEDGSCIHGSRQCNGI
RDCVDGSDEVNCKNVNQCLGPGKFKCRSGECIDISKVCNQEQDCRDWSDEPLKECHVNEC
LVNNGGCSHICKDSVIGYECDCAAGFELIDRKTCGDIDECQNPGICSQICINLKGGYKCE
CSRGYQMDLATGVCKAVGKEPSLIFTNRRDIRKIGLERKEYIQLVEQLRNTVALDADIAA
QKLFWADVSQKAIFSASIDDKVGRHVKMIDNVYNPAAIAVDWVYKTIYWTDAASRTISVA
TLDGAKRKFLFNSDLREPASIAVDPLSGFVYWSDWGEPAKIEKAGMNGFDRRPLVTVDIQ
WPNGITLDLIKSRLYWLDSKLHMLSSVDLNGQDRRIVLKSLEFLAHPLALTIFEDRVYWI
DGENEAVYGANKFTGSELATLVNNLNDAQDIIVYHELVQPSGKNWCEEDMENGGCEYLCL
PAPQINEHSPKYTCSCPNGYHLEENGRECQSTATTVTYSETKDTNTTEISPTSGLVPGEI
NVTTAVSEVSVPPKGTSAAWAILPLLLLAMAAVGGYLMWRNWQHKNMKSMNFDNPVYLKT
TEEDLSIDIGRHSASVGHTYPAISVVSTDDDLA
>sp|P08290|LECI_RAT Asialoglycoprotein receptor R2/3 (Hepatic lectin 2/3) (RHL-2) (ASGP-R) 
MEKDFQDIQQLDSEENDHQLIGDEEQGSHVQNLRTENPRWGGQPPSRPFPQRLCSKFRLS
LLALAFNILLLVVICVVSSQSMQLQKEFWTLKETLSNFSTTTLMEFKALDSHGGSRNDNL
TSWETILEKKQKDIKADHSTLLFHLKHFPLDLRTLTCQLAFFLSNGTECCPVNWVEFGGS
CYWFSRDGLTWAEADQYCQMEIAHLLVINSREEQEFVVKHRGAFHIWIGLTDKDGSWKWV
DGTEYRSNFKNWAFTQPDNCQGHEEGGSEDCAEILSDGLWNDNFCQQVNRWACERKRDIT
Y
>sp|P34927|LECH_MOUSE Asialoglycoprotein receptor 1 (Hepatic lectin 1) (MHL-1) (ASGP-R) 
TKDYQDFQHLDNDNDHHQLRRGPPPTPRLLQRLCSGSRLLLLSSSLSILLLVVVCVITSQ
NSQLREDLLALRQNFSNLTVSTEDQVKALSTQGSSVGRKMKLVESKLEKQQKDLTEDHSS
LLLHVKQLVSDVRSLSCQMAAFRGNGSERICCPINWVEYEGSCYWFSSSVRPWTEADKYC
QLENAHLVVVTSRDEQNFLQRHMGPLNTWIGLTDQNGPWKWVDGTDYETGFQNWRPEQPD
NWYGHGLGGGEDCAHFTTDGRWNDDVCRRPYRWVCETKLDKAN
>sp|P30836|LEM1_RAT L-selectin precursor (Lymph node homing receptor) (Leukocyte adhesion 
MVFPWRCQSAQRGSWSFLKLWIRTLLCCDLLPHHGTHCWTYHYSERSMNWENARKFCKHN
YTDLVAIQNKREIEYLEKTLPKNPTYYWIGIRKIGKTWTWVGTNKTLTKEAENWGTGEPN
NKKSKEDCVEIYIKRERDSGKWNDDACHKRKAALCYTASCQPESCNRHGECVETINNNTC
ICDPGYYGPQCQYVIQCEPLKAPELGTMNCIHPLGDFSFQSQCAFNCSEGSELLGNAKTE
CGASGNWTYLEPICQVIQCMPLAAPDLGTMECSHPLANFSFTSACTFTCSEETDLIGERK
TVCRSSGSWSSPSPICQKTKRSFSKIKEGDYNPLFIPVAVMVTAFSGLAFIIWLARRLKK
GKKSQERMDDPY
>sp|Q01102|LEM3_MOUSE P-selectin precursor (Granule membrane protein 140) (GMP-140) (PADGEM) 
MAGCPKGSWTPRLRSVILGGAQLIWFSALISELVNQKEVAAWTYNYSTKAYSWNNSRVFC
RRHFTDLVAIQNKNEIAHLNDVIPFFNSYYWIGIRKINNKWTWVGTNKTLTEEAENWADN
EPNNKKNNQDCVEIYIKSNSAPGKWNDEPCFKRKRALCYTASCQDMSCSNQGECIETIGS
YTCSCYPGFYGPECEYVKECGKVNIPQHVLMNCSHPLGEFSFNSQCTFSCAEGYELDGPG
ELQCLASGIWTNNPPKCDAVQCQSLEAPPHGTMACMHPIAAFAYDSSCKFECQPGYRARG
SNTLHCTGSGQWSEPLPTCEAIACEPPEIPIHGSMDCVPSTGTFGYNSSCTFLCAEGFVL
KGNDAIQCADSGQWTAPAPFCEALQCPEFPVPSKAQVNCSDPFGTLTYQSVCSFSCDEGS
LLVGASVIRCLATGHWNGAPPECQAVSCAPMLSPENGSMTCVQPLGNSTYKSTCQFMCDE
GFYLSGPERLDCSPSGHWTGTPPTCEAIKCPGIFAPEQGNLDCSHVHGEFGVGSICHFSC
NEDFELLGSENVECTVSGRWSAPPPTCKGITSLPAPAVRCPALTTPGQGTMSCQHHLGSF
GPNTTCYFGCKTGFTLRGANSLRCRASGQWTAVTPMCRAVKCSELHMDTAVAMNCSNPWG
NFSYGSTCTFQCPEGQSLNGSVRATCREDGHWSDAMPTCQAGTLTIQEALTYLGGAVAST
TGLAVGGTLLALLRKRLRKKDDGKCPLNPHSHLGTYGVFTNAAYDPTP
>sp|P11153|LIPL_CAVPO Lipoprotein lipase precursor (EC 3.1.1.34) (LPL). 
MNIDRKILNKALAKEKVANCQKDYTDIESKFARRTPENTVEDTCHLIPGVTESVANCHFN
HSSKTFMVIHGWTVTGMYESWVPKLVAALYKREPDSNVIVVDWLRRAQHHYPESADYTKL
VGEDVARFINWMEDEFKYSVDNVHLLGYSLGAHAAGVAGSRTNTKVSRITGLDPAGPNFE
YAEATSRLSPDDAQFVDVLHTFTRGSPGRSIGIQKPVGHVDIYPNGGSFQPGCNIQDALR
VISQKGFGDMDQLVKCSHERSIHLFIDSLLNEENPSKAYRCNSKEAFEKGLCLSCRKNRC
NNVGYEINKVRAKRSSKMYLKTRSQMPYKVFHYQVKIYFSGTETTTYTNQAFEISLYGTV
AESENIPFTLPEVSANNTYSFLIYTEVDIGELLMLKLKWITESYFSWSSWWGRPTFTIEK
IRVKAGETQKKIVFCSREKVSKLQKGKEAPVFVKCHDKSLNKKSG
>sp|Q05889|LPG1_LEIDO Galactofuranosyl glycosyltransferase (EC 2.4.1.-). 
MAPPRWHHDRRRMAIFVRVGLYTLLFLMGYVVPLIIFYNRSRADTFEDTPRSGEAFISDE
NFFHCIAERLSYKEQHPARIPYVLIPVTMDYQDIKQLFCNITVPMTYIMFINNGMFRPLR
SLLDRLAVDLRDYVDQNLFIIHHPENIAYASAVNEGLRHALNFSVAKVPWVFITNADVRF
APGLIDEFVSQANEKTQGQLERIRRLDQEIIAEARTLRNVPNRRFAFRSSQHPIITASSL
PYRIRTMPPEEMKKQFADTYGIFYTDHKDFMATFALSRLAIATVGFFDENYYPAYGEDHD
YVWRMAALGYQKYFSEPGKFVHFENANLNVGGSARNRGIFKNTAYFLQSVKFGRMNYQPF
RLQYRRAKWFPDGVTIYQDTGRNPLPFNGTIPLDMWVLDTDRRRSIWEIGENIRCHRDYK
PYSMKLLDFPVDPS
>sp|P09849|LPH_RABIT Lactase-phlorizin hydrolase precursor (Lactase-glycosylceramidase) 
MELFWSIVFTVLLSFSCRGSDWESDSNFISAAGPLTTDLLLSLQYPQGNQTSDFAAGGKD
LYVCSQPLPAFLPEYFSSLRASEITHYKVFLSWAQLLPAGHSGDPDGNAVRCYRQLLEAL
RAAQLQPMVVLHHQHLPASSALRSAVFADLFAEYATFAFHAFGDLVGVWLTFSDLEAAIR
ELPQPESRASRLQLLTEAHRKAYEIYHQKYAAQGGKVSVVLQAEEISELLLESSTSALAK
DSIDFLSLDLSYECQSEMSLPEKLSKLQTIEPKVKVFIFTLRLQDCPSSRKSPASLLFSF
IEAINKDQVLTLGFDVNAFLNCSSTSKKSISCFLTDSLALQTDHERAARNSAPVSTYQRV
WEMFAHQPRAERDAFLQDTFPQGFLWGVSTGAFNVEGGWAEGGRGPSVWDQFGHLKAAQG
QATPEVASDSYYKWASDVALLRGLRAQVYKFSISWSRIFPMGRGSSPSPQGVAYYNKLID
SLLDSHIEPMATLFHWDLPQALQDEGGWQNESVVDAFVDYAAFCFSAFGNRVKLWVTFHE
PWVMSYAGYGTGQHAPGISDPGIASFQVAHLVLKAHARTWHHYNSHHRPQQQGRVGIVLN
SDWAEPLSPERPEDLAASERFLHFMLGWFAHPIFVDGDYPATMKAQIQQRNEQCPSPVAQ
LPEFTDTEKQLLKGSADFLGLSHYTSRLISKAPEDSCIPSYDTIGGFSQHTDPAWPQTSS
PWIRVVPWGIRRLLQFVSLEYTKGKVPIYLAGNGMPIGESENLLSDSLRVDYFNQYINEV
LKAIKEDSVDVRSYIARSLMDGFEGPAGYSQRFGLYHVNFNESSKPRTPRKSAFLLTSII
EKNGFLTKAVKQPLPPNSAHLPSKTRASALPSEVPSKAKVVWEKFSNQTKFERDLFYHGT
FRDDFLWGVSSSAYQIEGAWDADGKGPSIWDNFTHTPGNGVTDNSTGDIACDSYNQLDAD
LNVLRALKVKAYRFSLSWSRIFPTGTNSSINSHGVDYYNRLIDGLLASDIFPMVTLFHWD
LPQALQDIGGWENPSLIDLFDSYADYCFQTFGDRVKFWITFNEPTYYSWWSYGSGTFPPN
VNDPGWAPYRISHALIKAHARVYHTYDEKYRQSQNGVISLSLVAQWAEPKSPDVLRDVEA
ADRKMQFTLGWYAHPIFKTGDYPDAMKWKVGNRSELQHLATSRLPSFTEEEKSYIRGTAD
VFCLNTYSSKIVQHKTPALNPPSYEDDQELAEEEDTSWPTTAMNRAASFGMRRLLNWIKE
EYGDIPIYITENGVGLTNPRLEDIDRIFYYKTYINEALKAYRLDGVNLRGYFAWSLMDNF
EWLQGYTIKFGLYHVDFENVNRPRTARISASYYTELITNNGMPLPSEDEFVYGQFPEGFV
WSTSTAAFQIEGAWRADGKGLGIWDTFTHTRLKIENDDIADVACDSYHKISEDVVALQNL
AVTHYRFSISWSRILPDGTTNYINEAGLNYYVRLIDALLAANIKPQVTMYHFDLPQALQD
VGGWENETIVQRFKEYADVLFQRLGDKVKFWITLNEPFVVAYHGYGTGLYAPGIYFRPGT
APYIVGHNLIKAHAEAWHLYNDVYRASQGGVISITISSDWAEPRDPSNQEDVEAAKRYVQ
FMGGWFAHPIFKNGDYNEVMKTQIRERSLAAGLNESRLPEFTESEKRRINGTYDFFGFNH
YTTVLAYNFNYPSIMSTVDADRGVASIVDRSWPGSGSYWLKMTPFGFRRILNWIKEEYNN
PPIYVTENGVSHRGDSYLNDTTRIYYLRSYINEALKAVQQDKVDLRGYTVWTLMDNFEWY
TGFSDKFGLHFVNYSDPSLPRIPRESAKFYASIVRCNGFPDPAEGPHPCLLQPEDTDPTM
SPVSQEEVQFLGLSLGSTEAETALYVLFSLMLLGVCGLAFLSYALCKSSKQRKKLSQQEL
SPVSSF
>sp|P22292|M2OM_BOVIN Mitochondrial 2-oxoglutarate/malate carrier protein (OGCP). 
AATASPGASGMDGKPRTSPKSVKFLFGGLAGMGATVFVQPLDLVKNRMQLSGEGAKTREY
KTSFHALISILRAEGLRGIYTGLSAGLLRQATYTTTRLGIYTVLFERLTGADGTPPGFLL
KAVIGMTAGATGAFVGTPAEVALIRMTADGRLPVDQRRGYKNVFNALFRIVQEEGVPTLW
RGCIPTMARAVVVNAAQLASYSQSKQFLLDSGYFSDNILCHFCASMISGLVTTAASMPVD
IVKTRIQNMRMIDGKPEYKNGLDVLVKVVRYEGFFSLWKGFTPYYARLGPHTVLTFIFLE
QMNKAYKRLFLSG
>sp|P20916|MAG_HUMAN Myelin-associated glycoprotein precursor. 
MIFLTALPLFWIMISASRGGHWGAWMPSSISAFEGTCVSIPCRFDFPDELRPAVVHGVWY
FNSPYPKNYPPVVFKSRTQVVHESFQGRSRLLGDLGLRNCTLLLSNVSPELGGKYYFRGD
LGGYNQYTFSEHSVLDIVNTPNIVVPPEVVAGTEVEVSCMVPDNCPELRPELSWLGHEGL
GEPAVLGRLREDEGTWVQVSLLHFVPTREANGHRLGCQASFPNTTLQFEGYASMDVKYPP
VIVEMNSSVEAIEGSHVSLLCGADSNPPPLLTWMRDGTVLREAVAESLLLELEEVTPAED
GVYACLAENAYGQDNRTVGLSVMYAPWKPTVNGTMVAVEGETVSILCSTQSNPDPILTIF
KEKQILSTVIYESELQLELPAVSPEDDGEYWCVAENQYGQRATAFNLSVEFAPVLLLESH
CAAARDTVQCLCVVKSNPEPSVAFELPSRNVTVNESEREFVYSERSGLVLTSILTLRGQA
QAPPRVICTARNLYGAKSLELPFQGAHRLMWAKIGPVGAVVAFAILIAIVCYITQTRRKK
NVTESPSFSAGDNPPVLFSSDFRISGAPEKYESERRLGSERRLLGLRGEPPELDLSYSHS
DLGKRPTKDSYTLTEELAEYAEIRVK
>sp|Q16706|M2A1_HUMAN Alpha-mannosidase II (EC 3.2.1.114) (Mannosyl-oligosaccharide 
MKLSRQFTVFGSAIFCVVIFSLYLMLDRGHLDYPRNPRREGSFPQGQLSMLQEKIDHLER
LLAENNEIISNIRDSVINLSESVEDGPKSSQSNFSQGAGSHLLPSQLSLSVDTADCLFAS
QSGSHNSDVQMLDVYSLISFDNPDGGVWKQGFDITYESNEWDTEPLQVFVVPHSHNDPGW
LKTFNDYFRDKTQYIFNNMVLKLKEDSRRKFIWSEISYLSKWWDIIDIQKKDAVKSLIEN
GQLEIVTGGWVMPDEATPHYFALIDQLIEGHQWLENNIGVKPRSGWAIDPFGHSPTMAYL
LNRAGLSHMLIQRVHYAVKKHFALHKTLEFFWRQNWDLGSVTDILCHMMPFYSYDIPHTC
GPDPKICCQFDFKRLPGGRFGCPWGVPPETIHPGNVQSRARMLLDQYRKKSKLFRTKVLL
APLGDDFRYCEYTEWDLQFKNYQQLFDYMNSQSKFKVKIQFGTLSDFFDALDKADETQRD
KGQSMFPVLSGDFFTYADRDDHYWSGYFTSRPFYKRMDRIMESHLRAAEILYYFALRQAH
KYKINKFLSSSLYTALTEARRNLGLFQHHDAITGTAKDWVVVDYGTRLFHSLMVLEKIIG
NSAFLLIGKDKLTYDSYSPDTFLEMDLKQKSQDSLPQKNIIRLSAEPRYLVVYNPLEQDR
ISLVSVYVSSPTVQVFSASGKPVEVQVSAVWDTANTISETAYEISFRAHIPPLGLKVYKI
LESASSNSHLADYVLYKNKVEDSGIFTIKNMINTEEGITLENSFVLLRFDQTGLMKQMMT
KEDGKHHEVNVQFSWYGTTIKRDKSGAYLFLPDGNAKPYVYTTPPFVRVTHGRIYSEVTC
FFDHVTHRVRLYHIQGIEGQSVEVSNIVDIRKVYNREIAMKISSDIKSQNRFYTDLNGYQ
IQPRMTLSKLPLQANVYPMTTMAYIQDAKHRLTLLSAQSLGVSSLNSGQIEVIMDRRLMQ
DDNRGLEQGIQDNKITANLFRILLEKRSAVNTEEEKKSVSYPSLLSHITSSLMNHPVIPM
ANKFSSPTLELQGEFSPLQSSLPCDIHLVNLRTIQSKVGNGHSNEAALILHRKGFDCRFS
SKGTGLFCSTTQGKILVQKLLNKFIVESLTPSSLSLMHSPPGTQNISEINLSPMEISTFR
IQLR
>sp|P27573|MYP0_MOUSE Myelin P0 protein precursor (Myelin protein zero) (Myelin peripheral 
MAPGAPSSSPSPILAALLFSSLVLSPALAIVVYTDREIYGAVGSQVTLHCSFWSSEWVSD
DISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGAFKERIQWVGDPRWKDGSIVIHNLDYS
DNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGILGVVLLLLLLFYLIR
YCWLRRQAALQRRLSAMEKGRFHKSSKDSSKRGRQTPVLYAMLDHSRSTKAASEKKSKGL
GESRKDKK
>sp|P15535|B4G1_MOUSE Beta-1,4-galactosyltransferase 1 (EC 2.4.1.-) (Beta-1,4-GalTase 1) 
MRFREQFLGGSAAMPGATLQRACRLLVAVCALHLGVTLVYYLSGRDLSRLPQLVGVSSTL
QGGTNGAAASKQPPGEQRPRGARPPPPLGVSPKPRPGLDSSPGAASGPGLKSNLSSLPVP
TTTGLLSLPACPEESPLLVGPMLIDFNIAVDLELLAKKNPEIKTGGRYSPKDCVSPHKVA
IIIPFRNRQEHLKYWLYYLHPILQRQQLDYGIYVINQAGDTMFNRAKLLNIGFQEALKDY
DYNCFVFSDVDLIPMDDRNAYRCFSQPRHISVAMDKFGFSLPYVQYFGGVSALSKQQFLA
INGFPNNYWGWGGEDDDIFNRLVHKGMSISRPNAVVGRCRMIRHSRDKKNEPNPQRFDRI
AHTKETMRFDGLNSLTYKVLDVQRYPLYTQITVDIGTPR
>sp|P13590|NCA1_CHICK Neural cell adhesion molecule 1, 180 kDa isoform precursor (N-CAM 
MLPAAALPWTLFFLGAAASLQVDIVPSQGEISVGESKFFLCQVAGEAKYKDISWFSPNGE
KLTPNQQRISVVRNDDFSSTLTIYNANIDDAGIYKCVVSSVEEGDSEATVNVKIFQKLMF
KNAPTPQEFKEGDDAVIVCDVVSSLPPTIIWKHKGRDVMLKKDVRFIVLSNNYLQIRGIK
KTDEGTYRCEGRILARGEINFKDIQVIVNVPPSVRARQSTMNATANLSQSVTLACDADGF
PEPTMTWTKDGEPIEQEDNEEKYSFNYDGSELIIKKVDKSDEAEYICIAENKAGEQDATI
HLKVFAKPKITYVENKTAMELEDQITLTCEASGDPIPSITWKTSTRNISNEEKTLDGRIV
VRSHARVSSLTLKEIQYTDAGEYVCTASNTIGQDSQAMYLEVQYAPKLQGPVAVYTWEGN
QVNITCEVFAYPSAVISWFRDGQLLPSSNYSNIKIYNTPSASYLEVTPDSENDFGNYNCT
AVNRIGQESSEFILVQADTPSSPSIDRVEPYSSTARVEFDEPEATGGVPILKYKAEWRAL
GEGEWHSRLYDAKEANVEGTITISGLKPETTYSVRLSAVNGKGVGEISLPSDFKTQPVRE
PSAPKLEGQMGEDGNSIKVNVIKQDDGGSPIRHYLIKYKAKHSSEWKPEIRLPSGIDHVM
LKSLDWNAEYEVYVIAENQQGKSKPAHYAFRTSAQPTVIPASTSPTSGLGTAAIVGILIV
IFVLLLVAVDVTCYFLNKCGLLMCIAVNLCGKSGPGAKGKDMEEGKAAFSKDESKEPIVE
VRTEEERTPNHDGGKHTEPNETTPLTEPEHTADTAATVEDMLPSVTTGTTNSDTITETFA
TAQNSPTSETTTLTSSIAPPATAIPDSNAMSPGQATPAKAGASPVSPPPPSSTPKVAPLV
DLSDTPSSAPATNNLSSSVLSNQGAVLSPSTVANMAETSKAAAGNKSAAPTPANLTSPPA
PSEPKQEVSSTKSPEKEAAQPSTVKSPTETAKNPSNPKSEAASGGTTNPSQNEDFKMDEG
TFKTPDIDLAKDVFAALGTTTPASVASGQARELASSTADSSVPAAPAKTEKTPVEDKSEV
QATEIRHLQQK
>sp|P13594|NCA2_MOUSE Neural cell adhesion molecule 1, 120 kDa isoform precursor (N-CAM 120) 
MLRTKDLIWTLFFLGTAVSLQVDIVPSQGEISVGESKFFLCQVAGDAKDKDISWFSPNGE
KLSPNQQRISVVWNDDDSSTLTIYNANIDDAGIYKCVVTAEDGTQSEATVNVKIFQKLMF
KNAPTPQEFKEGEDAVIVCDVVSSLPPTIIWKHKGRDVILKKDVRFIVLSNNYLQIRGIK
KTDEGTYRCEGRILARGEINFKDIQVIVNVPPTVQARQSIVNATANLGQSVTLVCDADGF
PEPTMSWTKDGEPIENEEEDERSRSSVSDSSEVTIRNVDKNDEAEYVCIAENKAGEQDAS
IHLKVFAKPKITYVENQTAMELEEQVTLTCEASGDPIPSITWRTSTRNISSEEQDLDGHM
VVRSHARVSSLTLKSIQYRDAGEYMCTASNTIGQDSQSIDLEFQYAPKLQGPVAVYTWEG
NQVNITCEVFAYPSATISWFRDGQLLPSSNYSNIKIYNTPSASYLEVTPDSENDFGNYNC
TAVNRIGQESLEFILVQADTPSSPSIDRVEPYSSTAQVQFDEPEATGGVPILKYKAEWKS
LGEESWHFTWYDAKEANMEGIVTIMGLKPETTYSDRLAALNGKGLGEIMQPSESKTQPVP
ELSAPKLEGQMGEDGNSIKVNLIKQDDGGSPIRHYLVKYRALASEWKPEIRLPSGSHHVM
LKSLDWNAEYEVYVVAENQQGKSKAAHFVFRTSAQPTAIPATLGGSSTSYTLVSLLFSAV
TLLLL
>sp|P27811|NK11_MOUSE Natural killer cell surface protein P1-2 (NKR-P1 2) (NKR-P1.7). 
MDTARVYFGLKPPRTPGAWHESPPSLPPDACRCPRSHRSALKLSCAGLILLVVTLIGMSV
LVRVLIQKPSIEKCYVLIQENLNKTTDCSAKLECPQDWLSHRDKCFHVSQVSNTWEEGLV
DCDGKGATLMLIQDQEELRFLLDSIKEKYNSFWIGLRYTLPDMNWKWINGSTLNSDVLKI
TGDTENDSCAAISGDKVTFESCNSDNRWICQKELYHETLSNYVGYGH
>sp|P27812|NK12_MOUSE Natural killer cell surface protein P1-34 (NKR-P1 34). 
MDSTTLVYADLNLARIQEPKHDSPPSLSPDTCRCPRWHRLALKFGCAGLILLVLVVIGLC
VLVLSVQKSSVQKICADVQENRTHTTDCSVNLECPQDWLSHRDKCFRVFQVSNTWEEGQA
DCGRKGATLLLIQDQEELRFLLDSIKEKYNSFWIGLRFTLPDMNWKWINGTTFNSDVLKI
TGDTENGSCASISGDKVTSESCSTDNRWICQKELNHETPSNDS
>sp|P27471|NK13_RAT Natural killer cell surface protein P1-3.2.3 (NKR-P1 3.2.3) (Antigen 
MDTARVYLSLKPSKTAAGAQCVSPPSLPPDACRCPRSHRLALKLSCAGLILLVLALVGMS
ILVRVLVQKPSVEPCRVLIQENLSKTGSPAKLKCPKDWLSHRDKCFHVSQTSITWKESLA
DCGGKGATLLLVQDQEELRFLRNLTKRISSSFWIGLSYTLSDENWKWINGSTLNSDVLSI
TGDTEKDSCASVSQDKVLSESCDSDNIWVCQKELKCECMCNDS
>sp|P27814|NK14_MOUSE Natural killer cell surface protein P1-40 (NKR-P1 40) (NKR-P1.9). 
MDTASIYLGLKPPRTLGAWHESPPSLPPDACRCPRSHRLALKLSCAGLILLVLTLIGMSV
LVRVLVQKPSREKCCVFIQENLNKTTVNLECPQDWLLHRDKCFHVSQVSNTWEEGQADCG
RKGATLLLIQDQEELRFLLDSIKEKYNSFWIGLRFTLPDMNWKWINGTTFNSDVLKITGV
TENGSCASILGDKVTPESCASDNRWICQKELNHETPSNDS
>sp|P35331|NRCA_CHICK NG-CAM related cell adhesion molecule precursor (NR-CAM) (BRAVO). 
MMKEKSISASKASLVFFLCQMISALDVPLDSKLLEELSQPPTITQQSPKDYIVDPRENIV
IQCEAKGKPPPSFSWTRNGTHFDIDKDAQVTMKPNSGTLVVNIMNGVKAEAYEGVYQCTA
RNERGAAISNNIVIRPSRSPLWTKEKLEPNHVREGDSLVLNCRPPVGLPPPIIFWMDNAF
QRLPQSERVSQGLNGDLYFSNVQPEDTRVDYICYARFNHTQTIQQKQPISVKVFSTKPVT
ERPPVLLTPMGSTSNKVELRGNVLLLECIAAGLPTPVIRWIKEGGELPANRTFFENFKKT
LKIIDVSEADSGNYKCTARNTLGSTHHVISVTVKAAPYWITAPRNLVLSPGEDGTLICRA
NGNPKPSISWLTNGVPIAIAPEDPSRKVDGDTIIFSAVQERSSAVYQCNASNEYGYLLAN
AFVNVLAEPPRILTPANKLYQVIADSPALIDCAYFGSPKPEIEWFRGVKGSILRGNEYVF
HDNGTLEIPVAQKDSTGTYTCVARNKLGKTQNEVQLEVKDPTMIIKQPQYKVIQRSAQAS
FECVIKHDPTLIPTVIWLKDNNELPDDERFLVGKDNLTIMNVTDKDDGTYTCIVNTTLDS
VSASAVLTVVAAPPTPAIIYARPNPPLDLELTGQLERSIELSWVPGEENNSPITNFVIEY
EDGLHEPGVWHYQTEVPGSHTTVQLKLSPYVNYSFRVIAVNEIGRSQPSEPSEQYLTKSA
NPDENPSNVQGIGSEPDNLVITWESLKGFQSNGPGLQYKVSWRQKDVDDEWTSVVVANVS
KYIVSGTPTFVPYEIKVQALNDLGYAPEPSEVIGHSGEDLPMVAPGNVQVHVINSTLAKV
HWDPVPLKSVRGHLQGYKVYYWKVQSLSRRSKRHVEKKILTFRGNKTFGMLPGLEPYSSY
KLNVRVVNGKGEGPASPDKVFKTPEGVPSPPSFLKITNPTLDSLTLEWGSPTHPNGVLTS
YILKFQPINNTHELGPLVEIRIPANESSLILKNLNYSTRYKFYFNAQTSVGSGSQITEEA
VTIMDEAGILRPAVGAGKVQPLYPRIRNVTTAAAETYANISWEYEGPDHANFYVEYGVAG
SKEDWKKEIVNGSRSFFVLKGLTPGTAYKVRVGAEGLSGFRSSEDLFETGPAMASRQVDI
ATQGWFIGLMCAVALLILILLIVCFIRRNKGGKYPVKEKEDAHADPEIQPMKEDDGTFGE
YRSLESDAEDHKPLKKGSRTPSDRTVKKEDSDDSLVDYGEGVNGQFNEDGSFIGQYSGKK
EKEPAEGNESSEAPSPVNAMNSFV
>sp|P39656|OST4_HUMAN Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa 
MGYFRCAGAGSFGRRRKMEPSTAARAWALFWLLLPLLGAVCASGPRTLVLLDNLNVRETH
SLFFRSLKDRGFELTFKTADDPSLSLIKYGEFLYDNLIIFSPSVEDFGGNINVETISAFI
DGGGSVLVAASSDIGDPLRELGSECGIEFDEEKTAVIDHHNYDISDLGQHTLIVADTENL
LKAPTIVGKSSLNPILFRGVGMVADPDNPLVLDILTGSSTSYSFFPDKPITQYPHAVGKN
TLLIAGLQARNNARVIFSGSLDFFSDSFFNSAVQKAAPGSQRYSQTGNYELAVALSRWVF
KEEGVLRVGPVSHHRVGETAPPNAYTVTDLVEYSIVIQQLSNGKWVPFDGDDIQLEFVRI
DPFVRTFLKKKGGKYSVQFKLPDVYGVFQFKVDYNRLGYTHLYSSTQVSVRPLQHTQYER
FIPSAYPYYASAFPMMLGLFIFSIVFLHMKEKEKSD
>sp|P15725|TNR4_RAT Tumor necrosis factor receptor superfamily member 4 precursor (OX40L 
MYVWVQQPTAFLLLGLSLGVTVKLNCVKDTYPSGHKCCRECQPGHGMVSRCDHTRDTVCH
PCEPGFYNEAVNYDTCKQCTQCNHRSGSELKQNCTPTEDTVCQCRPGTQPRQDSSHKLGV
DCVPCPPGHFSPGSNQACKPWTNCTLSGKQIRHPASNSLDTVCEDRSLLATLLWETQRTT
FRPTTVPSTTVWPRTSQLPSTPTLVAPEGPAFAVILGLGLGLLAPLTVLLALYLLRKAWR
SPNTPKPCWGNSFRTPIQEEQTDTHFTLAKI
>sp|P16271|P1P_LACLC PI-type proteinase precursor (EC 3.4.21.-) (Wall-associated serine 
MQRKKKGLSILLAGTVALGALAVLPVGEIQAKAAISQQTKGSSLANTVTAATAKQAATDT
TAATTNQAIATQLAAKGIDYNKLNKVQQQDIYVDVIVQMSAAPASENGTLRTDYSSTAEI
QQETNKVIAAQASVKAAVEQVTQQTAGESYGYVVNGFSTKVRVVDIPKLKQIAGVKTVTL
AKVYYPTDAKANSMANVQAVWSNYKYKGEGTVVSVIDSGIDPTHKDMRLSDDKDVKLTKS
DVEKFTDTAKHGRYFNSKVPYGFNYADNNDTITDDTVDEQHGMHVAGIIGANGTGDDPAK
SVVGVAPEAQLLAMKVFTNSDTSATTGSSTLVSAIEDSAKIGADVLNMSLGSDSGNQTLE
DPELAAVQNANESGTAAVISAGNSGTSGSATEGVNKDYYGLQDNEMVGTPGTSRGATTVA
SAENTDVITQAVTITDGTGLQLGPGTIQLSSNDFTGSFDQKKFYVVKDASGNLSKGALAD
YTADAKGKIAIVKRGELSFDDKQKYAQAAGAAGLIIVNNDGTATPVTSMALTTTFPTFGL
SSVTGQKLVDWVTAHPDDSLGVKIALTLVPNQKYTEDKMSDFTSYGPVSNLSFKPDITAP
GGNIWSTQNNNGYTNMSGTSMASPFIAGSQALLKQALNNKNNPFYAYYKQLKGTALTDFL
KTVEMNTAQPINDINYNNVIVSPRRQGAGLVDVKAAIDALEKNPSTVVAENGYPAVELKD
FTSTDKTFKLTFTNSTTHELTYQMDSNTDTNAVYTSATDPNSGVLYDKKIDGAAIKAGSN
ITVPAGKTAQIEFTLSLPKSFDQQQFVEGFLNFKGSDGSRLNLPYMGFFGDWNDGKIVDS
LNGITYSPAGGNFGTVPLLTNKNTGTQYYGGMVTDADGNQTVDDQAIAFSSDKNALYNDI
SMKYYLLRNISNVQVDILDGQGNKVTTLSSSTNLTKTYYNAHSQQYIYYNAPAWDGTYYD
QRDGNIKTADDGSYTYRISGVPEGGDKRQVFDVPFKLDSKAPTVRHVALSAKTENGKTQY
YLTAEAKDDLSGLDATKSVKTAINEVTNLDATFTDAGTTADGYTKIETPLSDEQAQALGN
GDNSAELYLTDNASNATDQDASVQKPGSTSFDLIVNGGGIPDKISSTTTGYEANTQGGGT
YTFSGTYPAAVDGTYTNAQGKKHDLNTTYDAATNSFTASMPVTNADYAAQVDLYADKAHT
QLLKHFDTKVRLTAPTFTDLKFNNGSDQTSEATIKVTGTVSADTKTVNVGDTVAALDAQH
HFSVDVPVNYGDNTIKVTATDEDGNTTTEQKTITSSYDPDMLKNSVTFDQGVTFGANEFN
ATSAKFYDPKTGIATITGKVKHPTTTLQVDGKQIPIKDDLTFSFTLDLGTLGQKPFGVVV
GDTTQNKTFQEALTFILDAVAPTLSLESSTDAPVYTNDPNFQITGTATDNAQYLSLSING
SSVASQYVDININSGKPGHMAIDQPVKLLEGKNVLTVAVTDSEDNTTTKNITVYYEPKKT
LAAPTVTPSTTEPAKTVTLTANSAATGETVQYSADGGKTYQDVPAAGVTVTANGTFKFKS
TDLYGNESPAVDYVVTNIKADDPAQLQAAKQELTNLIASAKTLSASGKYDDATTTALAAA
TQKAQTALDQTNASVDSLTGANRDLQTAINQLAAKLPADKKTSLLNQLQSVKAALGTDLG
NQTDPSTGKTFTAALDDLVAQAQAGTQTDDQHQATLAKVLDAVLAKLAEGIKAATPAEVG
NAKDAATGKTWYADIADTLTSGQASADASDKLAHLQALQSLKTKVAAAVEAAKTVGKGDG
TTGTSDKGGGQGTPAPAPGDIGKDKGDEGSQPSSGGNIPTNPATTTSTSTDDTTDRNGQL
TSGKGALPKTGETTERPAFGFLGVIVVILMGVLGLKRKQREE
>sp|P24392|PEX2_RAT Peroxisome assembly factor-1 (PAF-1) (Peroxin-2) (Peroxisomal membrane 
MAAREESTQSANRVLRISQLDALELNKALEQLVWSQFTQCFHGFKPGLLARFEPEVKAFL
WLFLWRFTIYSKNATVGQSVLNIQYKNDSSPNPVYQPPSKNQKLLYAVCTIGGRWLEERC
YDLFRNRHLASFGKAKQCMNFVVGLLKLGELMNFLIFLQKGKFATLTERLLGIHSVFCKP
QSMREVGFEYMNRELLWHGFAEFLVFLLPLINIQKLKAKLSSWCIPLTSTAGSDSTLGSS
GKECALCGEWPTMPHTIGCEHVFCYYCVKSSFLFDMYFTCPKCGTEVHSVQPLKSGIEMS
EVNAL
>sp|Q08481|PEC1_MOUSE Platelet endothelial cell adhesion molecule precursor (PECAM-1) 
MLLALGLTLVLYASLQAEENSFTINSIHMESLPSWEVMNGQQLTLECLVDISTTSKSRSQ
HRVLFYKDDAMVYNVTSREHTESYVIPQARVFHSGKYKCTVMLNNKEKTTIEYEVKVHGV
SKPKVTLDKKEVTEGGVVTVNCSLQEEKPPIFFKIEKLEVGTKFVKRRIDKTSNENFVLM
EFPIEAQDHVLVFRCQAGILSGFKLQESEPIRSEYVTVQESFSTPKFEIKPPGMIIEGDQ
LHIRCIVQVTHLVQEFTEIIIQKDKAIVATSKQSSEAVYSVMAMVEYSGHYTCKVESNRI
SKASSIMVNITELFPKPKLEFSSSRLDQGELLDLSCSVSGTPVANFTIQKEETVLSQYQN
FSKIAEESDSGEYSCTAGIGKVVKRSGLVPIQVCEMLSKPSIFHDAKSEIIKGHAIGISC
QSENGTAPITYHLMKAKSDFQTLEVTSNDPATFTDKPTRDMEYQCRADNCHSHPAVFSEI
LRVRVIAPVDEVVISILSSNEVQSGSEMVLRCSVKEGTSPITFQFYKEKEDRPFHQAVVN
DTQAFWHNKQASKKQEGQYYCTASNRASSMRTSPRSSTLAVRVFLAPWKKGLIAVVVIGV
VIATLIVAAKCYFLRKAKAKQKPVEMSRPAAPLLNSNSEKISEPSVEANSHYGYDDVSGN
DAVKPINQNKDPQNMDVEYTEVEVSSLEPHQALGTRATETVYSEIRKVDPNLMENRYSRT
EGSLNGT
>sp|P35419|PERT_MOUSE Thyroid peroxidase precursor (EC 1.11.1.8) (TPO). 
MRTLGAMAIMLVVMGTVIFLSFILRSRDILCGKTMKSHVISAVETSQLMVDHAVYNTMKR
NLKKREVLSPAQLLSFFKLPESTSGAISRAAEIMETSIQVMKREQSQFSTDALSADILGT
IANLSGCLPFMLPPRCPDTCLANKYRPITGACNNRDHPRWGASNTALARWLPPVYEDGFS
QPKGWNPNFLYHGFPLPPVREVTRHLIQVSNEAVTEDDQYSDFLPVWGQYIDHDIALTPQ
STSTAAFWGGVDCQLTCENQNPCFPIQLPSNSSGTTACLPFYRSSAACGTGDQGALFGNL
SAANPRQQMNGLTSFLDASTVYGSSPGVEKQLRNWSSSAGLLRVNTLHLDAGRAYLPFAT
AACAPEPGTPRTNRTPCFLAGDGRASEVPALAAVHTLWLREHNRLASAFKAINKHWSANT
AYQEARKVVGALHQIITMRDYIPKILGPDAFRQYVGPYEGYNPTVNPTVSNIFSTAAFRF
GHATVHPLVRRLNTDFQEHTELPRLQLRDVFFRPWRLIQEGGLDPIVRGLLARAAKLQVQ
GQLMNEELTERLFVLSNVGTLDLASLNLQRGRDHGLPDYNEWREFCGLSRLETPAELNKA
IANRSMVNKIMDLYKHADNIDVWLGGLAEKFLPGARTGPLFACIIGKQMKALRDGDRFWW
ENTNVFTDAQRQELEKHSLPRVICDNTGLTRVPVDAFRIGKFPQDFESCEDIPSMDLELW
RETFPQDDKCVFPEEVDNGNFVHCEESGKLVLVYSCFHGYKLQGQEQVTCTQKGWDSEPP
VCKDVNECADLTHPPCHPSAQCKNTKGSFQCVCTDPYVLGEDEKTCIDSGRLPRASWVSI
ALGALLIGGLASLTWIVICRWTHADKKATLPITERVTTQSGCRKSQGRGISPHKAAAQDT
GQEPASGSRVLLCE
>sp|P26619|PGDS_XENLA Alpha platelet-derived growth factor receptor precursor (EC 2.7.1.112) 
MMPAMRASLILGCLLIIGPWAILAENPLPTIFPDKDELVQALHSSFTLKCTGESEVSWQN
PNSNPEKQNVVIRSEENNSGLFVSILEVSDASAFDTGLYTCYHNHTQTEESEIEGTDIYI
YVPDPNVPFAPPGLFDHIIVVEEDESALVPCRTTDPSSEVTLKNIESSRTVFAFYDSKQG
FAGNFPPGSYICETTSNKMVYQTEPYILQTWKATHNISVEMEAPKTMFRAGETIAIDCIV
LDNEVVDLKWTYPGKQRGVGIRNVEESKVPYQRLVYTLTLANATTEDSGEYECAVIHATL
DNRVVKKTNITVHEKGFIDLEPMFGSEEFANLHEVKSFIVNLHAYPTPGLFWLKDNRTLS
ENLTEITTSIVTTKETRFQSKLKLIRAKEEDSGLYTLVAQNDRETKSYSFILQIKVPALI
LELVDKHHGASGEQTVGCLAKGMPVPDVEWLVCKDIKRCNNDTLWSILATNGSEISMETH
QDDEQIESQVTFKKIEETMAIRCIAKNELGVVARELKLVAPTLRSELTVAAAVLVLLVIV
IISLIVLVIIWKQKPRYEIRWRVIESISPDGHEYIYVDPMQLPYDSRWEFPRDGLVLGRI
LGSGAFGKVVEGAAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGAHLNIV
NLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFQSRHPEKPKKDLDIFGLNPADESTR
SYVILSFENNGDYMDMKQADTMQYVPMLEMKEPSKYSDIQRSLYDRPASYKKKPLSEVKN
ILSDDGFEGLTVLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAHGKIVKICDFGLA
RDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSFGILLWEIFSLGGTPYPGMI
VDSTFYNKIKSGYRMAKPDHATHEVYDIMVKCWNSEPEKRPSFRHLSDIVESLLPMEYKR
CYETVLHDFLKSDHPAVTRMRSDSDNSYIGVTYKNEHKMKDRESGFDEQRLSADSGYIIP
LPDIDPVSEDESGKRNRHSSQTSEESAIETGSSSSTFIKRDDETIEDIDMMDDIGIDSSD
LVEDSFL
>sp|P14292|PMPA_CANBO Peroxisomal membrane protein A (PMP20). 
APIKRGDRFPTTDDVYYIPPEGGEPGPLELSKFVKTKKFVVVSVPGAFTPPCTEQHLPGY
IKNLPRILSKGVDFVLVISQNDPFVLKGWKKELGAADAKKLVFVSDPNLKLTKKLGSTID
LSAIGLGTRSGRLALIVNRSGIVEYAAIENGGEVDVSTAQKIIAKL
>sp|P14293|PMPB_CANBO Peroxisomal membrane protein B (PMP20). 
APIKRGDRFPTTDDVYYIPPEGGEPGAFELSKFVKTKKFVVVSVPGAFTPPCTEQHLPGY
IKNLPRILSKGVDFVLVITQNDPFVLKGWKKELGAADAKKLIFVSDPNLKLTKKLGSTID
LSSIGLGTRSGRLALIVNRSGIVEYAAIENGGEVDVSTAQKIIAKL
>sp|P26677|PPLA_CHICK Cardiac phospholamban (PLB). 
MEKVQYITRSALRRASTLEVNPQARQRLQELFVNFCLILICLLLICIIVMLL
>sp|P37259|PSBT_ARATH Photosystem II reaction center T protein. 
MEALVYTFLLVSTLGIIFFAIFFREPPKISTKK
>sp|Q09108|SCF_CHICK Kit ligand precursor (C-kit ligand) (Stem cell factor) (SCF) (Mast 
MKKAQTWIITCFCLQLLLLNPLVKAQSSCGNPVTDDVNDIAKLVGNLPNDYLITLKYVPK
MDSLPNHCWLHLMVPEFSRSLHNLLQKFSDISDMSDVLSNYSIINNLTRIINDLMACLAF
DKNKDFIKENGHLYEEDRFIPENFFRLFNSTIEVYKEFADSLDKNDCIMPSTVETPENDS
RVAVTKTISFPPVAASSLRNDSIGSNTSSNSNKEALGFISSSSLQGISIALTSLLSLLIG
FILGAIYWKKTHPKSRPESNETIQCHGCQEENEISMLQQKEKEHLQV
>sp|P16967|SSRA_CANFA Translocon-associated protein, alpha subunit precursor (TRAP-alpha) 
MRVLPRLLLLLLLAFPAAVLLRGGPGGSLVAAQDLTEDEETVEDSIIEDEDDEAEVEEDE
PTDLAEDKEEEDVSGEPEASPSADTTILFVKGEDFPANNIVKFLVGFTNKGTEDFIVESL
DASFRYPQDYQFYIQNFTALPLNTVVPPQRQATFEYSFIPAEPMGGRPFGLVINLNYKDL
NGNVFQDAVFNQTVTIIEREDGLDGETIFMYMFLAGLGLLVVVGLHQLLESRKRKRPIQK
VEMGTSSQNDVDMSWIPQETLNQINKASPRRLPRKRAQKRSVGSDE
>sp|P24055|TF_RABIT Tissue factor precursor (TF) (Coagulation factor III). 
MAPPTRLQVPRPGTAVPYTVLLGWLLAQVARAADTTGRAYNLTWKSTNFKTILEWEPKSI
DHVYTVQISTRLENWKSKCFLTAETECDLTDEVVKDVGQTYMARVLSYPARNGNTTGFPE
EPPFRNSPEFTPYLDTNLGQPTIQSFEQVGTKLNVTVQDARTLVRRNGTFLSLRAVFGKD
LNYTLYYWRASSTGKKTATTNTNEFLIDVDKGENYCFSVQAVIPSRKRKQRSPESLTECT
SREQGRAREMFFIIGAVVVVALLIIVLSVTVYKCRKARAGPSGKESSPLNIA
>sp|P38438|TGR2_RAT TGF-beta receptor type II precursor (EC 2.7.1.37) (TGFR-2) (TGF-beta 
MGRGLLRGLWPLHIVLWTRIASTIPPHVPKSVNSDLMAGDNSGAVKLPQLCKFCDVTLST
CDNQKSCMSNCSVTSICEKPQEVCVAVWRKNDKNITLETVCHDPKFTYHGFTLEDATSPT
CVMKEKKRAGETFFMCSCNTEECNDYIIFNEEYTTSSPDLLLVIIQVTGVSLLPPLGIAI
AVIAIFYCYRVHRQQKLSPSWESSKPRKLMDFSDNCAIILEDDRSDISSTCANNINHNTE
LLPIELDTLVGKGRFAEVYKAKLKQNTSEQFETVAVKIFPYEEYSSWKTEKDIFSDINLK
HENILQFLTAEERKTEMGKQYWLITAFHAKGNLQEYLTRHVISWEDLRKLGSSLARGIAH
LHSDHTPCGRPKMPIVHRDLKSSNILVKNDLTCCLCDFGLSLRLDPTLSVDDLANSGQVG
TARYMAPEVLESRMNLENMESFKQTDVYSMALVLWEMTSRCNAVGEVKDYEPPFGSKVRE
HPCVESMKDNVLRDRGRPEIPSFWLNHQGIQIVCETLTECWDHDPEARLTAQCVAERFSE
LEHPDRLSGRSCSQEKIPEDGSLNTTK
>sp|P35054|TGR3_PIG TGF-beta receptor type III precursor (TGFR-3) (Betaglycan). 
MTLHCVVALFALISSCLATAGPEPGVQCALSPVNASHPVQALMESFTVLSGCASRGTMGR
PQEVHVLNLRAADQGPGQRQSEVTLHLNPISSVHIHHKPVVFLLNSPQPLVWHLKTERLA
VGVSRLFLVSEGSVVHFSSGNFSLSAETEERNFPHGNEHLLNWARKEYGAVTSFTELKIA
RNIYIKVGEDQVFPPTCSIGKNFLSLNYLAEYLQPKPAEGCVVSGRPQEKEVHIIELIAP
NSNPYSAFQVDIIIDIRPSRKDPELVKNLILILKCKKSVNWVIKSFDVKGNLKVLAPNSI
GFGRESERSMIMTKSVRDDIPSTQEKLLRWALDNGYSPVTSYTVAPVANRFHLRLENNEE
MRDEEVHTIPPELQILLDPGALPVLDHPPSGEGAARHGGLPFPFPYIPRRGRQDGGKDRL
PRPKDPVVPSIQLLPGPREPQEAQGSRDVALSVRCDSEKMLVAVEKDSFQASGYPGLELT
LLDPTCKAKTNGTHFILESPLDGCGTRHRRSAPDGVVYYNSIVIQAPPSGDSSGWPDGYE
DLESGDNGFPGDVDEGDVALSSRPELVVFNCSLRPARHPSRAQDPPTRNVTFSMDLYTTD
LFLAPAQGVFSVAENGHVYVEVSVTKADQELGFAIQTCFISPYSNPDRMSDYTIIENICP
KDESVKFYDPKRVHFPIPQAETDKKRFSFVFKPVFNTSLLFLQCELTLCTKREKEPQKLP
KCVLPDEACTSLDASMIWAMMQNKKTFTKPLAVIHHEVQFKGPSTKESNPISPPIFHGLD
TLTVMGIAFAAFVIGALLTGALWYIYSHTGDSAGRQPVPTSPPASENSSAAHSLGSTQST
PCSSSSAA
>sp|Q06806|TIE1_MOUSE Tyrosine-protein kinase receptor Tie-1 precursor (EC 2.7.1.112). 
MVWWGSSLLLPTLFLASHVGASVDLTLLANLRITDPQRFFLTCVSGEAGAGRSSDPPLLL
EKDDRIVRTFPPGQPLYLARNGSHQVTLRGFSKPSDLVGVFSCVGGAGARRTRVLYVHNS
PGAHLFPDKVTHTVNKGDTAVLSAHVHKEKQTDVIWKNNGSYFNTLDWQEADDGRFQLQL
QNVQPPSSGIYSATYLEASPLGSAFFRLIVRGCGAGRWGPGCVKDCPGCLHGGVCHDHDG
ECVCPPGFTGTRCEQACREGRFGQSCQEQCPGTAGCRGLTFCLPDPYGCSCGSGWRGSQC
QEACAPDHFGADCRLQCQCQNGGTCDRFSGCVCPSGWHGVHCEKSDRIPQILSMATEVEF
NIGTMPRINCAAAGNPFPVRGSMKLRKPDGTMLLSTKVIVEPDRTTAEFEVPSLTLGDSG
FWECRVSTSGGQDSRRFKVNVKVPPVPLTAPRLLAKQSRQLVVSPLVSFSGDGPISSVRL
HYRPQDSTIAWSAIVVDPSENVTLMNLKPKTGYNVRVQLSRPGEGGEGGWGPSALMTTDC
PEPLLQPWLESWHVEGPDRLRVSWSLPSVPLSGDGFLLRLWDGARGQERRENISFPQART
ALLTGLTPGTHYQLDVRLYHCTLLGPASPPAHVHLPPSGPPAPRHLHAQALSDSEIQLMW
QHPEAPSGPISKYIVEIQVAGGSGDPQWMDVDRPEETSIIVRGLNASTRYLFRVRASVQG
LGDWSNTVEEATLGNGLQSEDPVRESRAAEEGLDQQLVLAVVGSVSATCLTILAALLALV
CIRRSCLHRRRTFTYQSGSGEETILQFSSGTLTLTRRPKPQPEPLSYPVLEWEDITFEDL
IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEYASENDHRDFAGELEVLCKLGHHPNIINLL
GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAREHGTASTLSSRQLLRFASDAA
NGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIES
LNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEQPRNCDDEVYE
LMRQCWRDRPYERPPFAQIALQLGRMLEARKAYVNMSLFENFTYAGIDATAEEA
>sp|P24422|TIP2_TOBAC Tonoplast intrinsic protein, root-specific RB7-18C (RT-TIP). 
MVLIAFGSIGDSFSVGSLKAYVAEFIATLLFVFAGVGSAIAYNKLTADAALDPAGLVAVA
VAHAFALFVGVSIAANISGGHLNPAVTLGLAVGGNITILTGFFYWIAQLLGSTVACLLLK
YVTNGLAVPTHGVAAGLNGFQGVVMEIIITFALVYTVYATAADPKKGSLGTIAPIAIGFI
VGANILAAGPFSGGSMNPARSFGPAVVAGDFSQNWIYWAGPLIGGGLAGFIYGDVFIGCH
TPLPTSEDYA
>sp|P21652|TIPR_ARATH Tonoplast intrinsic protein, root-specific RB7. 
MPIRNIAIGRPDEATRPDALKAALAEFISTLIFVVAGSGSGMAFNKLTENGATTPSGLVA
AAVAHAFGLFVAVSVGANISGGHVNPAVTFGAFIGGNITLLRGILYWIAQLLGSVVACLI
LKFATGGLAVPPFGLSAGVGVLNAFVFEIVMTFGLVYTVYATAIDPKNGSLGTIAPIAIG
FIVGANILAGGAFSGASMNPAVAFGPAVVSWTWTNHWVYWAGPLVGGGIAGLIYEVFFIN
TTHTSSSNHRLLN
>sp|P25794|TIPW_PEA Water-stress induced tonoplast intrinsic protein (WSI-TIP) (Turgor- 
MEAKEQDVSLGANKFPERQPLGIAAQSQDEPKDYQEPPPAPLFEPSELTSWSFYRAGIAE
FIATFLFLYITVLTVMGVVRESSKCKTVGIQGIAWAFGGMIFALVYCTAGISGGHINPAV
TFGLFLARKLSLTRAIFYMVMQVLGAICGAGVVKGFEGKQRFGDLNGGANFVAPGYTKGD
GLGAEIVGTFILVYTVFSATDAKRSARDSHVPILAPLPIGFAVFLVHLATIPITGTGINP
ARSLGAAIVFNKKIGWNDHWIFWVGPFIGAALAALYHQVVIRAIPFKSK
>sp|P36941|TNR3_HUMAN Tumor necrosis factor receptor superfamily member 3 precursor 
MLLPWATSAPGLAWGPLVLGLFGLLAASQPQAVPPYASENQTCRDQEKEYYEPQHRICCS
RCPPGTYVSAKCSRIRDTVCATCAENSYNEHWNYLTICQLCRPCDPVMGLEEIAPCTSKR
KTQCRCQPGMFCAAWALECTHCELLSDCPPGTEAELKDEVGKGNNHCVPCKAGHFQNTSS
PSARCQPHTRCENQGLVEAAPGTAQSDTTCKNPLEPLPPEMSGTMLMLAVLLPLAFFLLL
ATVFSCIWKSHPSLCRKLGSLLKRRPQGEGPNPVAGSWEPPKAHPYFPDLVQPLLPISGD
VSPVSTGLPAAPVLEAGVPQQQSPLDLTREPQLEPGEQSQVAHGTNGIHVTGGSMTITGN
IYIYNGPVLGGPPGPGDLPATPEPPYPIPEEGDPGPPGLSTPHQEDGKAWHLAETEHCGA
TPSNRGPRNQFITHD
>sp|P15306|TRBM_MOUSE Thrombomodulin precursor (Fetomodulin) (TM). 
MLGIFFLGVLAPASLGLSALAKLQPTGSQCVEHECFALFQGPATFLDASQACQRLQGHLM
TVRSSVAADVISLLLSQSSMDLGPWIGLQLPQGCDDPVHLGPLRGFQWVTGDNHTSYSRW
ARPNDQTAPLCGPLCVTVSTATEAAPGEPAWEEKPCETETQGFLCEFYFTASCRPLTVNT
RDPEAAHISSTYNTPFGVSGADFQTLPVGSSAAVEPLGLELVCRAPPGTSEGHWAWEATG
AWNCSVENGGCEYLCNRSTNEPRCLCPRDMDLQADGRSCARPVVQSCNELCEHFCVSNAE
VPGSYSCMCETGYQLAADGHRCEDVDDCKQGPNPCPQLCVNTKGGFECFCYDGYELVDGE
CVELLDPCFGSNCEFQCQPVSPTDYRCICAPGFAPKPDEPHKCEMFCNETSCPADCDPNS
PTVCECPEGFILDEGSVCTDIDECSQGECFTSECRNFPGSYECICGPDTALAGQISKDCD
PIPVREDTKEEEGSGEPPVSPTPGSPTGPPSARPVHSGVLIGISIASLSLVVALLALLCH
LRKKQGAARAELEYKCASSAKEVVLQHVRTDRTLQKF
>sp|P13972|TRJ4_ECOLI TraJ protein. 
MYPTDPRQLNTERQIYLDKQFFVDVFSIPACVRNTNGDLSATNEKFSKEFIGSLDIKEWF
YSLPVQVATSFLREELDAMSLPSSMNKIQSVAIGDKLWLVQFIPLIYGEVVNVLWLFFCK
NSNVIVDYCRGLRTNITNDRMLEFKNKSTEIQWKVFILYSFGFCHESIASLLSITNGSSR
NAISEVYKFFGIHSKHDLLMIFHTSRMHSLFFDELFFILKCAE
>sp|P54274|TRF1_HUMAN Telomeric repeat binding factor 1. 
MAEDVSSAAPSPRRCADGRDADPTEEQMAETERNDEEQFECQELLECQVQVGAPEEEEEE
EEDAGLVAEAEAVAAGWMLDFLCLSLCRAFRDGRSEDFRRTRNSAEAIIHGLSSLTACQL
RTIYICQFLTRIAAGKTLDAQFENDERITPLESALMIWGSIEKEHDKLHEEIQNLIKIQA
IAVCMENGNFKEAEEVFERIFGDPNSHMPFKSKLLMIISQKDTFHSFFQHFSYNHMMEKI
KSYVNYVLSEKSSTFLMKAAAKVVESKRTRTITSQDKPSGNDVEMETEANLDTRKSVSDK
QSAVTESSEGTVSLLRSHKNLFLSKLQHGTQQQDLNKKERRVGTPQSTKKKKESRRATES
RIPVSKSQPVTPEKHRARKRQAWLWEEDKNLRSGVRKYGEGNWSKILLHYKFNNRTSVML
KDRWRTMKKLKLISSDSED
>sp|P04575|UCP1_MESAU Mitochondrial brown fat uncoupling protein 1 (UCP 1) (Thermogenin). 
VNPTTSEVHPTMGVKIFSAGVAACLADIITFPLDTAKVRLQIQGEGQISSTIRYKGVLGT
ITTLAKTEGLPKLYSGLPAGIQRQISFASLRIGLYDTVQEYFSSGKETPPTLGNRISAGL
MTGGVAVFIGQPTEVVKVRLQAQSHLHGIKPRYTGTYNAYRIIATTESFSTLWKGTTPNL
LRNVIINCVELVTYDLMKGALVNNQILADDVPCHLLSAFVAGFCTTFLASPADVVKTRFI
NSLPGQYPSVPSCAMTMLTKEGPTAFFKGFVPSFLRLASWNVIMFVCFEQLKKELSKSRQ
TVDCTT
>sp|P23004|UCR2_BOVIN Ubiquinol-cytochrome C reductase complex core protein 2, mitochondrial 
MKLLTRAGSLSRFYSLKVAPKVKATEAPAGVPPHPQDLEFTRLPNGLVIASLENYAPASR
IGLFIKAGSRYENSNNLGTSHLLRLASSLTTKGASSFKITRGIEAVGGKLSVTSTRENMA
YTVECLRDDVDILMEFLLNVTTAPEFRRWEVAALQPQLRIDKAVALQNPQAHVIENLHAA
AYRNALANSLYCPDYRIGKVTPVELHDYVQNHFTSARMALIGLGVSHPVLKQVAEQFLNI
RGGLGLSGAKAKYHGGEIREQNGDSLVHAALVAESAAIGSAEANAFSVLQHVLGAGPHVK
RGSNATSSLYQAVAKGVHQPFDVSAFNASYSDSGLFGFYTISQAASAGDVIKAAYNQVKT
IAQGNLSNPDVQAAKNKLKAGYLMSVESSEGFLDEVGSQALAAGSYTPPSTVLQQIDAVA
DADVINAAKKFVSGRKSMAASGNLGHTPFIDEL
>sp|P00130|UCRX_BOVIN Ubiquinol-cytochrome C reductase complex 7.2 kDa protein (EC 1.10.2.2) 
VAPTLTARLYSLLFRRTSTFALTIVVGALFFERAFDQGADAIYEHINEGKLWKHIKHKYE
NK
>sp|P07552|UCRY_BOVIN Ubiquinol-cytochrome C reductase complex 6.4 kDa protein (EC 1.10.2.2) 
MLTRFLGPRYRQLARNWVPTASLWGAVGAVGLVWATDWRLILDWVPYINGKFKKDD
>sp|P35503|UD13_HUMAN UDP-glucuronosyltransferase 1-3 precursor, microsomal (EC 2.4.1.17) 
MATGLQVPLPWLATGLLLLLSVQPWAESGKVLVVPIDGSHWLSMREVLRELHARGHQAVV
LTPEVNMHIKEENFFTLTTYAISWTQDEFDRHVLGHTQLYFETEHFLKKFFRSMAMLNNM
SLVYHRSCVELLHNEALIRHLNATSFDVVLTDPVNLCAAVLAKYLSIPTVFFLRNIPCDL
DFKGTQCPNPSSYIPRLLTTNSDHMTFMQRVKNMLYPLALSYICHAFSAPYASLASELFQ
REVSVVDILSHASVWLFRGDFVMDYPRPIMPNMVFIGGINCANRKPLSQEFEAYINASGE
HGIVVFSLGSMVSEIPEKKAMAIADALGKIPQTVLWRYTGTRPSNLANNTILVKWLPQND
LLGHPMTRAFITHAGSHGVYESICNGVPMVMMPLFGDQMDNAKRMETKGAGVTLNVLEMT
SEDLENALKAVINDKSYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLRPAAH
DLTWYQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRKCLGKKGRVKKAHKSKTH
>sp|P35504|UD15_HUMAN UDP-glucuronosyltransferase 1-5 precursor, microsomal (EC 2.4.1.17) 
MATGLQVPLPQLATGLLLLLSVQPWAESGKVLVVPTDGSHWLSMREALRDLHARGHQVVV
LTLEVNMYIKEENFFTLTTYAISWTQDEFDRLLLGHTQSFFETEHLLMKFSRRMAIMNNM
SLIIHRSCVELLHNEALIRHLHATSFDVVLTDPFHLCAAVLAKYLSIPAVFFLRNIPCDL
DFKGTQCPNPSSYIPRLLTTNSDHMTFLQRVKNMLYPLALSYLCHAVSAPYASLASELFQ
REVSVVDLVSHASVWLFRGDFVMDYPRPIMPNMVFIGGINCANGKPLSQEFEAYINASGE
HGIVVFSLGSMVSEIPEKKAMAIADALGKIPQTVLWRYTGTRPSNLANNTILVKWLPQND
LLGHPMTRAFITHAGSHGVYESICNGVPMVMMPLFGDQMDNAKRMETKGAGVTLNVLEMT
SEDLENALKAVINDKSYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLRPAAH
DLTWYQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRKCLGKKGRVKKAHKSKTH
>sp|P36511|UDBC_RAT UDP-glucuronosyltransferase 2B12 precursor, microsomal (EC 2.4.1.17) 
MSGKWISALLLLQISFCFKSGNCGKVLVWPMEYSHWMNIKIILEELVQKGHEVTVLRPSA
FVFLDPKETSDLKFVTFPTSFSSHDLENFFTRFVNVWTYELPRDTCLSYFLYLQDTIDEY
SDYCLTVCKEAVSNKQFMTKLQESKFDVVFSDAIGPCGELIAELLQIPFLYSLRFSPGYT
IEQYIGGVLFPPSYVPMIFSGLAGQMTFIERVHNMICMLYFDFWFQTFREKKWDPFYSKT
LGRPTTLAEIMGKAEMWLIRSYWDLEFPHPISPNVDYIGGLHCKPAKPLPKDIEDFVQSS
GEHGVVVFSLGSMVRNMTEEKANIIAWALAQIPQKVLWRFDGKKPPTLGPNTRLYKWLPQ
NDLLGHPKTKAFVTHGGANGIYEAIHHGIPMIGIPLFAEQHDNIAHMVAKGAAVEVNFRT
MSKSDLLNALEEVIDNPFYKKNAMWLSTIHHDQPTKPLDRAVFWIEFVMRHKGAKHLRSL
GHNLPWYQYHSLDVIGFLLSCVAVTVVLALKCFLFVYRFFVKKEKKTKNE
>sp|P30530|UFO_HUMAN Tyrosine-protein kinase receptor UFO precursor (EC 2.7.1.112) (AXL 
MGRVPLAWCLALCGWACMAPRGTQAEESPFVGNPGNITGARGLTGTLRCQLQVQGEPPEV
HWLRDGQILELADSTQTQVPLGEDEQDDWIVVSQLRITSLQLSDTGQYQCLVFLGHQTFV
SQPGYVGLEGLPYFLEEPEDRTVAANTPFNLSCQAQGPPEPVDLLWLQDAVPLATAPGHG
PQRSLHVPGLNKTSSFSCEAHNAKGVTTSRTATITVLPQQPRNLHLVSRQPTELEVAWTP
GLSGIYPLTHCTLQAVLSDDGMGIQAGEPDPPEEPLTSQASVPPHQLRLGSLHPHPPYHI
RVACTSSQGPSSWTHWLPVETPEGVPLGPPENISATRNGSQAFVHWQEPRAPLQGTLLGY
RLAYQGQDTPEVLMDIGLRQEVTLELQGDGSVSNLTVCVAAYTAAGDGPWSLPVPLEAWR
PGEAQPVHQLVKEPSTPAFSWPWWYVLLGAVVAAACVLILALFLVHRRKKETRYGEVFEP
TVERGELVVRYRVRKSYSRRTTEATLNSLGISEELKEKLRDVMVDRHKVALGKTLGEGEF
GAVMEGQLNQDDSILKVAVKTMKIAICTRSELEDFLSEAVCMKEFDHPNVMRLIGVCFQG
SERESFPAPVVILPFMKHGDLHSFLLYSRLGGQPVYLPTQMLVKFMADIASGMEYLSTKR
FIHRDLAARNCMLNENMSVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYT
SKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPADCLDGLYALMSRCWE
LNPQDRPSFTELREDLENTLKALPPAQEPDEILYVNMDEGGGYPEPPGAAGGADPPTQPD
PKDSCSCLTAAEVHPAGRYVLCPSTTPSPAQPADRGSPAAPGQEDGA
>sp|P31407|VAB1_BOVIN Vacuolar ATP synthase subunit B, kidney isoform (EC 3.6.3.14) (V- 
MAAEVDSRPRGLPGGGASLGAAREHVQAVTRNYITHPRITYRTVCSVNGPLVVLDQVKFA
QYAEIVNFTLPNGTQRSGQVLEVSGTKAIVQVFEGTSGIDAQKTTCEFTGDILRTPVSED
MLGRVFNGSGKPIDKGPVVMAEDFLDINGQPINPHDRIYPEEMIETGISPIDVMNSIARG
QKIPIFSAAGLPHNEIAAQICRQAGLVKKSKAVLDYHDDNFAIVFAAMGVNMETARFFKS
DFEQNGTMGNVCLFLNLANDPTIERIITPRLALTTAEFLAYQCEKHVLVILTDMSSYAEA
LREVSAAREEVPGRRGFPGYMYTDLATIYERAGRVEGRGGSITQIPILTMPNDDITHPIP
DLTGFITEGQIYVDRQLHNRQIYPPINVLPSLSRLMKSAIGEGMTRKDHGDVSNQLYACY
AIGKDVQAMKAVVGEEALTSEDLLYLEFLQKFEKKFINQGPYEKRSVFESLDLGWKLLRT
FPKEMLKRIPQNIIDEFFSREGAPQDTEADTAL
>sp|P38078|VATA_CANTR Vacuolar ATP synthase catalytic subunit A (EC 3.6.3.14) (V-ATPase A 
MAGALENARKEIKRLSLDDTNESQYGQIYSVSGPVVIAENMIGCAMYELVKVGHDNLVGE
VIRINGDKATIQVYEETAGVTVGDPVLRTGKPLSVELGPGLMETIYDGIQRPLKAIKDES
QSIYIPRGIDVPALSRTVQYDFTPGQLKVGDHITGGDIFGSIYENSLLDDHKILLPPRAR
GTITSIAEAGSYNVEEPVLEVEFDGKKHKYSMMHTWPVRVPRPVAEKLTADHPLLTGQRV
LDSLFPCVQGGTTCIPGAFGCGKTVISQSLSKFSNSDVIIYVGCFTKGTQVMMADGADKS
IESIEVGDKVMGKDGMPREVVGLPRGYDDMYKVRQLSSTRRNAKSEGLMDFTVSADHKLI
LKTKQDVKIATRKIGGNTYTGVTFYVLEKTKTGIELVKAKTKVFGHHIHGQNGAEEKAAT
FAAGIDSKEYIDWIIEARDYVQVDEIVKTSTTQMINPVHFESGKLGNWLHEHKQNKSLAP
QLGYLLGTWAGIGNVKSSAFTMNSKDDVKLATRIMNYSSKLGMTCSSTESGELNVAENEE
EFFNNLGAEKDEAGDFTFDEFTDAMDELTINVHGAAASKKNNLLWNALKSLGFRAKSTDI
VKSIPQHIAVDDIVVRESLIAGLVDAAGNVETKSNGSIEAVVRTSFRHVARGLVKIAHSL
GIESSINIKDTHIDAAGVRQEFACIVNLTGAPLAGVLSKCALARNQTPVVKFTRDPVLFN
FDLIKSAKENYYGITLAEETDHQFLLSNMALVHNCGERGNEMAEVLMEFPELFTEISGRK
EPIMKRTTLVANTSNMPVAAREASIYTGITLAEYFRDQGKNVSMIADSSSRWAEALREIS
GRLGEMPADQGFPAYLGAKLASFYERAGKATALGSPDRVGSVSIVAAVSPAGGDFSDPVT
TSTLGITQVFWGLDKKLAQRKHFPSINTSVSYSKYTNVLNKYYDSNYPEFPQLRDKIREI
LSNAEELEQVVQLVGKSALSDSDKITLDVATLIKEDFLQQNGYSSYDAFCPIWKTFDMMR
AFISYYDEAQKAIANGAQWSKLAESTSDVKHAVSSAKFFEPSRGQKEGEKEFGDLLTTIS
ERFAEASE
>sp|P02856|VCL1_PEA Vicilin, 14 kDa component. 
DRRQELSNENVLVKVSRRQLEELSKNAKSSSRRSVSSESGPFNLRSEDPLYSNNSGKFFE
LTPEKNQQLQDLDLFVNSVDLKEGSLLLPNYNSRALLVLVLVVNEGKGDFELVGQRNENQ
GKEN
>sp|P22651|VGLC_HSVMM Secretory glycoprotein GP57-65 precursor (A antigen) (Glycoprotein A) 
MLTPRVLRALGWTGLFFLLLSPSNVLGASLSRDLETPPFLSFDPSNISINGAPLTEVPHA
PSTESVSTNSESTNEHTITETTGKNAYIHNNASTDKQNANDTHKTPNILCDTEEVFVFLN
ETGRFVCTLKVDPPSDSEWSNFVLDLIFNPIEYHANEKNVEAARIAGLYGVPGSDYAYPR
QSELISSIRRDPQGTFWTSPSPHGNKYFIWINKTTNTMGVEIRNVDYADNGYMQVIMRDH
FNRPLIDKHIYIRVCQRPASVDVLAPPVLSGENYKASCIVRHFYPPGSVYVSWRQNGNIA
TPRKDRDGSFWWFESGRGATLVSTITLGNSGIDFPPKISCLVAWKQGDMISTTNATAIPT
VYHHPRLSLAFKDGYAICTIECVPSEITVRWLVHDEAQPNTTYNTVVTGLCRTIDRHRNL
LSRIPVWDNWTKTKYTCRLIGYPFDEDKFQDSEYYDATPAARGTPMVITVTAVLGLAVIL
GMGIIMTALCLYNSTRKNIRL
>sp|Q02004|VGLM_DUGBV M polyprotein precursor [Contains: Glycoprotein G2; Nonstructural 
MSKRVLIIAVVVYLVFTTQNQITGNHTTINSSSPSTTEASSTPTVSRTPQTTTTSTAVST
TITATTTPTASWTTQSQYFNKTTQHHWREETMISRNPTVLDRQSRASSVRELLNTKFLML
LGFIPKGEVNHLENACNREGKNCTELILKERIARFFSETEKESCYNTYLEKHLRSVSPEV
SLTPYRVLGLREDILLKEIDRRIIRFETDSQRVTCLSASLLKPDVFIREQRIDAKPSNGP
KIVPVDSVACMNLEANVDVRSNKLVIQSLMTTVKISLKNCKVVVNSRQCIHQQTGSGVIK
VPKFEKQQGGTWSSYIAGVYTATIDLLDENNQNCKLFTECIVKGRELVKGQSELKSFNIE
VLLPRVMKTRRKLLAVTDGSTECNSGTQLIEGKSIEVHKQDIGGPGKKLTICNGTSVLDV
PLDEGHGCYTINVITSKRACRPKNSKLQCSIDKELKPCDSGKCLSISQKGAGHIKVSRGK
TILITECKEHCQIPVPTGKGDIMVDCSGGRQHYLEVNIVDIHCPNTKFLGGIMLYFCRMS
SRPTVALLLGIWIGCGYILTCIFSFLLYHLILFFANCIKQCRKKGERLGEICVKCEQQTV
NLMDQELHDLNCNFNLCPYCCNRMSDEGMSRHVGKCPKRLERLNEIELYLTTSECLCLSV
CYQLLISVGIFLKRTTWLVVLLVLLGLAISPVQGAPTEVSNVKQDGDYSICYFIFGCLVT
AALLLKVKRTNSNGIVVVVDSFGRCPYCNEFTDSLFEEVLHDTLCSLCVCPFCEKQALDL
VTLEEHVKECYKVATRKDIFKILGRKFTNALVRREKLFTTGLQLFINKTNVVVFALIMCF
LLLLTGHNASAFDSGDLPDGVWEESSQLVKSCTQFCYIEEDVCYCPAEDGVGRKLLFFNG
LQNSVKRLSDSHKLLTSVSIDAPWGRINVESTWKPTLAASNIAMSWSSTDIKGEKVILSG
RSTSIIKLKEKTGVMWKLVGSGLASEKKKPFRFPIMDFAQVYNSVFQYITGDRLLSEWPK
AVCTGDCPHRCGCQTSTCMAKECHTQECVSTHMVLGIGTGCTCCGMDVERPFNKYLGVKW
STEYLRTEVLVCVEVTEEERHCEIVEAGTRFNIGPITITISDPQNIGSKLPESLMTVQEI
DDSNFVDIMHVGNVISADNSCRLQSCTHGSAVTTRFTALTALIKDDHSSGLNLAVLDPKV
NSSWLSWEGCDMDYYCNVGDWPTCTYTGVVTQKLREFLKLDQHRKRLHTTLSFSLKKNLS
KRSHTSVRLEGKTVTRMEVKVTALIEVDGMELHSKTIRLSGIRLTGLKCSGCFSCTSGIS
CSVNAKLTSPDEFTLHLRSTSPNVVVAETSIIARKGPSATTSRFKVFSVRDTKKICFEVV
EREYCKDCTPDELTTCTGVELEPTKDILLEHRGTIVQHQNDTCKSKIDCWSNSISSFASG
IGDFFKHYIGSIAVGVLGTVLPFALLILFFIYGDKMLWPFKVFCRPCRRCCRKNEGYNKL
AEEEELRDIIRKFSKSGELINKDAKDKRTLARLFMSDNPKLKKEKKLSEIA
>sp|P35969|VGR1_MOUSE Vascular endothelial growth factor receptor 1 precursor (EC 2.7.1.112) 
MVSCWDTAVLPYALLGCLLLTGYGSGSKLKVPELSLKGTQHVMQAGQTLFLKCRGEAAHS
WSLPTTVSQEDKRLSITPPSACGRDNRQFCSTLTLDTAQANHTGLYTCRYLPTSTSKKKK
AESSIYIFVSDAGSPFIEMHTDIPKLVHMTEGRQLIIPCRVTSPNVTVTLKKFPFDTLTP
DGQRITWDSRRGFIIANATYKEIGLLNCEATVNGHLYQTNYLTHRQTNTILDVQIRPPSP
VRLLHGQTLVLNCTATTELNTRVQMSWNYPGKATKRASIRQRIDRSHSHNNVFHSVLKIN
NVESRDKGLYTCRVKSGSSFQSFNTSVHVYEKGFISVKHRKQPVQETTAGRRSYRLSMKV
KAFPSPEIVWLKDGSPATLKSARYLVHGYSLIIKDVTTEDAGDYTILLGIKQSRLFKNLT
ATLIVNVKPQIYEKSVSSLPSPPLYPLGSRQVLTCTVYGIPRPTITWLWHPCHHNHSKER
YDFCTENEESFILDPSSNLGNRIESISQRMTVIEGTNKTVSTLVVADSQTPGIYSCRAFN
KIGTVERNIKFYVTDVPNGFHVSLEKMPAEGEDLKLSCVVNKFLYRDITWILLRTVNNRT
MHHSISKQKMATTQDYSITLNLVIKNVSLEDSGTYACRARNIYTGEDILRKTEVLVRDSE
APHLLQNLSDYEVSISGSTTLDCQARGVPAPQITWFKNNHKIQQEPGIILGPGNSTLFIE
RVTEEDEGVYRCRATNQKGAVESAAYLTVQGTSDKSNLELITLTCTCVAATLFWLLLTLF
IRKLKRSSSEVKTDYLSIIMDPDEVPLDEQCERLPYDASKWEFARERLKLGKSLGRGAFG
KVVQASAFGIKKSPTCRTVAVKMLKEGATASEYKALMTELKILTHIGHHLNVVNLLGACT
KQGGPLMVIVEYCKYGNLSNYLKSKRDLFCLNKDAALHMELKKESLEPGLEQGQKPRLDS
VSSSSVTSSSFPEDRSVSDVEGDEDYSEISKQPLTMEDLISYSFQVARGMEFLSSRKCIH
RDLAARNILLSENNVVKICDFGLARDIYKNPDYVRRGDTRLPLKWMAPESIFDKVYSTKS
DVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRLKEGMRMRTPEYATPEIYQIMLDCWHKD
PKERPRFAELVEKLGDLLQANVQQDGKDYIPLNAILTRNSSFTYSTPTFSEDLFKDGFAD
PHFHSGSSDDVRYVNAFKFMSLERIKTFEELSPNSTSMFEDYQLDTSTLLGSPLLKRFTW
TETKPKASMKIDLRIASKSKEAGLSDLPRPSFCFSSCGHIRPVQDDESELGKESCCSPPP
DYNSVVLYSSPPA
>sp|P27382|VP11_BPPRD Infectivity protein P11. 
MVGSGPVYQQAGSGAWITLWRLLPCKPIRNYSAQNAQLQAQMDASRLQLETQLNIETLAA
DNAHYSTQSQLQLGMAQVDLSKYLGDLQSTTSTALAGMQSDTAKYQSNIQLQAENIRANT
SLAEIDAQKYIVGKQADIAKYQAKTERRGQDYGFALGLLNFGGKFF
>sp|Q00254|VS09_ROTBK Glycoprotein VP7 (Serotype-specific antigen) (Outer shell 
MYGIEYTTFLIYLISIILFNYILKSITRMMDYIIYKFLLIVTITSIVVNAQNYGVNLPIT
GSMDTSYVNATKGKPFLTSTLCLYYPTEARTEINDNEWTNTLSQLFLTKGWPTGSVYFKE
YDDIATFSVDPQLYCDYNIVLMRYNSNLELDMSELANLILNEWLCNPMDITLYYYQQTDE
ANKWIAMGQSCTIKVCPLNTQTLGIGCQTTNTRTFEEVATAEKLVITDVVDGVNHKLDVT
TATCTIRNCKKLGPRENVAVIQVGGADILDITSDPTTNPQTERIMRINWKKWWQVFYTIV
DYVNQIVQAMSKRSRSLNSAAFYYRV
